<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">51685</article-id><article-id pub-id-type="doi">10.7554/eLife.51685</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cell Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Neuroscience</subject></subj-group></article-categories><title-group><article-title><italic>C9orf72</italic> arginine-rich dipeptide repeat proteins disrupt karyopherin-mediated nuclear import</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="author-156273"><name><surname>Hayes</surname><given-names>Lindsey R</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-4818-6054</contrib-id><email>lhayes@jhmi.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-158701"><name><surname>Duan</surname><given-names>Lauren</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-158702"><name><surname>Bowen</surname><given-names>Kelly</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" equal-contrib="yes" id="author-158703"><name><surname>Kalab</surname><given-names>Petr</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-8145-7728</contrib-id><email>petr@jhu.edu</email><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes" id="author-37612"><name><surname>Rothstein</surname><given-names>Jeffrey D</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution>Department of Neurology, Johns Hopkins University School of Medicine</institution><addr-line><named-content content-type="city">Baltimore</named-content></addr-line><country>United States</country></aff><aff id="aff2"><label>2</label><institution>Brain Science Institute, Johns Hopkins University School of Medicine</institution><addr-line><named-content content-type="city">Baltimore</named-content></addr-line><country>United States</country></aff><aff id="aff3"><label>3</label><institution>Department of Psychological and Brain Sciences, Krieger School of Arts and Sciences, Johns Hopkins University</institution><addr-line><named-content content-type="city">Baltimore</named-content></addr-line><country>United States</country></aff><aff id="aff4"><label>4</label><institution>Department of Chemical and Biomolecular Engineering, Whiting School of Engineering, Johns Hopkins University</institution><addr-line><named-content content-type="city">Baltimore</named-content></addr-line><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Cleveland</surname><given-names>Don W</given-names></name><role>Reviewing Editor</role><aff><institution>University of California, San Diego</institution><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Zoghbi</surname><given-names>Huda Y</given-names></name><role>Senior Editor</role><aff><institution>Texas Children's Hospital</institution><country>United States</country></aff></contrib></contrib-group><author-notes><fn fn-type="con" id="equal-contrib1"><label>†</label><p>These authors contributed equally to this work</p></fn></author-notes><pub-date date-type="publication" publication-format="electronic"><day>02</day><month>03</month><year>2020</year></pub-date><pub-date pub-type="collection"><year>2020</year></pub-date><volume>9</volume><elocation-id>e51685</elocation-id><history><date date-type="received" iso-8601-date="2019-09-06"><day>06</day><month>09</month><year>2019</year></date><date date-type="accepted" iso-8601-date="2020-02-17"><day>17</day><month>02</month><year>2020</year></date></history><permissions><copyright-statement>© 2020, Hayes et al</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>Hayes et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-51685-v1.pdf"/><abstract><p>Disruption of nucleocytoplasmic transport is increasingly implicated in the pathogenesis of neurodegenerative diseases, including ALS caused by a <italic>C9orf72</italic> hexanucleotide repeat expansion. However, the mechanism(s) remain unclear. Karyopherins, including importin β and its cargo adaptors, have been shown to co-precipitate with the <italic>C9orf72</italic> arginine-containing dipeptide repeat proteins (R-DPRs), poly-glycine arginine (GR) and poly-proline arginine (PR), and are protective in genetic modifier screens. Here, we show that R-DPRs interact with importin β, disrupt its cargo loading, and inhibit nuclear import of importin β, importin α/β, and transportin cargoes in permeabilized mouse neurons and HeLa cells, in a manner that can be rescued by RNA. Although R-DPRs induce widespread protein aggregation in this in vitro system, transport disruption is not due to nucleocytoplasmic transport protein sequestration, nor blockade of the phenylalanine-glycine (FG)-rich nuclear pore complex. Our results support a model in which R-DPRs interfere with cargo loading on karyopherins.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>nucleocytoplasmic transport</kwd><kwd>amyotrophic lateral sclerosis</kwd><kwd>importin beta</kwd><kwd>dipeptide repeat proteins</kwd><kwd>karyopherins</kwd><kwd>C9orf72</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000065</institution-id><institution>National Institute of Neurological Disorders and Stroke</institution></institution-wrap></funding-source><award-id>K08NS104273</award-id><principal-award-recipient><name><surname>Hayes</surname><given-names>Lindsey R.</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000065</institution-id><institution>National Institute of Neurological Disorders and Stroke</institution></institution-wrap></funding-source><award-id>R01NS094239</award-id><principal-award-recipient><name><surname>Rothstein</surname><given-names>Jeffrey D</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000065</institution-id><institution>National Institute of Neurological Disorders and Stroke</institution></institution-wrap></funding-source><award-id>P01NS099114</award-id><principal-award-recipient><name><surname>Rothstein</surname><given-names>Jeffrey D</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000049</institution-id><institution>National Institute on Aging</institution></institution-wrap></funding-source><award-id>RF1AG062171</award-id><principal-award-recipient><name><surname>Rothstein</surname><given-names>Jeffrey D</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Poly-PR and poly-GR interact with importin β, disrupt importin-cargo loading, and inhibit nuclear import in permeabilized cells in a manner that can be rescued by RNA.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>A GGGGCC hexanucleotide repeat expansion (HRE) in <italic>C9orf72</italic> is the most common known cause of amyotrophic lateral sclerosis (ALS) and is also a major cause of frontotemporal dementia (FTD) and the ALS/FTD overlap syndrome (<xref ref-type="bibr" rid="bib13">DeJesus-Hernandez et al., 2011</xref>; <xref ref-type="bibr" rid="bib67">Renton et al., 2011</xref>; <xref ref-type="bibr" rid="bib51">Majounie et al., 2012</xref>). The <italic>C9orf72</italic> HRE is thought to cause disease by a toxic gain of function involving expanded repeat RNA and dipeptide repeat proteins (DPRs) produced by repeat-associated (non-AUG) translation, although a modest reduction in C9ORF72 protein is also seen (reviewed by <xref ref-type="bibr" rid="bib12">Cook and Petrucelli, 2019</xref>). Predicted products of <italic>C9orf72</italic> HRE translation in both the sense (poly-GP, poly-GA, poly-GR) and antisense (poly-GP, poly-PR, poly-PA) directions have been identified in postmortem tissue (<xref ref-type="bibr" rid="bib94">Zu et al., 2013</xref>; <xref ref-type="bibr" rid="bib2">Ash et al., 2013</xref>; <xref ref-type="bibr" rid="bib48">Mackenzie et al., 2013</xref>; <xref ref-type="bibr" rid="bib20">Gendron et al., 2013</xref>), and overexpression of a subset of DPRs, including poly-GA and the arginine-containing DPRs poly-GR and poly-PR (R-DPRs), is toxic in cell culture (<xref ref-type="bibr" rid="bib53">May et al., 2014</xref>; <xref ref-type="bibr" rid="bib82">Wen et al., 2014</xref>) and animal models (<xref ref-type="bibr" rid="bib90">Zhang et al., 2016</xref>; <xref ref-type="bibr" rid="bib91">Zhang et al., 2018</xref>; <xref ref-type="bibr" rid="bib92">Zhang et al., 2019</xref>).</p><p>Growing evidence suggests that disruption of nucleocytoplasmic transport (NCT), the regulated trafficking of proteins and ribonucleoprotein complexes between the nucleus and cytoplasm, is a major pathophysiologic mechanism in neurodegenerative diseases (reviewed by <xref ref-type="bibr" rid="bib30">Hutten and Dormann, 2019</xref>). Bidirectional NCT across the nuclear envelope occurs through nuclear pore complexes (NPC), which are large (125 MDa) assemblies comprised of multiple copies of ~30 different nucleoporins (Nups) (<xref ref-type="bibr" rid="bib66">Reichelt et al., 1990</xref>). Although small cargoes passively equilibrate across the NPC, larger cargoes are increasingly excluded by a matrix of natively unfolded phenylalanine-glycine (FG)-rich nucleoporins lining the central channel (<xref ref-type="bibr" rid="bib55">Mohr et al., 2009</xref>; <xref ref-type="bibr" rid="bib77">Timney et al., 2016</xref>; <xref ref-type="bibr" rid="bib18">Frey et al., 2018</xref>). Transport of restricted cargoes requires karyopherins (also known as nuclear transport receptors), including importins (importins and transportins), exportins, and bidirectional transporters that mediate the rapid transport of cargo through the FG-barrier (reviewed by <xref ref-type="bibr" rid="bib3">Baade and Kehlenbach, 2019</xref>). The small GTPase Ran dictates the directionality of transport via a steep concentration gradient of RanGTP across the nuclear membrane, established by the nuclear guanine nucleotide exchange factor RCC1 and the cytoplasmic GTPase-activating protein RanGAP1. Nuclear RanGTP promotes importin-cargo unloading and exportin-cargo complex assembly, while the cytoplasmic conversion of RanGTP to RanGDP disassembles exportin-cargo complexes and enables importin-cargo binding.</p><p>We and others have found evidence of NPC and NCT disruption in postmortem tissue and animal models of <italic>C9orf72-</italic>ALS, Alzheimer’s disease, and Huntington's disease, including mislocalization and loss of Nups and disruption of the Ran gradient (<xref ref-type="bibr" rid="bib89">Zhang et al., 2015</xref>; <xref ref-type="bibr" rid="bib23">Grima et al., 2017</xref>; <xref ref-type="bibr" rid="bib15">Eftekharzadeh et al., 2018</xref>). The functional implications of this pathology for NCT, and consequences for neuronal survival, remain largely unknown. However, cytoplasmic aggregates of amyloid-like proteins, including artificial β-sheet proteins and poly-GA, have been reported to sequester Nups, karyopherins, and other components of the NCT machinery in cell culture models, associated with nuclear transport deficits (<xref ref-type="bibr" rid="bib83">Woerner et al., 2016</xref>; <xref ref-type="bibr" rid="bib37">Khosravi et al., 2016</xref>). Interactome screens have also shown that <italic>C9orf72</italic> R-DPRs co-precipitate NPC and NCT proteins, notably importins, including importin β, its importin α family of cargo adaptors, and transportin (<xref ref-type="bibr" rid="bib42">Lee et al., 2016</xref>; <xref ref-type="bibr" rid="bib44">Lin et al., 2016</xref>; <xref ref-type="bibr" rid="bib87">Yin et al., 2017</xref>). <italic>C9orf72</italic> genetic modifier screens in <italic>Drosophila,</italic> yeast, and neurons have also identified a beneficial role for this class of proteins (<xref ref-type="bibr" rid="bib89">Zhang et al., 2015</xref>; <xref ref-type="bibr" rid="bib16">Freibaum et al., 2015</xref>; <xref ref-type="bibr" rid="bib33">Jovičić et al., 2015</xref>; <xref ref-type="bibr" rid="bib5">Boeynaems et al., 2016</xref>; <xref ref-type="bibr" rid="bib39">Kramer et al., 2018</xref>). However, direct interactions between R-DPRs and importins, and consequences for nuclear transport, remain to be explored.</p><p>Importins represent the largest group of karyopherins (16 out of more than 20 in vertebrates) and they operate in parallel to transport a repertoire of distinct cargoes defined by their nuclear localization signals (NLS) (reviewed by <xref ref-type="bibr" rid="bib3">Baade and Kehlenbach, 2019</xref>; <xref ref-type="bibr" rid="bib61">Oka and Yoneda, 2018</xref>). While importin β (KPNB1) binds directly to a subset of cargoes, most cargoes are loaded on importin β via a heterodimer with importin α (KPNA2 and 6 others in humans). The C-terminal NLS-binding site of free importins α is autoinhibited by the N-terminal importin β-binding domain (IBB), and unmasked upon binding to importin β, enabling cargo recognition and formation of the trimeric import complex (cargo•importin α•importin β) (reviewed by <xref ref-type="bibr" rid="bib46">Lott and Cingolani, 2011</xref>). A wide array of importin α/β cargoes have been reported (<xref ref-type="bibr" rid="bib3">Baade and Kehlenbach, 2019</xref>), including TDP-43, a nuclear DNA/RNA-binding protein that mislocalizes to the cytoplasm and forms pathologic aggregates in &gt;97% of ALS cases (<xref ref-type="bibr" rid="bib58">Neumann et al., 2006</xref>; <xref ref-type="bibr" rid="bib49">Mackenzie et al., 2014</xref>). Transportins-1 and -2 are a class of importins that bind cargoes directly and with considerable overlap based on the PY-NLS consensus sequence, found in cargoes such as hnRNPs and FUS (reviewed by <xref ref-type="bibr" rid="bib75">Soniat and Chook, 2015</xref>). Notably, the NLSs recognized by importin α (mono- and bipartite) or directly by importin β, the PY-NLS, and the importin α IBB (a disordered region that is also a functional NLS), are all enriched in arginine and lysine residues that mediate high-affinity interactions within nuclear import complexes. We hypothesized that R-DPRs may mimic these arginine-and lysine-rich domains, binding either to the import cargoes or their carriers, and disrupting the formation of importin•cargo complexes.</p><p>Here, we took advantage of well-characterized fluorescent probes, FRET techniques and biochemical assays to investigate R-DPR-mediated effects on the importin β pathway, and show that R-DPRs bind importin β, disrupt importin β•IBB interactions, and confer dose- and length-dependent disruption of importin β-mediated nuclear import in the permeabilized cell assay. As predicted, R-DPRs also disrupt transportin-dependent nuclear import. R-DPRs rapidly induce aggregate formation within the transport assay, which recruit numerous RNA-binding and ribosomal proteins, as well as NPC and NCT proteins. However, by separating the soluble and insoluble phases of the reaction, we show that transport disruption in this model is not due to sequestration of NCT components, nor blockade of the FG-permeability barrier, but due to perturbation of importins in the vicinity of the nuclear envelope, an effect that is reversible by RNA. Notably, the behavior of GR and PR differed in many of our assays, with PR overall acting as a more potent and selective inhibitor.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>R-DPRs bind importin β and inhibit nuclear import</title><p>Although importin β has been shown to co-precipitate with poly-GR and poly-PR, a direct interaction between R-DPRs and importin β has not been demonstrated, and the consequences for functional nuclear import are unknown. To test for an interaction between <italic>C9orf72</italic> DPRs and importin β, we used a variant of the FRET sensor Rango (‘<underline>Ran</underline>-regulated importin β car<underline>go</underline>’) (<xref ref-type="bibr" rid="bib34">Kaláb et al., 2006</xref>), which consists of the IBB domain of importin α1 (KPNA2), flanked by CyPet (donor) and YPet (acceptor). When bound to importin β (KPNB1), Rango FRET is low, but in the presence of RanGTP, importin β is displaced from the sensor and FRET increases (<xref ref-type="fig" rid="fig1">Figure 1A–C</xref>). Since conserved arginine and lysine residues of the IBB domain are required for binding to importin β (<xref ref-type="bibr" rid="bib22">Görlich et al., 1996</xref>; <xref ref-type="bibr" rid="bib81">Weis et al., 1996</xref>; <xref ref-type="bibr" rid="bib10">Cingolani et al., 1999</xref>), we hypothesized that the arginine-rich DPRs could bind to the corresponding sites on importin β and compete with the IBB. Synthetic GP10, GA10, and PA10 peptides did not affect Rango FRET even at high concentrations (<xref ref-type="fig" rid="fig1">Figure 1D</xref>). However, we observed a dose-dependent increase in FRET with low-nanomolar GR10 and PR10, indicating these DPRs are capable of binding to importin β and displacing the sensor. To further validate this observation, we used GFP nanobody-coated beads to bind Rango and probe for co-immunoprecipitation of importin β in the presence of increasing concentrations of DPRs (<xref ref-type="fig" rid="fig1">Figure 1E–F</xref>). We observed the dose-dependent displacement of importin β from the sensor at low nanomolar concentrations of GR10 and PR10, with little if any effect of GP10, GA10, or PA10, confirming that Rango release is responsible for the increases in FRET.</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>R-DPRs bind importin β and inhibit nuclear import.</title><p>(<bold>A</bold>) Schematic of Rango FRET sensor, consisting of the importin β-binding domain (IBB) of importin α1 (KPNA2), flanked by CyPET (donor) and YPet (acceptor). (<bold>B–C</bold>) Rango spectral profile (<bold>B</bold>) and FRET ratio (<bold>C</bold>) demonstrating increase in FRET by adding hydrolysis-deficient Ran-Q69L-GTP to importin β-bound Rango (representative of three experiments). (<bold>D</bold>) Change in Rango FRET ratio induced by adding DPRs (10-mers) to importin β-bound Rango (representative of five experiments, data in C-D fit to non-linear model with one binding site). (<bold>E</bold>) GFP-trap co-immunoprecipitation of importin β by Rango in the presence of GR10 and PR10. (<bold>F</bold>) Quantification of Rango-bound importin β in (<bold>E</bold>), normalized to Rango and expressed as a fraction of untreated lysate (mean ± SD, three technical replicates, legend as in D). (<bold>G</bold>) Diagram of permeabilized cell nuclear import assay, which was adapted and validated for primary neurons (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>). (<bold>H</bold>) Longitudinal wide-field images of Rango import in permeabilized mouse primary cortical neurons. Scale bar = 10 µm. (<bold>I–J</bold>) Nuclear to cytoplasmic (N/C) ratio of Rango import in (<bold>H</bold>), calculated by automated high content analysis. GR and PR graphs are separated for clarity; the control values are identical. All data are normalized to cells lacking energy/lysate and expressed as percent untreated controls (mean ± SEM of n = 4 biological replicates, 189 ± 125 cells per data point). (<bold>K</bold>) Steady state N/C ratio of Rango in primary neurons fixed after 2 hr (mean ± SEM of n = 7 biological replicates, 409 ± 202 cells per data point, *p&lt;0.05, **p&lt;0.01, ****p&lt;0.001 vs. untreated cells, one-way ANOVA with Dunnett’s post hoc test). (<bold>L</bold>) IC50 of R-DPRs for inhibition of nuclear import of designated cargoes, from (<bold>K</bold>) and <xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2</xref>. 95% confidence intervals are shown (n = 3–6 biological replicates/condition, 409 ± 202 cells/ replicate for neurons, 1290 ± 305 cells/replicate for HeLa).&gt;20 denotes conditions for which the IC50 was not reached up to the highest dose tested (20 µM). See source file for raw data and exact p values.</p><p> <supplementary-material id="fig1sdata1"><label>Figure 1—source data 1.</label><caption><title>Raw data and p values for data in <xref ref-type="fig" rid="fig1">Figure 1</xref> and supplements.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-51685-fig1-data1-v1.xlsx"/></supplementary-material> </p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-51685-fig1-v1.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Neuron permeabilized cell assay validation.</title><p>(<bold>A</bold>) Mouse primary cortical neurons were permeabilized with hypotonic buffer + BSA cushion, and incubated for 2 hr with 200 nM Rango and 70 kD Texas Red dextran in the indicated conditions. Scale bar = 5 µm. (<bold>B</bold>) The automated method for N/C ratio determination calculates the mean intensity at a defined distance inside and outside the nuclear rim (inset; nuclear boundaries determined by Hoechst signal). Representative raw data are shown for conditions in (<bold>A</bold>), from a single well of a 96-well plate. (<bold>C</bold>) N/C ratio of Rango import in neurons treated with 100 µM GP10, GA10, PA10, or importazole (IPZ). All data are normalized to cells lacking energy/lysate and expressed as percent untreated controls (mean ± SEM of n = 4 biological replicates, 278 ± 238 cells per data point). See source file for raw data.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-51685-fig1-figsupp1-v1.tif"/></fig><fig id="fig1s2" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 2.</label><caption><title>Extended HeLa nuclear import data.</title><p>Diagram of cargo import mechanisms and HeLa nuclear import data in the presence of increasing concentrations of DPR 10- and 20-mers, at steady state (2 hr for Rango (<bold>A–C</bold>), 4 hr for NLS-GFP (<bold>D–F</bold>), and 2 hr for M9 (<bold>G–I</bold>)). These data correspond to those summarized in the table in <xref ref-type="fig" rid="fig1">Figure 1L</xref>. Mean ± SEM is shown, n ≥ 3 biological replicates for R-DPRs, n ≥ 2 biological replicates for GP, GA, and PA. 1209 ± 305 cells per replicate, *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001 vs. untreated cells, one-way ANOVA with Dunnett’s post-hoc test. See source file for raw data and exact p values.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-51685-fig1-figsupp2-v1.tif"/></fig></fig-group><p>To test the functional consequence of R-DPR-importin β interactions for nuclear import, we performed the permeabilized cell assay (<xref ref-type="bibr" rid="bib1">Adam et al., 1990</xref>), in which the plasma membrane of cultured cells is selectively permeabilized, leaving the nuclear membrane intact as verified by nuclear exclusion of 70 kD dextran (<xref ref-type="fig" rid="fig1">Figure 1G</xref>). Fluorescent transport cargo is then added, with energy regeneration mix and cell lysate to provide a source of importins and Ran for nuclear import, which is measured by increasing nuclear fluorescence. Traditionally, this method uses digitonin for permeabilization; however, when attempted with primary mouse cortical neurons, we found that even minimal concentrations of digitonin opened both the plasma and nuclear membranes. Since the nuclear envelope is devoid of the digitonin target cholesterol (<xref ref-type="bibr" rid="bib11">Colbeau et al., 1971</xref>; <xref ref-type="bibr" rid="bib1">Adam et al., 1990</xref>), we reasoned that its rupture in permeabilized neuronal cells was caused by mechanical perturbation upon depletion of cytoplasmic proteins. Therefore, we developed a protocol of rapid hypotonic cell opening in the presence of a concentrated BSA cushion, which protected the nucleus against rupture and facilitated the selective plasma membrane opening of neurons (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>).</p><p>Using this method, we performed live imaging of nuclear import of Rango, a direct importin β cargo whose Ran-, importin β-, and energy-dependent nuclear translocation is conferred by the IBB domain (<xref ref-type="bibr" rid="bib34">Kaláb et al., 2006</xref>). We verified that Rango import in permeabilized neurons is indeed dependent on energy and cell lysate, and can be inhibited by the importin β small molecule inhibitor, importazole (IPZ; <xref ref-type="bibr" rid="bib74">Soderholm et al., 2011</xref>) in primary cortical neurons (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>). Time-lapse imaging of Rango import for 30 min in permeabilized neurons showed no effect of GP10, GA10, or PA10 at up to 100 µM, whereas GR10 and PR10 showed dose-dependent inhibition of transport (<xref ref-type="fig" rid="fig1">Figure 1H–J</xref>, <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>). The reaction was allowed to reach steady-state and fixed at 2 hr, at which point we observed statistically significant transport inhibition beginning at 25 µM for both GR and PR (<xref ref-type="fig" rid="fig1">Figure 1K</xref>), with estimated IC50s as shown in <xref ref-type="fig" rid="fig1">Figure 1L</xref>. In contrast, only trace inhibition by GA10 and PA10 was seen even at 100 µM, and there was no effect of 100 µM GP10. To facilitate testing of a broader range of cargoes and concentrations, we performed the assay in HeLa cells, with similar results to those seen in neurons (<xref ref-type="fig" rid="fig1">Figure 1L</xref> and <xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2</xref>). To verify that the behavior of Rango in nuclear import signals indeed corresponds to endogenous importin α/β complexes, we tested the effect of DPRs on import of GST-GFP-NLS (hereafter referred to as GFP-NLS), a similarly sized cargo that is loaded on importin β-bound importin α. Consistent with the expected lower efficiency of tripartite nuclear import complex assembly, R-DPRs perturbed GFP-NLS import even more strongly than that of Rango (<xref ref-type="fig" rid="fig1">Figure 1L</xref> and <xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2</xref>).</p><p>The mechanisms of cargo recognition for importin β differ even from its structurally closest relative transportin, whose cargos are marked by the PY-NLS motif (<xref ref-type="bibr" rid="bib41">Lee et al., 2006</xref>). However, since the sequence of the PY-NLS also contains basic residues, we tested the effect of R-DPRs on the nuclear import of YFP-M9-CFP (hereafter referred to as M9), a transportin substrate based on the prototypic PY-NLS sequence of hnRNPA1 (<xref ref-type="bibr" rid="bib73">Siomi and Dreyfuss, 1995</xref>; <xref ref-type="fig" rid="fig1">Figure 1L</xref> and <xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2</xref>). Similar to the importin cargoes, M9 nuclear import in permeabilized HeLa cells was selectively inhibited by R-DPRs, which was more potent for PR than GR and approximately threefold more potent on average for 20mers than 10mers. Taken together, these results confirm that R-DPRs inhibit importin β-, importin α/β- and transportin-mediated nuclear import in this in vitro model system.</p></sec><sec id="s2-2"><title>R-DPRs interact with importin β in the bead halo assay</title><p>To further validate the direct interaction between R-DPRs and importin β, we performed the bead halo assay. This equilibrium-based binding assay is capable of identifying both low- and high-affinity interactions between ‘bait’ proteins immobilized to beads, and fluorescent ‘prey’ in the surrounding buffer, which forms a fluorescent halo on the bead surface (<xref ref-type="bibr" rid="bib63">Patel et al., 2007</xref>; <xref ref-type="bibr" rid="bib64">Patel and Rexach, 2008</xref>). First, we examined the propensity for all five DPRs to interact with biotinylated importin β, immobilized on the surface of neutravidin beads (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). To quantify non-specific binding, we also tested bare beads and beads coated with biotinylated BSA. Confirming the specificity of the assay, the Rango sensor exclusively bound to importin β-coated beads, and neither of the control beads. Fluorescent dextran did not form a halo in any conditions. AF488-labeled PR10 and GR10 (200 nM) both showed modest non-specific binding to bare and BSA-coated beads, despite adjustments to pH, salt concentration, and the addition of detergent and BSA to minimize non-specific interactions. However, the R-DPR halo around importin β-coated beads was approximately two-fold more intense than controls (<xref ref-type="fig" rid="fig2">Figure 2B</xref>), as quantified by the ratio of the fluorescent rim of the beads (the intensity around the surface of the beads at their equator) to the background fluorescence (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>). When 1 mg/ml neuronal lysate was added to test the stringency of the interaction, all binding between GR10 and the beads, including importin β, was lost (<xref ref-type="fig" rid="fig2">Figure 2C–D</xref>). For PR10, nonspecific binding decreased, but the intensity of the importin β halo persisted (and even slightly increased, perhaps due to recruitment of additional importin β- and PR-binding partners from the lysate). To further support the specificity of the observed interactions, we also tested the ability of free (unlabeled) importin β to compete for R-DPR binding to the importin β-coated beads, and saw that the haloes could be readily dispersed in a concentration-dependent manner (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2</xref>). These findings further support a direct interaction between R-DPRs and importin β, while indicating a higher relative selectivity of PR for importin β, compared to GR.</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>R-DPRs bind importin β in the bead halo assay.</title><p>(<bold>A</bold>) Confocal images of AF488-labeled <italic>C9orf72</italic> DPRs added to neutravidin beads coated with biotinylated ‘bait’ proteins, in binding buffer or in the presence of 1 mg/ml neuron lysate (at right). FITC-dextran = negative control (-), Rango sensor = positive control (+). Scale bar = 4 µm. <bold>B</bold> Rim vs. background ratio in binding buffer (see <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref> for quantification method). (<bold>C–D</bold>) Rim vs. background ratio for GR10 (<bold>C</bold>) and PR10 (<bold>D</bold>) in 1 mg/ml neuron lysate. In <bold>B–D</bold>, mean ± SEM is shown for n = 20 beads (5 intensity profiles/bead). **p&lt;0.01, ***p&lt;0.001 vs. control beads by two-way ANOVA with Tukey post-hoc test. See source file for raw data and exact p values.</p><p> <supplementary-material id="fig2sdata1"><label>Figure 2—source data 1.</label><caption><title>Raw data and p values for data in <xref ref-type="fig" rid="fig2">Figure 2</xref> and supplements.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-51685-fig2-data1-v1.xlsx"/></supplementary-material> </p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-51685-fig2-v1.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Quantification method for bead halo assay.</title><p>Examples of line intensity profiles for control versus PR10 beads (Fiji), with rim vs. background levels indicated.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-51685-fig2-figsupp1-v1.tif"/></fig><fig id="fig2s2" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 2.</label><caption><title>Free importin β competes for R-DPR binding to importin β-coated beads.</title><p>(<bold>A</bold>) Confocal images of AF488-labeled GR10 and PR10 added to neutravidin beads coated with biotinylated proteins as indicated, in assay buffer or in the presence of increasing concentrations of free (unlabeled) importin β. Scale bar = 4 µm. (<bold>B–C</bold>) Rim vs. background ratio in binding buffer for GR10 (<bold>B</bold>) and PR10 (<bold>C</bold>) ± free importin β. In B-C, mean ± SEM is shown for n = 20 beads (5 intensity profiles/bead). ***p&lt;0.001 (vs. no importin β) by one-way ANOVA with Tukey post-hoc test. See source file for raw data and exact p values.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-51685-fig2-figsupp2-v1.tif"/></fig></fig-group></sec><sec id="s2-3"><title>R-DPRs do not block passive nuclear influx</title><p>To test if the disruption of nuclear import resulted from changes in the passive exclusion limit of NPCs, we tested the effects of R-DPRs on the passive influx of small cargoes. Passive diffusion of GFP and small fluorescent dextrans into the nuclei of permeabilized HeLa cells was imaged at 10 s intervals for 5 min, and nuclear fluorescence quantified over time. All experiments were done in the context of energy and cell lysate, identical to the active transport conditions, so as not to miss putative effects that may depend on simultaneous active transport (i.e. recruitment of importins and DPRs to the NPC). Under these conditions, we observed the expected differences in the rates of passive influx of 10-, 40-, and 70-kD dextrans, and verified that addition of energy and lysate did not affect the baseline rate of passive influx of GFP (27 kD, no NLS) (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>). When we preincubated permeabilized nuclei with high concentrations of R-DPR 10mers or 20mers for 30–60 min, we observed no slowing of passive nuclear influx (<xref ref-type="fig" rid="fig3">Figure 3</xref>). Instead, R-DPRs caused apparent acceleration of the nuclear influx of both GFP and 40-kD dextran, an effect that was specific to R-DPRs and not observed for GP10, GA10, or PA10 (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>).</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>PR and GR accelerate passive nuclear influx.</title><p>(<bold>A</bold>) Confocal time-lapse imaging of GFP nuclear influx in permeabilized HeLa cells following ≥ 30 min. incubation with buffer (untreated), 20 µM GR20, 20 µM PR20, or 0.8 mg/ml wheat germ agglutinin (WGA, positive control). Scale bar = 10 µm. (<bold>B–C</bold>) Nuclear GFP (<bold>B</bold>) and 40 kD dextran (<bold>C</bold>) intensity normalized to background fluorescence, expressed vs. time 0 (no influx = 1). GR and PR are separated for clarity; the control values are identical. All experiments included lysate and energy. See <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref> for validation of assay conditions and non-R-DPR testing, and <xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2</xref> for binding studies with FG-domains which contribute to the NPC selectivity barrier. Data are mean ± SEM for n = 3–6 biological replicates/condition (20–30 cells/replicate). *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001 vs. untreated cells at 5 min by one-way ANOVA with Dunnett’s post hoc test. See source file for raw data and exact p values.</p><p> <supplementary-material id="fig3sdata1"><label>Figure 3—source data 1.</label><caption><title>Raw data and p values for data in <xref ref-type="fig" rid="fig3">Figure 3</xref> and supplements.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-51685-fig3-data1-v1.xlsx"/></supplementary-material> </p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-51685-fig3-v1.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>Validation of passive nuclear influx assay.</title><p>(<bold>A</bold>) Confocal images of permeabilized HeLa cells incubated with Texas Red-labeled dextrans of the indicated molecular weight for 15 min. Scale bar = 10 µm. (<bold>B</bold>) Time lapse imaging of dextran nuclear influx from 0 to 5 min. Nuclear intensity is normalized to time 0 for each cell (1 = no influx). Mean ± SEM is shown for n = 3 biological replicates (20–30 cells/replicate/condition). (<bold>C</bold>) Time lapse imaging of GFP nuclear influx, with or without lysate/energy, to verify passive transport of this 27 kD, non-NLS-containing protein. A subset of cells were pre-incubated with 0.8 mg/ml WGA as a positive control for impediment to transport. n = 1 (20–30 cells/condition). (<bold>D–E</bold>) Nuclear GFP (<bold>D</bold>) and 40 kD dextran (<bold>E</bold>) intensity for cells preincubated with 100 µM GP10, GA10, or PA10. All experiments included lysate and energy. Mean ± SEM is shown for n = 3 biological replicates (20–30 cells/replicate/condition, ns = no significant difference vs. untreated controls).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-51685-fig3-figsupp1-v1.tif"/></fig><fig id="fig3s2" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 2.</label><caption><title>R-DPRs show modest binding to FG-domains in the bead halo assay, which can be augmented by importin β.</title><p>(<bold>A</bold>) Confocal images of AF488-labeled DPRs added to glutathione beads coated with yeast FG- and GLFG-domain GST-fusion proteins, in binding buffer with or without added unlabeled importin β. FITC-dextran = negative control (-), full length AF647-importin β = positive control (+). Scale bar = 4 µm. (<bold>B</bold>) Intensity profiles (rim vs. background) across all beads tested, including the Nup116 F→ A mutant which is used to define the background/non-specific binding level as indicated by the horizontal dashed lines. Correspondence between yeast and human Nups is given in the inset. Mean ± SEM is shown, for n = 20 beads (5 intensity profiles/bead). *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001 vs. Nup116 F→A by two-way ANOVA with Tukey post-hoc test (*denotes GR statistics, # denotes PR statistics, red arrows denote augmentation of binding by importin β (p&lt;0.001)). See source file for raw data and exact p values.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-51685-fig3-figsupp2-v1.tif"/></fig></fig-group><p>The rate of passive transport through the NPC is governed by the FG-Nup barrier (<xref ref-type="bibr" rid="bib55">Mohr et al., 2009</xref>; <xref ref-type="bibr" rid="bib77">Timney et al., 2016</xref>; <xref ref-type="bibr" rid="bib18">Frey et al., 2018</xref>), in addition to local concentrations of importin β and RanGTP (<xref ref-type="bibr" rid="bib47">Ma et al., 2012</xref>; <xref ref-type="bibr" rid="bib36">Kapinos et al., 2017</xref>). R-DPR/FG-domain interactions are predicted based on the propensity of arginines to undergo cation-pi interactions with aromatic phenylalanine rings (reviewed by <xref ref-type="bibr" rid="bib19">Gallivan and Dougherty, 1999</xref>; <xref ref-type="bibr" rid="bib4">Banani et al., 2017</xref>). Indeed, previous interactome studies predicted R-DPR interactions with FG-Nups including Nup54, 62, 98, 153, and 214 (<xref ref-type="bibr" rid="bib44">Lin et al., 2016</xref>; <xref ref-type="bibr" rid="bib87">Yin et al., 2017</xref>), and PR20 peptides were shown to bind and stabilize Nup54 and 98 FG-domain polymers, a property hypothesized to decrease NPC permeability for passive and active transport (<xref ref-type="bibr" rid="bib72">Shi et al., 2017</xref>). To test for direct DPR/FG binding, we probed for interactions between the five <italic>C9orf72</italic> DPRs and FG-domains of yeast homologs of Nup62 (Nsp1) and Nup98 (Nup100 and Nup116) in the bead halo assay (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2</xref>). These represent two distinct categories of FG-motifs, the more charged FxFG of the Nsp1 C-terminal region, versus the more hydrophobic and less-charged GLFG-domains of Nup100 and Nup116, the latter of which are particularly highly conserved and thought to be critical for determining the mesh-like properties of the FG hydrogel (reviewed by <xref ref-type="bibr" rid="bib70">Schmidt and Görlich, 2016</xref>).</p><p>We again observed non-selective binding by the R-DPRs, including to beads coated with a Nup116 F-&gt;A mutant construct. However, quantification of the halo intensities showed modest selective binding of GR10 and PR10 to GLFG-domains of Nup100, but not Nsp1 or Nup116, in a pattern that appeared primarily dependent on the length of the FG-domains tested (Nup100<sub>1-607</sub> &gt; Nup100<sub>1-310</sub>&gt;Nsp1<sub>497-609</sub>&gt;Nup116<sub>348-458</sub>). For PR10, FG-binding could be augmented (to Nup100 and Nsp1 fragments) by adding unlabeled importin β to the assay, suggesting that recruitment of PR to FG-domains at the NPC could be mediated in part by an indirect interaction through importin β. Overall, these results support modest direct and indirect binding of R-DPRs to FG domains, which based on our passive transport data, do not decrease NPC permeability and even increase passive influx, by a mechanism that remains to be elucidated.</p></sec><sec id="s2-4"><title>R-DPR-induced aggregates recruit NCT proteins</title><p>Upon addition of R-DPRs to cell lysate for the transport assays, we observed the rapid formation of insoluble aggregates (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). To identify the components of these aggregates and determine their potential relevance for the nuclear import defect, we spun them down and analyzed their protein content via mass spectrometry (<xref ref-type="fig" rid="fig4">Figure 4A–B</xref>; data available via ProteomeXchange with identifier PXD015656). 858 proteins were identified in each of two GR replicates and 758 in two PR replicates, with 647 (67%) in common. Consistent with previous reports, these included numerous nucleic acid-binding proteins and ribosomal subunits. Gene ontology (GO) analysis confirmed enrichment of nucleolar proteins, ribonucleoproteins, spliceosomal complex subunits, stress granule constituents, and others (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>). Among these, low complexity domain (LCD)-containing proteins implicated in ALS/FTD were identified including TDP-43, FUS, Matrin-3, and hnRNPs. Multiple NCT proteins including karyopherins, Nups, Ran cycle proteins, and THO complex proteins, which participate in mRNA biogenesis and nuclear export (<xref ref-type="bibr" rid="bib69">Rondón et al., 2010</xref>), were also found among the identified targets (<xref ref-type="fig" rid="fig4">Figure 4A–B</xref>).</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>R-DPR-induced aggregates recruit NCT proteins.</title><p>(<bold>A</bold>) Aggregates formed by adding R-DPRs to HEK cell lysate in transport buffer (before and after 15 min centrifugation). Venn diagram indicates number of proteins identified by mass spectrometry analysis of pellets (n = 2 technical replicates). Enriched NCT-related GO terms are shown, with fold change and p value calculated by the DAVID algorithm. Overall top GO terms are shown in <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>. (<bold>B</bold>) List of identified NCT-related proteins, in all 4 samples (black), n = 2 GR10 samples (blue), and n = 2 PR10 samples (red). Asterisk denotes samples seen in n = 2 GR10 samples and only n = 1 PR10 sample. (<bold>C</bold>) Western blots for indicated NCT and Nup proteins in pellet vs. supernatant fractions. RCC1 is marked with an asterisk, as this protein was not identified in the MS results and serves as the negative control. All samples were loaded by volume, see <xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2</xref> for membrane protein stain and additional Western blots of disordered RNA binding proteins. (<bold>D</bold>) Quantification of blots in (<bold>C</bold>). Mean ± SD for two technical replicates is shown (TP = TNPO1, β = importin β, α = importin α, RG = RanGAP1, RC = RCC1, Ran = RanGTPase). See source file for raw data.</p><p> <supplementary-material id="fig4sdata1"><label>Figure 4—source data 1.</label><caption><title>Raw data and p values for data in <xref ref-type="fig" rid="fig4">Figure 4</xref> and supplements.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-51685-fig4-data1-v1.xlsx"/></supplementary-material> </p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-51685-fig4-v1.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>Overall top GO terms enriched in R-DPR aggregates.</title><p>(<bold>A-B</bold>) Top molecular function GO terms for GR10 and PR10 aggregates according to p value (shown as -log<sub>10</sub>) (<bold>A</bold>) and fold change (<bold>B</bold>). In B, selected GO categories enriched in PR samples are highlighted in red, and GR in blue.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-51685-fig4-figsupp1-v1.tif"/></fig><fig id="fig4s2" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 2.</label><caption><title>Western blots for selected low complexity-domain (LCD)-containing proteins in R-DPR supernatant vs. pellet fractions.</title><p>(<bold>A</bold>) Western blot for indicated proteins identified by R-DPR aggregate mass spectrometry in supernatant vs. pellet, loaded by volume. A representative post-transfer Faststain (total protein stain) is shown. (<bold>B</bold>) Quantification of blots in (<bold>A</bold>). Mean ± SD is shown for two technical replicates. See source file for raw data.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-51685-fig4-figsupp2-v1.tif"/></fig></fig-group><p>Next, we validated a subset of these identified proteins by an immunoblotting-based sedimentation assay. We added each of the five DPRs to transport cell lysate in the presence of energy, allowed aggregates to form for 1 hr, and pelleted the aggregates by centrifugation. Supernatants were removed, and the pellets rinsed with PBS before preparing samples of supernatants and pellets for separation by SDS-PAGE. Samples corresponding to equal volumes of supernatants and pellets (precipitated from equal fractions of the initial extract), were then analyzed by immunoblotting. In this manner, we assessed the the partitioning of NCT proteins, Nups, and LCD-containing proteins between the soluble and aggregate fraction of the extracts (<xref ref-type="fig" rid="fig4">Figure 4C–D</xref> and <xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2</xref>). We saw R-DPR-mediated enrichment in the pellet for importin β, RanGAP1, transportin-1, Ran, and importin α, with only minor decreases in the supernatant. RCC1 was not identified by mass spectrometry, and as predicted did not sediment with the DPRs, serving as a negative control. We also confirmed deposition of Nups 54, 62, 98, and 133 in the pellet (<xref ref-type="fig" rid="fig4">Figure 4C–D</xref>), along with the low complexity domain (LCD)-containing RNA binding proteins TDP-43, FUS, Matrin-3, hnRNPA1, and hnRNPA2/B1, ribosomal protein RPS6, and the ATP-dependent RNA helicase DDX3X (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2</xref>). As opposed to the NCT proteins, many of these LCD-containing proteins were markedly or completely depleted from the supernatant.</p><p>These data confirm that R-DPR aggregates can recruit NCT constituents in addition to a host of nucleic acid-binding proteins. However, NCT proteins were not substantially depleted from the supernatant even in the presence of 100 µM GR10 and PR10, suggesting that sequestration of critical NCT factors in these insoluble protein assemblies is unlikely to fully explain the failure of nuclear import in the transport assays.</p></sec><sec id="s2-5"><title>R-DPR nuclear import blockade does not require aggregates and is rescued by RNA</title><p>Cytoplasmic aggregate formation, a pathological hallmark of neurodegenerative disease, has been proposed as a general mechanism for impairment of NCT by sequestration of critical NPC and NCT proteins (<xref ref-type="bibr" rid="bib83">Woerner et al., 2016</xref>). However, there is no evidence to date that such accumulation alters or disorganizes the NPC, and remains to be demonstrated whether it is the process of aggregate formation and sequestration, or the disordered proteins themselves, that disrupt NCT. To address this question in the context of R-DPR aggregates, we tested several approaches for preventing aggregate formation in our model system. Addition of the aliphatic alcohol, 1,6-hexanediol, previously shown to disrupt GR- and PR-induced protein assemblies (<xref ref-type="bibr" rid="bib42">Lee et al., 2016</xref>), was incompatible with transport and caused dose-dependent inhibition at baseline (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>). This is likely due to disruption of FG-domains within the central channel, as previously reported (<xref ref-type="bibr" rid="bib68">Ribbeck and Görlich, 2002</xref>). NTRs themselves, as hydrophobic interactors of aggregation-prone RNA binding proteins, have been shown to promote solubility of their cargoes and may have evolved in part as cytoplasmic chaperones (<xref ref-type="bibr" rid="bib32">Jäkel et al., 2002</xref>; <xref ref-type="bibr" rid="bib24">Guo et al., 2018</xref>; <xref ref-type="bibr" rid="bib26">Hofweber et al., 2018</xref>; <xref ref-type="bibr" rid="bib88">Yoshizawa et al., 2018</xref>; <xref ref-type="bibr" rid="bib65">Qamar et al., 2018</xref>). However, even low concentrations of exogenous, full-length importin β inhibited nuclear import when added to the transport assay, likely due to sequestration of Rango and available RanGTP. Moreover, neither 1,6-hexanediol nor exogenous importin β could reverse mild nuclear import inhibition due to 25 µM PR10 (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>).</p><p>Next, we tested the effect of increasing the concentration of RNA, based on the growing evidence that RNA mediates the solubility of intrinsically disordered proteins, including FUS, TDP-43, and RNA-dependent DEAD-box ATPases (<xref ref-type="bibr" rid="bib50">Maharana et al., 2018</xref>; <xref ref-type="bibr" rid="bib27">Hondele et al., 2019</xref>), and attenuates TDP-43 inclusions and neurotoxicity in vitro (<xref ref-type="bibr" rid="bib52">Mann et al., 2019</xref>). PolyU RNA has also been shown to colocalize with PR20 in phase separated droplets (<xref ref-type="bibr" rid="bib6">Boeynaems et al., 2017</xref>). We hypothesized that RNA may interact with R-DPRs and perhaps change the material properties of R-DPR induced aggregates in the transport assay. When total HEK cell RNA was added to the transport reaction, we indeed saw a dose-dependent rescue of nuclear import that was RNAse-sensitive (<xref ref-type="fig" rid="fig5">Figure 5A</xref>). This did not appear to be attributable to a significant reduction of the quantity of insoluble material in the transport reaction, either by protein stain or Western blot (<xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2</xref>), although these studies were not aimed to detect changes in aggregate size or composition. Electrophoretic mobility shift assays confirmed that in a purified system, RNA of a broad range of sizes binds to R-DPRs (<xref ref-type="fig" rid="fig5s3">Figure 5—figure supplement 3</xref>).</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>R-DPR nuclear import blockade does not require aggregates and is rescued by RNA.</title><p>(<bold>A</bold>) Rango N/C ratio in permeabilized HeLa transport reactions with 100 µM GR10 or PR10 and increasing concentrations of total HEK cell RNA +/- RNAse. See <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref> for attempts to rescue with 1,6-hexanediol and importin β. (<bold>B</bold>) Schematic of fractionated Rango transport assays, run with aggregates present or absent (supernatant only), followed by addition of RNA to a subset of reactions. See <xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2</xref> for western blots of fractionated samples ± RNA. (<bold>C</bold>) Rango N/C ratio from fractionated transport assays. (<bold>D</bold>) Confocal images of fractionated transport assays run in the presence of AF488-labeled R-DPRs and AF647-labeled importin β. Arrows mark R-DPR collection around the nuclear membrane in conditions where transport was inhibited. Acquisition parameters were kept constant for all images (scale bar = 10 µm). (<bold>E</bold>) Schematic of (1) lysate vs. (2) nuclei R-DPR preincubation assays. (<bold>F</bold>) Rango N/C ratio from preincubation assays. (<bold>G</bold>) Working model: R-DPRs block nuclear import by binding to importin β and preventing the formation of the importin α•importin β•NLS cargo complex in the soluble phase of the transport reaction, which can be alleviated by RNA. See <xref ref-type="fig" rid="fig5s3">Figure 5—figure supplement 3</xref> for DPR/RNA electrophoretic mobility shift assay. For A,C,F mean ± SEM of n ≥ 3 biological replicates are shown (each data point represents 1462 ± 555 cells). *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001 vs. untreated cells by one-way ANOVA with Dunnett’s post-hoc test. See source file for raw data and exact p values.</p><p> <supplementary-material id="fig5sdata1"><label>Figure 5—source data 1.</label><caption><title>Raw data and p values for data in <xref ref-type="fig" rid="fig5">Figure 5</xref> and supplements.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-51685-fig5-data1-v1.xlsx"/></supplementary-material> </p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-51685-fig5-v1.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>1,6-HD and importin β do not rescue nuclear import in the permeabilized cell assay.</title><p>(<bold>A-B</bold>) 1,6-hexanediol (1,6-HD) (<bold>A</bold>) and WT importin β (<bold>B</bold>) cause dose-dependent inhibition of Rango import in HeLa cells at baseline (mean ± SEM for n = 2 replicates is shown). (<bold>C</bold>) No rescue of mild Rango import inhibition (25 µM PR10) was seen for either intervention (n = 1 for 1,6-HD, and n = 2 replicates for importin β, 1622 ± 271 cells/data point). Note that values in C are not background corrected as some fell below the level observed for cells without energy or lysate added. See source file for raw data.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-51685-fig5-figsupp1-v1.tif"/></fig><fig id="fig5s2" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 2.</label><caption><title>RNA only minimally attenuates R-DPR aggregate formation.</title><p>(<bold>A</bold>) Sypro Ruby-stained protein gel showing effect of total HEK RNA on R-DPR-mediated aggregate formation. HEK lysate pellets were prepared as for mass spec and Western blots in <xref ref-type="fig" rid="fig4">Figure 4</xref>, +/- 20 µg total HEK RNA. Minimal reduction of predominantly low molecular weight species was apparent by the protein stain (bracketed in red). (<bold>B–C</bold>) Western blots for indicated proteins +/- RNA in pellet vs. supernatant fractions (<bold>B</bold>), and quantifification of band intensity, expressed as percent untreated control (<bold>C</bold>). All samples were loaded by volume as in the parent figure. Mean ± SD for two technical replicates is shown.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-51685-fig5-figsupp2-v1.tif"/></fig><fig id="fig5s3" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 3.</label><caption><title>RNA binds R-DPRs in an electrophoretic mobility shift assay.</title><p>Electrophoretic mobility shift assay of AF488-labeled DPRs (10mers), +/- total HEK RNA, imaged by UV transillumination to simultaneously visualize the AF488 and SYBR Gold signals. Note the co-migration of AF488 R-DPRs with RNA, as visualized by AF488. No SYBR Gold was added to these lanes.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-51685-fig5-figsupp3-v1.tif"/></fig></fig-group><p>Since the above approaches for mitigating aggregate formation were either ineffective or incompatible with the transport assay, we modified the assay to clarify the role of R-DPR induced aggregates in the disruption of nuclear import. Before adding the R-DPR-treated cell lysates to permeabilized cells, we separated the soluble phase of the extracts (supernatants) from the aggregates (pellets) by centrifugation (diagrammed in <xref ref-type="fig" rid="fig5">Figure 5B</xref>). We reasoned that if aggregates functionally sequester critical transport factors, the remaining supernatant would be insufficient to drive nuclear import. However, if the aggregates contain inhibitor(s) of nuclear import or are themselves inhibitory, depleting them could rescue transport impairment. The results were markedly different for GR versus PR (<xref ref-type="fig" rid="fig5">Figure 5C</xref>). For GR10, removing the insoluble pellet restored nuclear import to normal, confirming that the inhibitory factor was present in (or was) the aggregates. In contrast, nuclear import remained perturbed in the supernatants of the PR10 aggregates, and was restored by the addition of RNA.</p><p>Next, we monitored the location of the R-DPRs with respect to the aggregates and the NPC by adding AF488-labeled DPRs and AF647-labeled importin β to the transport reactions. By confocal microscopy, we observed that the transport disruption correlated with the presence of GR and PR in the vicinity of the nuclear envelope (<xref ref-type="fig" rid="fig5">Figure 5D</xref>). AF488-GR10 fully sedimented into the pellet, leaving no visible GR10 in the supernatant, where transport proceeded normally. In contrast, a subset of AF488-PR10 remained in the supernatant and was present at the nuclear envelope, paralleling the persistent inhibition of nuclear import by the PR10 supernatants. RNA dispersed AF488-R-DPRs from the permeabilized cell nuclei in all conditions, restoring nuclear import. These results suggest that the import inhibition depends on GR or PR acting directly, rather than through putative intermediary factor(s), to inhibit nuclear import. The strikingly divergent segregation of GR vs. PR between the supernatant and pellet demonstrates that, while both bind importin β in a purified system, in the context of cell lysate, PR more readily dissociates from the aggregates into the soluble phase, where it can bind and inhibit importin β.</p><p>The critical steps of importin β-mediated nuclear import take place at NPCs via interactions with FG-Nups. To test whether the interaction between R-DPRs and the NPC is sufficient to block import, we ran two parallel sets of import reactions (diagrammed in <xref ref-type="fig" rid="fig5">Figure 5E</xref>). In the ‘lysate preincubation’ paradigm, as for previous active import assays, R-DPRs were added to lysates used to supply transport factors, preincubated for 1 hr, and then added to permeabilized cells along with Rango and energy to initiate the transport reaction. In the ‘nuclei preincubation’ set, we first exposed the permeabilized cell nuclei to R-DPRs (in the presence of lysate and energy, but no fluorescent cargo). After 1 hr, the DPR-lysate mix was removed from the nuclei, and fresh transport lysate, energy, and cargo added to initiate transport (without R-DPRs). We hypothesized that, if the R-DPRs inhibited Rango import by associating with and perturbing the NPC, we should see reduced import in the ‘nuclei preincubation’ group. However, transport proceeded normally (<xref ref-type="fig" rid="fig5">Figure 5F</xref>). These results support a model in which the R-DPRs inhibit nuclear import by directly interfering with factor(s) present in the soluble phase of the NCT machinery (<xref ref-type="fig" rid="fig5">Figure 5G</xref>), which is consistent with the hypothesis that DPRs interfere with the cargo loading on importins.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>In this study, we investigated disruption of importin-mediated nuclear import by mutant <italic>C9orf72-</italic>associated R-DPRs. We observed that R-DPRs bind importin β at low-nanomolar concentrations, disrupt its interaction with the importin α IBB domain, and impair nuclear import of importin β and importin α/β cargos in permeabilized cells. Nuclear import by transportin, a related member of the importin class that recognizes the structurally distinct PY-NLS, was also disrupted. Import inhibition in the permeabilized cells could not be explained by aggregate-mediated sequestration of NCT machinery; rather, our data support a model in which R-DPRs, particularly PR, directly interfere with importin-cargo loading.</p><sec id="s3-1"><title>Molecular mechnanisms of R-DPR nuclear import inhibition</title><p>The high arginine content of R-DPRs predicts several molecular mechanisms through which they could interfere with importin•cargo complex formation. Since positively charged arginine and lysine residues are characteristic of several classes of NLSs, R-DPRs could compete with or displace such cargoes from importins by charge-based mimicry. In addition to the IBB domains (discussed below), such K/R-rich NLSs include the ‘classic’ mono- and bipartite NLS for importin α, the R-rich NLS of ribosomal proteins that directly bind importin β, importin 5, and importin 7 (<xref ref-type="bibr" rid="bib31">Jäkel, 1998</xref>), the basic N-terminal portion of the transportin PY-NLS, and the SR-NLS of transportin 3 (<xref ref-type="bibr" rid="bib75">Soniat and Chook, 2015</xref>). The potential for IBB domains as targets of R-DPR mimicry is evidenced both by the presence of K/R-rich regions and their relevance for a wide variety of cargos carried by the seven importin α isoforms in humans, and the otherwise structurally unrelated snurportin 1, which also contains an IBB domain (<xref ref-type="bibr" rid="bib46">Lott and Cingolani, 2011</xref>; <xref ref-type="bibr" rid="bib61">Oka and Yoneda, 2018</xref>). Thus, R-DPR cargo mimicry could potentially slow the loading of NLS cargos on many diverse types of importins in parallel. Second, electrostatic cation-pi interactions of arginines with aromatic rings (<xref ref-type="bibr" rid="bib19">Gallivan and Dougherty, 1999</xref>; <xref ref-type="bibr" rid="bib4">Banani et al., 2017</xref>) could attract R-DPRs to the tyrosine of the transportin PY-NLS, disrupting in this case the cargo, rather than the karyopherin. Notably, consensus nuclear export signals (NES) recognized by exportins do not depend on K/R-rich motifs, but rather three dimensional structures based on hydrophobic residues, including aromatic phenylalanines (<xref ref-type="bibr" rid="bib84">Xu et al., 2012</xref>). Thus, although not examined here, exportin-NES interactions could also be be subject to electrostatic interference by R-DPRs. Future studies will be needed to examine exactly how R-DPRs target each class of karyopherins, and the hierarchy of the relevance of such interactions to the mechanisms of R-DPR cellular toxicity.</p></sec><sec id="s3-2"><title>Lack of R-DPR blockade of NPC channels</title><p>Previously published interactomes (<xref ref-type="bibr" rid="bib44">Lin et al., 2016</xref>; <xref ref-type="bibr" rid="bib87">Yin et al., 2017</xref>) and mechanistic studies (<xref ref-type="bibr" rid="bib72">Shi et al., 2017</xref>) predict binding between R-DPRs and FG-Nups, which line the central channel of the NPC and are fundamental for establishing the permeability barrier (reviewed by <xref ref-type="bibr" rid="bib70">Schmidt and Görlich, 2016</xref>). <xref ref-type="bibr" rid="bib72">Shi et al. (2017)</xref> proposed that stabilization of FG-Nup polymers and the ensuing blockade of NPC passage may be responsible for PR20-mediated inhibition of nuclear import. To explore this further, we tested the effect of R-DPR 10- and 20-mers on passive nuclear influx. Surprisingly, we observed acceleration rather than slowing. The precise cause is unclear. Studies in yeast suggest that to pass through the NPC, cargos must overcome collisions with highly mobile, disordered FG domains, particularly the Nup98 homologues Nup100 and Nup116 (<xref ref-type="bibr" rid="bib77">Timney et al., 2016</xref>). If R-DPRs directly or indirectly target these FG domains, as suggested by Shi et al., and by our bead halo studies, this could drastically increase their positive charge or reduce their mobility and thus perturb their gate-keeping function. In addition to FG-Nups, the passive properties of the pore have also been shown to depend on karyopherins. Using superresolution microscopy, <xref ref-type="bibr" rid="bib47">Ma et al. (2012)</xref> showed that when extra importin β accumulates within the NPCs, concentrating inside the peripherally-localized active transport zone, the central passive transport channel widens. Alternatively, by monitoring the passive cargo transport rate, <xref ref-type="bibr" rid="bib36">Kapinos et al. (2017)</xref> showed that when importin•cargo complexes were depleted from the NPC, the pore became leaky. Permeabilized cell experiments in which we monitored the location of AF647-labeled importin β (<xref ref-type="fig" rid="fig5">Figure 5D</xref>) suggest that in the presence of the R-DPR-transport blockade, importin β indeed accumulates at the nuclear rim. Superresolution microscopy would be needed to show the precise site of importin β accumulation in this paradigm, to further clarify if either of these proposed mechanisms may contribute. Nevertheless, our passive transport data (<xref ref-type="fig" rid="fig3">Figure 3</xref>) do not support the conclusion that R-DPRs induce a blockade to nuclear transport by occluding the NPC. This conclusion is also strongly supported by the results of the ‘nuclei preincubation’ experiment (<xref ref-type="fig" rid="fig5">Figure 5E–F</xref>), in which no inhibition of active import was observed despite prolonged exposure of permeabilized nuclei to R-DPRs.</p></sec><sec id="s3-3"><title>Divergent properties of GR and PR</title><p>Throughout this study, we observed marked differences in the behavior of GR and PR. Although both readily displaced importin β from the Rango FRET sensor, PR showed greater potency for inhibiting nuclear import in the permeabilized cell assay and higher relative selectivity for importin β in the bead halo assays. Moreover, while both PR and GR readily induced aggregate formation in the transport lysates, PR showed greater tendency to dissociate from the aggregates (<xref ref-type="fig" rid="fig5">Figure 5D</xref>). Based on their divergent molecular properties, the differing behavior of GR and PR is not surprising. On one hand, both are positively charged, with a predicted disordered state and polynucleotide binding activity (<ext-link ext-link-type="uri" xlink:href="https://predictprotein.org/">https://predictprotein.org/</ext-link>; <xref ref-type="bibr" rid="bib85">Yachdav et al., 2014</xref>). However, because glycine is conformationally flexible and its side chain is comprised of a single hydrogen, while the integrated proline cyclic side-chain induces a rigid bend in the peptide backbone, GR is predicted to accommodate many different macromolecular ligands, while PR may be more selective. As recently reviewed, GR and PR have also been found to have differing half-lives, intracellular localization, and propensity to disrupt stress granule dynamics and mitochondrial function (<xref ref-type="bibr" rid="bib17">Freibaum and Taylor, 2017</xref>). PR20, but not GR20, was also recently shown to inhibit proteosomal degradation (<xref ref-type="bibr" rid="bib25">Gupta et al., 2017</xref>), and a recent comparison of modifiers of GR and PR toxicity in yeast showed little overlap (<xref ref-type="bibr" rid="bib7">Chai and Gitler, 2018</xref>). Although our MS analysis did not permit quantitative comparison between PR and GR aggregates, 21% of hits were unique to GR, and 11% to PR, with varying selectivity for target proteins also observed by western blot. This lack of overlap was also reported for GR50 and PR50 interactomes, which showed 35% and 25% unique hits, respectively (<xref ref-type="bibr" rid="bib42">Lee et al., 2016</xref>).</p><p>Thus, although in a purified system GR and PR show a similar propensity to bind importin β, in the more complex environment of the cell, our findings predict PR to be the more potent disruptor. Micromolar concentrations of R-DPRs were required to observe functional import blockade in the permeabilized cell assay; however, 20mers were on average 3.3-fold more potent than 10mers across all cargoes, suggesting that longer DPRs, as are likely present in patients, may be significantly more potent. However, the size of polyGR and polyPR peptides in patients is unknown. GGGGCC repeat lengths in the 1000s have been reported in postmortem brain (<xref ref-type="bibr" rid="bib78">van Blitterswijk et al., 2013</xref>; <xref ref-type="bibr" rid="bib14">Dols-Icardo et al., 2014</xref>; <xref ref-type="bibr" rid="bib60">Nordin et al., 2015</xref>), although the processivity of ribosomes along the repeat RNA, and what terminates repeat-associated non-AUG translation, is unclear. High-molecular-weight smears have been observed by SDS-PAGE (<xref ref-type="bibr" rid="bib94">Zu et al., 2013</xref>). By ELISA, the poly-GP concentration in postmortem motor cortex was estimated at a median of 322 ng/mg protein (<xref ref-type="bibr" rid="bib21">Gendron et al., 2015</xref>), but comparable measurements for R-DPRs, and in particular the relative abundance of GR vs. PR in patient tissue, remain to be determined.</p></sec><sec id="s3-4"><title>RNA-mediated rescue of the R-DPR import blockade</title><p>Based on growing evidence that RNA is integral to the solubility of disordered protein assemblies (<xref ref-type="bibr" rid="bib50">Maharana et al., 2018</xref>; <xref ref-type="bibr" rid="bib40">Langdon et al., 2018</xref>; <xref ref-type="bibr" rid="bib27">Hondele et al., 2019</xref>), and polyU RNA can phase separate with PR (<xref ref-type="bibr" rid="bib6">Boeynaems et al., 2017</xref>), we tested the effect of adding total cellular RNA to the transport reaction, and observed dose-dependent rescue. Total protein aggregates were not substantially reduced by the RNA, based on our sedimentation assays; however, significantly less AF488-labeled R-DPRs were observed in the vicinity of the nuclear envelope by confocal microscopy. Our electrophoretic mobility shift assay shows that a broad range of cellular RNAs can bind to R-DPRs directly, and previous evidence in a purified system showed that synthetic RNAs can facilitate suspension of R-DPRs in a droplet-like state (<xref ref-type="bibr" rid="bib6">Boeynaems et al., 2017</xref>), indicating that direct sequestration of R-DPRs by RNA could contribute to the reduced deposition of AF488-DPRs along the nuclear envelope, and the beneficial effects on nuclear import. At the same time, RNA could act indirectly to sequester the R-DPRs away from importins, by reducing the average aggregate size and thus increasing the number of exposed R-DPR binding sites. While future studies will be needed to fully elucidate the mechanisms of direct and indirect effects of RNA on R-DPRs, our data suggest that, at least in the permeabilized cell model, RNA can mitigate aberrant protein-protein interactions in a functionally meaningful way.</p></sec><sec id="s3-5"><title>DPR-mediated NCT disruption in <italic>C9orf72</italic>-ALS</title><p>Initial reports of NCT disruption as a pathogenic mechanism in <italic>C9orf72</italic>-ALS were based on genetic modifier screens of expanded repeat RNA and DPRs in <italic>Drosophila</italic> and yeast. These studies implicated numerous karyopherins, Nups, and Ran cycle proteins as potential direct and indirect mediators of <italic>C9orf72-</italic>ALS pathogenesis (<xref ref-type="bibr" rid="bib89">Zhang et al., 2015</xref>; <xref ref-type="bibr" rid="bib33">Jovičić et al., 2015</xref>; <xref ref-type="bibr" rid="bib16">Freibaum et al., 2015</xref>; <xref ref-type="bibr" rid="bib5">Boeynaems et al., 2016</xref>). RanGAP1 was identified as a direct interactor of expanded repeat RNA, providing one mechanism by which mutant <italic>C9orf72</italic> repeat RNA may impair NCT, via disruption of the RanGTP gradient (<xref ref-type="bibr" rid="bib89">Zhang et al., 2015</xref>).</p><p>Additional studies have since investigated mechanisms by which individual DPRs may disrupt the nuclear transport apparatus. Cytoplasmic expression of poly-GA, a hydrophobic DPR proposed to form amyloid fibrils (<xref ref-type="bibr" rid="bib8">Chang et al., 2016</xref>), was shown to impair importin α/β- but not transportin-mediated import in transfected HeLa and primary hippocampal neurons (<xref ref-type="bibr" rid="bib37">Khosravi et al., 2016</xref>). Overexpression of Nup54, Nup62, and importin α3 rescued GA-mediated import disruption, suggesting these factors may be rate-limiting due to sequestration within cytoplasmic aggregates. PR20 was previously shown by STED microscopy to localize to the central channel of the NPC in <italic>Xenopus</italic> oocytes (<xref ref-type="bibr" rid="bib72">Shi et al., 2017</xref>), and impeded nuclear import of NLS-BSA in permeabilized HeLa cells. The import blockade was attributed to a propensity for PR20 to bind FG domains and stabilize them in a polymerized state, altering the permeability barrier of the NPC. While the current study was under review, Vanneste and colleagues reported that they were unable to impede nuclear transport of fluorescent NLS-NES shuttle proteins by addition of synthetic GR20 or PR20 to HeLa cells in the culture media, or lentiviral expression of mCherry-tagged poly-GR100 and poly-PR100 in multiple cell types (<xref ref-type="bibr" rid="bib79">Vanneste et al., 2019</xref>). Poly-GA100 also failed to inhibit nuclear import in HeLa or SH-SY5Y cells, and caused only a mild decrement in iPSC-derived motor neurons.</p><p>These examples highlight several mechanistic discrepancies. Based on its markedly different biophysical properties, it is not surprising that GA would behave differently with respect to the NCT apparatus than R-DPRs. The ‘sequestration model’, in which cytoplasmic aggregates consume NCT components, is also supported by recent studies of artificial β-sheet constructs (<xref ref-type="bibr" rid="bib83">Woerner et al., 2016</xref>) suggesting that strongly hydrophobic proteins may share this behavior. While we did not see NCT inhibition by GA10 in permeabilized HeLa, and only minimal inhibition at high concentrations in permeabilized neurons, we also did not observe GA-induced aggregate formation. Longer peptides and/or prolonged incubation time may be needed to further test the sequestration capacity of poly-GA in the permeabilized cell model.</p><p>Our current study, and that of <xref ref-type="bibr" rid="bib72">Shi et al. (2017)</xref>, used the permeabilized cell assay to study PR-mediated inhibition of nuclear import. Although we both observed dose-dependent inhibition of cargo import, our conclusions differ with respect to the mechanism of import disruption, which we argue occurs via karyopherin disruption, rather than the interaction with FG-Nups, for reasons discussed above. Less clear is the reason for the lack of effect reported by <xref ref-type="bibr" rid="bib79">Vanneste et al. (2019)</xref>. We did observe promiscuous binding tendencies of GR in our assays, which could predict that GR rapidly becomes sequestered in living cells by other binding partners (i.e. ribosomes, histones, and other disordered proteins), preventing any significant disruption of the highly abundant karyopherins. PR expressed from tagged, randomized codon constructs is localized nearly exclusively in nuclei and concentrated in nucleoli (<xref ref-type="bibr" rid="bib82">Wen et al., 2014</xref>; <xref ref-type="bibr" rid="bib37">Khosravi et al., 2016</xref>; <xref ref-type="bibr" rid="bib79">Vanneste et al., 2019</xref>), which is distinct from the localization seen in human postmortem issue, where cytoplasmic aggregates of PR are seen in addition to the nuclear signal (<xref ref-type="bibr" rid="bib20">Gendron et al., 2013</xref>). It is possible that sequestration of PR in the nucleolus may protect against disruption of nuclear transport. Detailed investigation of endogenous nuclear transport receptors and cargoes in <italic>C9orf72-</italic>ALS patient tissue is needed, to help clarify the above discrepancies in an environment where RNA foci and all five DPRs are simultaneously expressed. Indeed, multiple gains of toxic function may converge in the pathologic cascade of this disease.</p></sec><sec id="s3-6"><title>Conclusion</title><p>In summary, we propose a model in which R-DPRs bind and interfere with importin•cargo loading at the NPC. Based on these findings, we speculate that importin β disruption may contribute to pathological protein mislocalization in <italic>C9orf72</italic>-mediated ALS/FTD, including TDP-43, for which links to downstream neurodegeneration are beginning to be unraveled (<xref ref-type="bibr" rid="bib45">Ling et al., 2015</xref>; <xref ref-type="bibr" rid="bib54">Melamed et al., 2019</xref>; <xref ref-type="bibr" rid="bib38">Klim et al., 2019</xref>). Further investigation is needed regarding disruption of endogenous cargoes in <italic>C9orf72</italic> patient tissue, and the potential for use of RNA-based strategies to mitigate aberrant R-DPR protein-protein interactions.</p></sec></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th>Reagent type <break/>(species) or <break/>resource</th><th>Designation</th><th>Source or <break/>reference</th><th>Identifiers</th><th>Additional <break/>information</th></tr></thead><tbody><tr><td>Cell line (<italic>Homo sapiens</italic>)</td><td>HeLa</td><td>ATCC <break/><xref ref-type="bibr" rid="bib34">Kaláb et al., 2006</xref></td><td>clone HeLa 61</td><td>Single cell-derived clone</td></tr><tr><td>Cell line (<italic>Homo sapiens)</italic></td><td>HEK293T</td><td>ATCC</td><td/><td/></tr><tr><td>Cell line (<italic>M. musculus)</italic></td><td>Primary cortical neurons (embryonic)</td><td>This paper</td><td/><td>Harvested from timed pregnant C57BL/6J females</td></tr><tr><td>Recombinant DNA reagent</td><td>pRSET zzRanQ69L</td><td>This paper</td><td>pKW1234; pK1097</td><td><italic>E. coli</italic> expression of Protein A-tagged human RanQ69L</td></tr><tr><td>Recombinant DNA reagent</td><td>pRSET zzRCC1</td><td>This paper</td><td>pKW1907; pK1098</td><td><italic>E. coli</italic> expression of Protein A-tagged human RCC1</td></tr><tr><td>Recombinant DNA reagent</td><td>pRSET Rango-2/α1+linkers</td><td>This paper</td><td>pK44</td><td><italic>E. coli</italic> expression of Rango 2 with importin α1 IBB, optimized for FRET</td></tr><tr><td>Recombinant DNA reagent</td><td>pRSET Rango-2/α1</td><td>This paper</td><td>pK188</td><td><italic>E. coli</italic> expression of Rango 2 with importin α1 IBB</td></tr><tr><td>Recombinant DNA reagent</td><td>pRSET GFP-AviTag</td><td>This paper</td><td>pK803</td><td><italic>E. coli</italic> expression of GFP, with C-terminal Avitag, used in non-biotinylated form here</td></tr><tr><td>Recombinant DNA reagent</td><td>pRSET Importin β- AviTag</td><td>This paper</td><td>pKW1982; pK1099</td><td><italic>E. coli</italic> expression of WT human Importin β, with C-terminal biotin tag</td></tr><tr><td>Recombinant DNA reagent</td><td>BirA ligase</td><td><ext-link ext-link-type="uri" xlink:href="https://www.avidity.com/">Avidity.com</ext-link></td><td>AVB101</td><td><italic>E. coli</italic> expression of untagged BirA biotin ligase for biotinylation of co-expressed AviTag proteins</td></tr><tr><td>Recombinant DNA reagent</td><td>pRSET YFP-M9-CFP</td><td><xref ref-type="bibr" rid="bib74">Soderholm et al., 2011</xref></td><td>pKW1006</td><td><italic>E. coli</italic> expression of fluorescent M9, TNPO1 cargo</td></tr><tr><td>Recombinant DNA reagent</td><td>pET30a 6His-S-Importin β<sub>(1-876)</sub></td><td><xref ref-type="bibr" rid="bib9">Chi et al., 1997</xref></td><td>pKW485</td><td><italic>E. coli</italic> expression of WT S-tagged human Importin β</td></tr><tr><td>Recombinant DNA reagent</td><td>pGEX GST-GFP-NLS</td><td><xref ref-type="bibr" rid="bib43">Levy and Heald, 2010</xref></td><td>pMD49</td><td><italic>E. coli</italic> expression of fluorescent importin α cargo with SV40 NLS</td></tr><tr><td>Recombinant DNA reagent</td><td>pGEX-2TK-Nup100<sub>(1-610)</sub></td><td><xref ref-type="bibr" rid="bib62">Onischenko et al., 2017</xref></td><td>pKW2960, ID 370</td><td><italic>E. coli</italic> expression of truncated GST-tagged GLFG domain of yeast Nup100 (human Nup98 homologue</td></tr><tr><td>Recombinant DNA reagent</td><td>pGEX-2TK-Nup100<sub>(1-307)</sub></td><td><xref ref-type="bibr" rid="bib62">Onischenko et al., 2017</xref></td><td>pKW2959, ID369</td><td><italic>E. coli</italic> expression of GST-tagged GLFG domain of yeast Nup100 (human Nup98 homologue)</td></tr><tr><td>Recombinant DNA reagent</td><td>pGEX-2TK-Nup116<sub>(348-458)</sub></td><td><xref ref-type="bibr" rid="bib62">Onischenko et al., 2017</xref></td><td>pKW2907, ID350</td><td><italic>E. coli</italic> expression of GST-tagged GLFG domain of yeast Nup116 (human Nup98 homologue)</td></tr><tr><td>Recombinant DNA reagent</td><td>pGEX-2TK-Nup116<sub>(348-458)</sub>F &gt; A</td><td><xref ref-type="bibr" rid="bib62">Onischenko et al., 2017</xref></td><td>pKW2908, ID351</td><td><italic>E. coli</italic> expression of GST-tagged mutant GLFG domain of yeast Nup116 (human Nup98 homologue)</td></tr><tr><td>Recombinant DNA reagent</td><td>pGEX-2TK Nsp1<sub>(497-609)</sub></td><td><xref ref-type="bibr" rid="bib86">Yamada et al., 2010</xref></td><td>pKW1609; pK1100</td><td><italic>E. coli</italic> expression of truncated, GST-tagged FG domain of yeast Nsp1 (human Nup62 homologue)</td></tr><tr><td>Antibody</td><td>Anti-TDP-43 (3H8) (mouse monoclonal)</td><td>Abcam</td><td>Cat#: ab104223</td><td>WB (1:2000)</td></tr><tr><td>Antibody</td><td>Anti-Matrin 3 (rabbit monoclonal)</td><td>Abcam</td><td>Cat#: ab151714</td><td>WB (1:5000)</td></tr><tr><td>Antibody</td><td>Anti-importin α (mouse monoclonal)</td><td>BD Bioscience</td><td>Cat#: 610485</td><td>WB (1:2000)</td></tr><tr><td>Antibody</td><td>Anti-transportin 1 (mouse monoclonal)</td><td>BD Bioscience</td><td>Cat#: 558660</td><td>WB (1:1000)</td></tr><tr><td>Antibody</td><td>Anti-Ran (mouse monoclonal)</td><td>BD Bioscience</td><td>BD:610341</td><td>WB (1:500)</td></tr><tr><td>Antibody</td><td>Anti-FUS (rabbit polyclonal)</td><td>Bethyl</td><td>Cat#: A300-302A</td><td>WB (1:1000)</td></tr><tr><td>Antibody</td><td>Goat anti-rat (goat polyclonal, HRP linked)</td><td>Cell Signaling Technology</td><td>Cat#: 7077S</td><td>WB (1:5000)</td></tr><tr><td>Antibody</td><td>Goat anti-rabbit (goat polyclonal, HRP-linked)</td><td>Cell Signaling Technology</td><td>Cat#: 7074S</td><td>WB (1:5000)</td></tr><tr><td>Antibody</td><td>Horse anti-mouse (horse polyclonal, HRP-linked)</td><td>Cell Signaling Technology</td><td>Cat#: 7076S</td><td>WB (1:5000)</td></tr><tr><td>Antibody</td><td>Anti-RCC1 (rabbit polyclonal)</td><td>GeneTex</td><td>Cat#: GTX104590</td><td>WB (1:2000)</td></tr><tr><td>Antibody</td><td>Anti-Nup62 (rat monoclonal)</td><td>Millipore Sigma</td><td>Cat#: MABE1043</td><td>WB (1:500)</td></tr><tr><td>Antibody</td><td>Anti-DDX3X (rabbit polyclonal)</td><td>Millipore Sigma</td><td>Cat#: HPA001648</td><td>WB (1:1000)</td></tr><tr><td>Antibody</td><td>Anti-importin β (mouse monoclonal)</td><td>Millipore Sigma</td><td>Cat#: I2534</td><td>WB (1:2000)</td></tr><tr><td>Antibody</td><td>Anti-Nup54 (rabbit polyclonal)</td><td>Millipore Sigma</td><td>Cat#: HPA035929</td><td>WB (1:250)</td></tr><tr><td>Antibody</td><td>Anti-ribosomal protein 6 (RPS6) (mouse monoclonal)</td><td>Santa Cruz Biotechnology</td><td>Cat#: sc-74459</td><td>WB (1:1000)</td></tr><tr><td>Antibody</td><td>Anti-Nup133 (mouse monoclonal)</td><td>Santa Cruz Biotechnology</td><td>Cat#: sc-376699</td><td>WB (1:2500)</td></tr><tr><td>Antibody</td><td>Anti-RanGAP1 (C-5) (mouse monoclonal)</td><td>Santa Cruz Biotechnology</td><td>Cat#: sc-28322</td><td>WB (1:50)</td></tr><tr><td>Antibody</td><td>Anti-Nup98 (2H10) (rat monoclonal)</td><td>Santa Cruz Biotechnology</td><td>Cat#: sc-101546</td><td>WB (1:2000)</td></tr><tr><td>Antibody</td><td>Anti-hnRNP A1 (4B10) (mouse monoclonal)</td><td>Santa Cruz Biotechnology</td><td>Cat#: sc-32301</td><td>WB (1:200)</td></tr><tr><td>Antibody</td><td>Anti-hnRNP A2/B1 (EF-67) (mouse monoclonal)</td><td>Santa Cruz Biotechnology</td><td>Cat#: sc-53531</td><td>WB (1:200)</td></tr><tr><td>Commercial assay or kit</td><td>miRNeasy kit</td><td>Qiagen</td><td>Cat#:217004</td><td/></tr><tr><td>Chemical compound, drug</td><td>Sypro Ruby Protein Gel Stain</td><td>Millipore Sigma</td><td>Cat#: S4942</td><td/></tr><tr><td>Chemical compound, drug</td><td>SYBR Gold Nucleic Acid Stain</td><td>ThermoFisher Scientific</td><td>Cat#: S11494</td><td/></tr><tr><td>Chemical compound, drug</td><td>Importazole</td><td>Millipore Sigma</td><td>Cat#: SML0341</td><td/></tr><tr><td>Chemical compound, drug</td><td>Alexa Fluor 647 NHS ester</td><td>ThermoFisher Scientific</td><td>Cat#: A37573</td><td/></tr><tr><td>Chemical compound, drug</td><td>Alexa Fluor 488 C5 maleimide</td><td>ThermoFisher Scientific</td><td>Cat#: A10254</td><td/></tr><tr><td>Chemical compound, drug</td><td>EZ-Link Sulfo-NHS-LC-biotin No-weigh format</td><td>ThermoFisher Scientific</td><td>Cat#: A39257</td><td/></tr><tr><td>Chemical compound, drug</td><td>Ni-NTA Agarose</td><td>Qiagen</td><td>Cat#: 30210</td><td/></tr><tr><td>Chemical compound, drug</td><td>Glutathione Sepharose 4B</td><td>GE Healthcare</td><td>Cat#:17-0756-01</td><td/></tr><tr><td>Chemical compound, drug</td><td>Dextran, Texas Red, 10,000 MW</td><td>ThermoFisher Scientific</td><td>Cat#: D1863</td><td/></tr><tr><td>Chemical compound, drug</td><td>Dextran, Texas Red, 40,000 MW</td><td>ThermoFisher Scientific</td><td>Cat#: D1829</td><td/></tr><tr><td>Chemical compound, drug</td><td>Dextran, Texas Red, 70,000 MW</td><td>ThermoFisher Scientific</td><td>Cat#: D1864</td><td/></tr><tr><td>Chemical compound, drug</td><td>Digitonin, high purity</td><td>Calbiochem</td><td>Cat#: 300410</td><td/></tr><tr><td>Other</td><td>Ribo Ruler High Range RNA ladder</td><td>ThermoFisher Scientific</td><td>Cat#: SM1821</td><td/></tr><tr><td>Other</td><td>HIS-Select HF Nickel Affinity Gel</td><td>Millipore Sigma</td><td>Cat#: HD537</td><td/></tr><tr><td>Other</td><td>DNase (RNase free)</td><td>Qiagen</td><td>Cat#: 79254</td><td/></tr><tr><td>Other</td><td>RNase A</td><td>ThermoFisher Scientific</td><td>Cat#: EN0531</td><td/></tr><tr><td>Other</td><td>Glutathione-coated polystyrene particles 6.0–8.0</td><td>Spherotech</td><td>Cat#: GSHP-60–5</td><td/></tr><tr><td>Other</td><td>Neutravidin-coated polystyrene particles 6.0–8.0</td><td>Spherotech</td><td>Cat#: NVP-60–5</td><td/></tr><tr><td>Other</td><td>GFP Trap Magnetic Agarose</td><td>Chromotek</td><td>Cat#: Gtma-20</td><td/></tr><tr><td>Other</td><td>Wheat germ agglutinin</td><td>Millipore Sigma</td><td>Cat#: L0636</td><td/></tr><tr><td>Other</td><td>BSA, fatty acid-free</td><td>Roche</td><td>Cat#: 03117057001</td><td/></tr></tbody></table></table-wrap><sec id="s4-1"><title>DPR synthesis</title><p>10-and 20-mer dipeptide repeat proteins with C-terminal lysine (for solubility) and cysteine (for fluorescent tagging, that is GPGPGPGPGPGPGPGPGPGPKC) were synthesized by Genscript (Nanjing, China) and 21st Century Biochemicals (Marlborough, MA) and verified by mass spectrometry to be free of trifluoroacetic acid adducts. Lyophilized powder was diluted in 0.1x XB’ buffer (5 mM sucrose, 10 mM KCl, 1 mM HEPES, pH 7.7) and frozen in single use 10 mM aliquots at −80°C after snap freezing in liquid nitrogen.</p></sec><sec id="s4-2"><title>Cloning of recombinant constructs</title><p>Restriction cloning was used to insert the ORF from pQE-ZZ-RanQ69L (<xref ref-type="bibr" rid="bib56">Nachury and Weis, 1999</xref>) between the BamH1 and HindIII sites in pRSET A, resulting in pRSET ZZ-RanQ69L. The pRSET zzRCC1 was created by inserting the PCR-amplified wild-type (WT) human RCC1 C-terminally of the ZZ-tag in pRSET A. Site-directed mutagenesis and PCR cloning were used to modify Rango-2 (<xref ref-type="bibr" rid="bib35">Kaláb and Soderholm, 2010</xref>) by removing the KPN1 sites from YPet and CyPet (<xref ref-type="bibr" rid="bib59">Nguyen and Daugherty, 2005</xref>) and replacing the Snurportin-1 IBB with the IBB amplified from human importin α1 (KPNA2). While doing so, the IBB-importin α1 domain was inserted either with (pK44) or without (pK188) flexible GGCGG linkers added between the 5’ and 3’ ends of IBB and the fluorophores. Restriction cloning was used to combine the C-terminal biotin acceptor peptide tag Avitag (GLNDIFEAQKIEWHE) from pAC-6 (Avidity, Aurora, CO) with WT human importin β (<xref ref-type="bibr" rid="bib9">Chi et al., 1997</xref>) in pRSET A vector, resulting in in pRSET importin β-Avitag (pKW1982; pK1099). Restriction cloning in the modified pRSET A with C-terminal Avitag was used to create pRSET-EGFP-Avitag (pK803). The pGEX-2TK1 plasmid for the expression of the <italic>S. cerevisiae</italic> Nsp1(497-608) FxFG domain was obtained from M. Rexach (<xref ref-type="bibr" rid="bib86">Yamada et al., 2010</xref>).</p></sec><sec id="s4-3"><title>Recombinant protein expression</title><p>Unless otherwise specified, recombinant proteins were expressed in <italic>E. coli</italic> BL21(DE3) cells (ThermoFisher, Waltham, MA) that were cultured in 1L batches of LB media contained in 2.8L baffle-free Fehrnbach flasks. Protein expression was induced with 0.3 mM IPTG. Centrifugation was used to collect the cells and wash them in the ice-cold protein-specific buffer, as indicated below. Unless otherwise specified, all buffers were pH 7.4. The washed cell pellets were flash-frozen in liquid nitrogen and stored at −80°C, and lysed in ice-cold conditions and in the presence of protease inhibitors, using French pressure cell or microfluidizers. After dialysis in the protein-specific buffer, protein concentration was measured with the Bradford assay (BioRad, Hercules, CA), and single-use aliquots of all proteins were stored at −80°C after flash-freezing in liquid nitrogen.</p><sec id="s4-3-1"><title>Recombinant proteins with GFP-derived tags</title><p>For expression of proteins containing GFP variants, including Rango (pK44 and pK188), YFP-M9-CFP, GST-GFP-NLS, and GFP-Avitag, the cells were first outgrown at 37°C until reaching OD<sub>600nm </sub>= 0.1–0.3. The cultures were cooled to room temperature (22–25°C), and protein expression was induced at 22–25°C for 12–14 hr.</p><p>Cells expressing 6His-tagged fluorescent proteins (Rango pK44 and pK188, YFP-M9-CFP, and GFP-Avitag) were washed and lysed in 10 mM imidazole/PBS and purified with either Ni-NTA agarose (Qiagen, Venlo, Netherlands) or HIS-Select HF Nickel Affinity Gel (Millipore Sigma, St. Louis, MO). The lysates were clarified (40 min, 16000 g, 4°C) and incubated with Ni resin (30–60 min, 4°C). The resin was placed into small chromatography columns, washed with ice-cold 10 mM imidazole/PBS, and the proteins eluted with increasing concentration of imidazole/PBS (25–300 mM). SDS-PAGE was used to select and pool batches with the highest purity, prior to dialysis in PBS or XB buffer (50 mM sucrose, 100 mM KCl, 10 mM HEPES, 0.1 mM CaCl<sub>2</sub>, 1 mM MgCl<sub>2</sub>, pH 7.7).</p><p>Cells expressing GST-GFP-NLS were washed and lysed with TBSE (50 mM Tris, 150 mM NaCl, 4 mM EDTA, pH8.0), the lysate clarified, and the protein affinity-purified on glutathione sepharose (Roche, Basel, Switzerland). After washes with TBSE, the proteins were eluted with TBSE containing increasing concentrations of glutathione (2.5–10 mM). Proteins eluted with 2.5 and 5 mM glutathione were pooled and dialyzed in PBS before storage.</p></sec><sec id="s4-3-2"><title>FRET assay mix with importin β and rango</title><p>Full-length human importin β was expressed from pET30a-WT importin β (pKW485; <xref ref-type="bibr" rid="bib9">Chi et al., 1997</xref>) at the Protein Expression Laboratory (PEL, National Cancer Institute, Frederick, MD). The transformed BL21DE3 cells were grown at 37°C in an 80L Bioflow 500 bioreactor (New Brunswick Scientific, Edison, NJ) until OD600<sub>nm</sub> = 0.6, cooled to 22°C and the expression was induced with 0.3 mM IPTG. After 12 hr induction, cells were harvested with the CARR continuous flow centrifuge and lysed in PBS with 10 mM imidazole and 5 mM TCEP with a 110EH Microfluidizer (Microfluidics, Westwood, MA) using 2 passes at 10,000 PSI under chilled conditions. The lysates were flash-frozen in liquid nitrogen and stored at −80°C. After thawing, the lysates were clarified and incubated with HIS-Select HF Nickel Affinity beads. The beads were washed with 10 mM imidazole/PBS and the protein eluted with 200 mM imidazole/PBS before dialysis in XB. The purified importin β was combined with a freshly thawed aliquot of Rango2-α1 (pK188) at 2.5:1 molar ratio ratio (12.5 µM importin β, 5 µM Rango) and supplemented with 3% glycerol. Measurement of Rango fluorescence emission in a spectrometer (see below) was used to verify the FRET-off state of the Rango/importin β mixture before freezing.</p></sec><sec id="s4-3-3"><title>FRET assay mix with zz-RCC1 and zz-RanQ69L</title><p>The expression of zz-RCC1 was induced at OD<sub>600nm </sub>= 0.4, followed by incubation at 22°C for 4 hr. The cells were washed with PBS, 10 mM Imidazole, 1 mM MgCl<sub>2</sub>, 5 mM TCEP, 0.2 mM AEBSF, pH 8.0, and lysed by ice-cold microfluidizer. The clarified lysates were used to isolate the zz-RCC1 proteins on HIS-Select HF Nickel Affinity beads, as described above. Proteins eluted with 0.2M imidazole/PBS were dialyzed in PBS before storage. The zz-RanQ69L (pKW1234; pK1097) was expressed from BL21DE3 cells at PEL in an 80L bioreactor, using conditions described for importin β above, except that expression was induced with 0.3 mM IPTG at 37°C for 3 hr, and lysis was performed in PBS with 10 mM Imidazole, 5 mM TCEP, 2 mM MgCl<sub>2</sub>, and 1 mM GTP. The lysates were clarified and bound to HIS-Select HF Nickel Affinity beads (Millipore Sigma). The Ni resin was washed with ice-cold 10 mM imidazole/PBS and the protein eluted with 0.2M imidazole/PBS, followed by dialysis in XB. After measuring the concentration, 60 µM zzRCC1 and 2.4 µM zzRCC1 were combined in XB containing 2 mM GTP. Before aliquoting and storage, the measurement of Rango fluorescence emission in a spectrometer (see below) was used to verify that the zzRanQ69L-GTP-containing mix robustly induced Rango dissociation from importin β.</p></sec><sec id="s4-3-4"><title>Importin β biotinylation</title><p>To prepare biotinylated WT importin β-Avitag (pKW1982, pK1099), BL21DE3 cells (New England Biolabs, Ipswich, MA) were co-transfected with the respective plasmids together with pAC-biotin ligase (Avidity), followed by plating and growth in LB media containing ampicillin and chloramphenicol. After the 37°C cultures reached OD<sub>600nm</sub> + 0.4–0.6, the cultures were cooled to room temperature, supplemented with 100 µM D-biotin, and the expression was induced with 0.3 mM IPTG at room temperature for 8–11 hr (pKW762). Proteins were purified on Ni-NTA resin as described for the non-biotinylated importin β fragments.</p></sec><sec id="s4-3-5"><title>FG- and GLFG-nucleoporin fragments</title><p>The expression of GST- Nsp1<sub>(497-609)</sub> in BL21(DE3) cells grown in LB media was induced at OD<sub>600nm </sub>= 0.4–0.6, followed by incubation at 37°C for 3–5 hr. The GST-tagged <italic>S. cerevisiae</italic> pGEX-Nup100<sub>(1-307)</sub>, Nup100<sub>(1-610)</sub>, Nup116<sub>(348-458)</sub> and Nup116<sub>(348-458)</sub>F &gt; A were expressed in T7 Shuffle cells (NEB) that were grown in Dynamite media (<xref ref-type="bibr" rid="bib76">Taylor et al., 2017</xref>) until OD<sub>600nm </sub>= 0.9 before induction with IPTG at 37°C for 3 hr. All the GST-tagged Nup fragments were purified using glutathione-sepharose affinity chromatography, as described for the GST-GFP-NLS above, and dialyzed into PBS before storage.</p></sec></sec><sec id="s4-4"><title>Importin β labeling with Alexa-647 and BSA biotinylation</title><p>Purified WT importin β (pKW485) diluted to 10 µM in XB was combined with 10-molar excess of Alexa Fluor 647 NHS ester (ThermoFisher), using freshly-prepared 10 mM dye in anhydrous DMSO. After incubation on ice for 2 hr, the sample was dialyzed in PBS and concentrated on 30kD MWCO filter (Millipore Sigma) before storage. A similar protocol was used to label BSA with 10-molar excess Sulfo-NHS-LC-biotin (ThermoFisher), followed by dialysis in PBS.</p></sec><sec id="s4-5"><title>DPR labeling with Alexa-488-maleimide</title><p>Just before labeling, Alexa Fluor 488 C5-maleimide (ThermoFisher) was diluted to 20 mM in anhydrous DMSO and further diluted to 1.6 mM in XB’ buffer. Freshly thawed 10 mM aliquots of DPRs were diluted to 2 mM with 0.1x XB’ and combined with an equal volume of 1.6 mM Alexa Fluor 488 C5-maleimide and kept overnight at 4°C. The unreacted maleimide was quenched by 1:50 (v/v) 100 mM DTT before aliquoting and storage at −80°C. To verify labeling, DPRs were separated by SDS-PAGE followed by fluorescence detection.</p></sec><sec id="s4-6"><title>Rango FRET detection</title><p>FRET assays for DPR-induced dissociation of the importin β-Rango complex were performed using a mix of 5 µM Rango-2/α1 (pK188) and 12.5 µM importin β (pKW485) prepared as described above. After thawing on ice, the mix was diluted to 20 nM Rango and 50 nM importin β in TBS, pH 7.4, 0.01% Tween-20 (TTBS), supplemented with increasing DPR concentrations, and mixed by brief vortexing at low speed. The positive control reactions for RanGTP-induced Rango-importin β dissociation were prepared by adding increasing concentrations of ZZ-RanQ69L-GTP to the samples, using a freshly thawed aliquot of 60 µM ZZ-RanQ69L, 2.4 µM ZZ-RCC1, 2 mM GTP in XB. The assay buffer alone was used as a blank. A Fluoromax-2 spectrometer (Jobin Yvon Horiba, Piscataway, NJ) was used to detect the Rango emission spectra (460–550 nm, in 1 nm increments) while exciting the samples at 435 nm. The excitation and emission bandpass were set to 5 nm and integration time to 0.05 s. Peak emissions were recorded at 480 nm (donor) and 535 nm (acceptor) in all samples, and background emission subtracted at the same wavelengths in the blank. The FRET signal was calculated as the ratio of background-subtracted acceptor/donor emissions. The signal detected in the untreated sample (20 nM Rango and 50 nM importin β-only, the lowest FRET), was then subtracted from the resulting values. Prism v6 (Graphpad, San Diego, CA) was used to calculate the non-linear fit with one site-specific binding model while using the D’Agostino and Pearson K2 test to verify the normality of residuals and the Runs test to assure non-significant deviation from the model.</p></sec><sec id="s4-7"><title>Biochemical pulldown assay for DPR-induced Rango-importin β dissociation</title><p>An aliquot of 5 µM Rango-2/α1 + 12.5 µM importin β mix was diluted to 20 nM Rango and 50 nM importin β in TTBS, supplemented with increasing concentrations of GR10 or PR10, mixed by vortexing, and incubated for 30 min at room temperature. GFP-Trap magnetic beads (Chromotek, Planegg-Martinsried, Germany) were washed and resuspended in TTBS. At the end of incubation, 8 µl bead suspension was added to each sample and mixed by rotation for 15 min. The supernatant was removed and beads washed 3 times with TTBS before boiling in 20 µl SDS-PAGE sample buffer with 2% β-mercaptoethanol. Samples were separated by SDS-PAGE and anti-GFP western blot performed as detailed below to detect Rango. After detecting the ECL signal, membranes were stained with Coomassie Brilliant R250 to detect importin β. Background-subtracted signals were determined by Image Lab 6.01 (BioRad) and the Rango ECL signal normalized to the importin β signal within each lane.</p></sec><sec id="s4-8"><title>Electrophoretic mobility gel shift assay for RNA-DPR interaction</title><p>Aliquots of total HEK RNA (3 µg) were mixed with either 4 µl 50 µM DPR-AF488 in 0.1x XB’ or with 1 µl 0.2% SYBR Gold nucleic acid stain (ThermoFisher) diluted in water. After 5 min incubation at room temperature, the samples were supplemented with Fast Digest loading buffer (ThermoFisher; no nucleic acid stain) and separated by electrophoresis on native 1% agarose gel in TBE, alongside with lanes containing HEK RNA (3 µg) or RNA ladder mixed with SYBR Gold. Immediately after electrophoresis, the gels were photographed with Bio-Rad ChemiDoc XRS+ using UV transillumination to simultaneously visualize the AF488-labeled R-DPRs and SYBR Gold-labeled RNA signals (where added).</p></sec><sec id="s4-9"><title>Bead halo assay</title><p>The bead halo assay was carried out as described with minor modifications (<xref ref-type="bibr" rid="bib64">Patel and Rexach, 2008</xref>), using 6–8 µM polystyrene beads coated with neutravidin (for biotinylated proteins) or glutathione (for GST-fusion proteins) (Spherotech, Lake Forest, IL). Beads were coated overnight at 4°C at saturating concentrations per manufacturers’ instructions and rinsed 2x in binding buffer (20 mM HEPES [pH 7.4], 150 mM KOAc, 2 mM Mg(OAc)<sub>2</sub>, 1 mM DTT, 0.1% Tween-20). Immediately prior to the assay, fluorescent bait proteins and beads were combined with 4x assay buffer (40 mM EDTA, 40 mg/ml BSA, 500 mM NaCl, and 0.2% Tween) to a total of 40 µL per well, in optical glass-bottom 96-well plates (Cellvis, Mountain View, CA). Reactions were allowed to equilibrate at room temperature for a minimum of 30 min prior to imaging at 100x on an LSM800 confocal microscope (Zeiss, Oberkochen, Germany). Intensity profiles comparing the maximum rim intensity to the background were plotted in ImageJ (NIH) by an investigator blinded to experimental conditions.</p></sec><sec id="s4-10"><title>Mouse primary cortical neuron culture and permeabilization</title><p>All animal procedures were approved by the Johns Hopkins Animal Care and Use Committee. Timed pregnant C57BL/6J females (Jackson Laboratory, Bar Harbor, ME) were sacrificed by cervical dislocation at E16, cortex dissociated, and cells plated at 50,000/well on poly-D-lysine/laminin-coated, optical glass-bottom 96-well plates. Growth medium consisted of Neurobasal supplemented with B27, Glutamax, and penicillin/streptomycin (Gibco/ThermoFisher). At 5–7 days in vitro, neurons were rinsed in prewarmed PBS and permeabilized for 4 min. at 37° in a hypotonic solution containing 0–40 µM Tris-HCl pH 7.5 (to cause osmotic swelling) and 50–150 mg/ml BSA (for molecular crowding/mechanical support). Following permeabilization, cells were placed on ice and rinsed 2 × 5 min in transport buffer (TRB, 20 mM HEPES, 110 mM KOAc, 2 mM Mg(OAc)<sub>2</sub>, 5 mM NaOAc, 0.5 mM EGTA, 250 mM sucrose, pH 7.3, with protease inhibitor cocktail). All rinse and assay buffers were supplemented with 50 mg/mL BSA. The optimal hypotonic buffer and BSA concentration varied by batch, and was optimized prior to each set of assays for ability to permeabilize the majority of plasma membranes while maintaining nuclear exclusion of a 70 kD fluorescent dextran (ThermoFisher).</p></sec><sec id="s4-11"><title>HeLa cell culture and permeabilization</title><p>A single cell-derived clone of HeLa cells (ATCC, Manassas, VA; mycoplasma negative and validated by STR profiling) were maintained in OptiMEM (Gibco/ThermoFisher) with 4% FBS and plated on uncoated optical glass-bottom 96 well plates, at appropriate densities to reach 70–90% confluence on the day of the transport assay. To permeabilize, cells were rinsed for 2 min in ice-cold PBS, and permeabilized on ice for 10 min in 15–30 µg/mL digitonin (Calbiochem, San Diego, CA) in permeabilization buffer (PRB, 20 mM HEPES, 110 mM KOAc, 5 mM Mg(OAc)2, 0.5 mM EGTA, 250 mM sucrose, pH 7.5, with protease inhibitor cocktail). Following permeabilization, cells were placed on ice and rinsed 3 × 5 min in transport buffer (TRB, 20 mM HEPES, 110 mM KOAc, 2 mM Mg(OAc)<sub>2</sub>, 5 mM NaOAc, 0.5 mM EGTA, 250 mM sucrose, pH 7.3, with protease inhibitor cocktail). The optimal digitonin concentration varied by cell density and passage number, and was optimized prior to each set of assays for the ability to permeabilize the majority of plasma membranes while maintaining nuclear exclusion of a 70 kD fluorescent dextran (ThermoFisher).</p></sec><sec id="s4-12"><title>Nuclear import assays</title><sec id="s4-12-1"><title>Assay components</title><p>Nuclear import was carried out essentially as described (<xref ref-type="bibr" rid="bib1">Adam et al., 1990</xref>) with modified sucrose-containing buffers (<xref ref-type="bibr" rid="bib93">Zhu et al., 2016</xref>). Concentrated whole cell lysates were prepared from HEK293T cells (ATCC, mycoplasma negative and validated by STR profiling), grown in 150 mm dishes and sonicated on ice in 1X TRB in the presence of protease inhibitor cocktail (Roche). The lysates were clarified (15 min, 14000 g, 4C), snap frozen in liquid nitrogen, and stored in single use aliquots at −80C. Total HEK cell RNA was extracted using miRNEasy kits according to the manufacturers’ protocol, with DNase digestion (Qiagen). RNA concentration was measured by Nanodrop (ThermoFisher), and all 260/280 ratios were verified to be &gt; 2.0. Energy regeneration (ER) mix consisted of 100 µM ATP, 100 µM GTP, 4 mM creatine phosphate, and 20 U/mL creatine kinase (Roche).</p></sec><sec id="s4-12-2"><title>Standard assay setup</title><p>Reaction mixes consisting of 2.5 mg/ml lysate, ER, fluorescent cargo (200 nM Rango and YFP-M9-CFP, 500 nM GST-GFP-NLS), Hoechst, DPRs, RNA, or inhibitors (100 µM importazole (IPZ, Millipore Sigma); 0.8 mg/mL wheat germ agglutinin (WGA, Millipore Sigma) were assembled on ice during cell permeabilization. DPRs or inhibitors were allowed to equilibrate in cell lysate for at least 30 min prior to initiation of transport. Every plate included: (1) Cargo alone: fluorescent cargo, but no ER or lysate, (2) Untreated controls: fluorescent cargo, ER, and lysate, and (3) Inhibitor: fluorescent cargo, ER, lysate, and IPZ (Rango and GST-GFP-NLS reactions) or WGA (YFP-M9-CFP). Preassembled transport reactions were then transferred onto permeabilized cells via multichannel pipette, and allowed to proceed at room temperature for 2 hr (Rango, YFP-M9-CFP) or 4 hr (GST-GFP-NLS). Cells were fixed in 4% paraformaldehyde/PBS, rinsed 2x with PBS, and transferred to 50% glycerol/PBS for immediate imaging.</p></sec><sec id="s4-12-3"><title>Variations</title><p>For a subset of neuron transport assays, transport was monitored live via time lapse imaging every 5 min for 30 min. In a subset of HeLa assays, transport reactions were centrifuged before use at 14,000g × 15 min to separate soluble and insoluble fractions. In another variation, the transport lysate + DPR and ER mix was allowed to preincubate on the permeabilized HeLa cells for 1 hour prior to initiation of transport, rinsed 1x with TRB, and transport initiated with fresh lysate, cargo, and ER.</p></sec><sec id="s4-12-4"><title>Imaging and data analysis</title><p>Multiple non-overlapping fields per well (4 for time-lapse imaging, 9-16 for fixed imaging), were captured at 40x on an ImageXpress Micro XLS high-content microscope (Molecular Devices, San Jose, CA), and the ratio of nuclear to cytoplasmic fluorescence intensity was calculated using the MetaXpress automated translocation-enhanced module. Raw data were filtered to exclude autofluorescence and the mean N/C ratio from wells without ER or cell lysate was subtracted from all values. Resulting N/C ratios were expressed as % untreated, to permit comparisons across biological replicates.</p></sec></sec><sec id="s4-13"><title>Passive import assays</title><p>HeLa cells were permeabilized as above, rinsed 3x with TRB, and reaction mix containing 2.5 mg/ml HEK lysate, ER (to mimic the active import conditions), Hoechst, and/or DPRs were added and allowed to preincubate directly on the permeabilized cells for at least 30 min. 0.8 mg/ml WGA was used as a positive control. Cells were mounted on a Zeiss LSM800 confocal microscope, reaction mix withdrawn, and immediately replaced with fluorescent dextran (ThermoFisher) or recombinant GFP (pK803) in fresh lysate/ER mix to initiate the passive import reaction. A single 40x frame (containing 20–30 cells/well) was imaged per well, with images collected every 10 s for 5 min. The ratio of nuclear fluorescence intensity to local background at each timepoint was analyzed using Imaris (Bitplane, Zurich, Switzerland), and values for each cell were expressed as a ratio of time 0 (1 = no influx, &gt;1 = influx).</p></sec><sec id="s4-14"><title>Mass spectrometry</title><p>50 µM GR10 or 25 µM PR10 (in duplicate) were added to 5 mg/ml HEK whole cell lysate (in TRB with ER), incubated for 60 min at 37°C and aggregates were pelleted by centrifugation at 16,000 g for 10 min. Supernatants were removed and pellets washed 2x and resuspended in MgCl<sub>2</sub>- and CaCl<sub>2</sub>- free DPBS (ThermoFisher), then flash-frozen in liquid nitrogen and stored at −80°C before further processing and analysis by the Johns Hopkins Mass Spectrometry and Proteomics core facility. Pellets were reduced/alkylated with DTT/IAA, reconstituted in TEAB/acetonitrile, and sonicated for 15 min prior to overnight digestion with Trypsin/LysC (Promega, Madison, WI) at 37°C. Some precipitate remained; supernatants were desalted and analyzed by LC/MS/MS on a QExactive_Plus mass spectrometer (ThermoFisher). MS/MS spectra were searched via Proteome Discoverer 2.2 (ThermoFisher) with Mascot 2.6.2 (Matrix Science, London, UK) against the RefSeq2017_83_ human species database (NCBI). Protein probabilities were assigned by the Protein Prophet algorithm (<xref ref-type="bibr" rid="bib57">Nesvizhskii et al., 2003</xref>). Protein identifications were accepted if they contained at least 2 identified peptides at false discovery rate less than 1.0%. Gene ontology analysis was carried out using the DAVID algorithm v6.8 (May 2016, <ext-link ext-link-type="uri" xlink:href="https://david.ncifcrf.gov/">https://david.ncifcrf.gov/</ext-link>; <xref ref-type="bibr" rid="bib28">Huang et al., 2009a</xref>; <xref ref-type="bibr" rid="bib29">Huang et al., 2009b</xref>). The mass spectrometry data have been uploaded to the ProteomeXchange Consortium (<ext-link ext-link-type="uri" xlink:href="http://proteomecentral.proteomexchange.org">http://proteomecentral.proteomexchange.org</ext-link>) via the PRIDE partner repository (<xref ref-type="bibr" rid="bib80">Vizcaíno et al., 2013</xref>) with the dataset identifier PXD015656 and 10.6019/PXD015656.</p></sec><sec id="s4-15"><title>DPR aggregation assay and western blots</title><p>Supernatant and pellet fractions (for all 5 DPRs, and control/buffer only) were prepared as in the nuclear transport assays, by adding 100 µM 10mers to 2.5 mg/ml HEK lysate in 100 µL TRB. Supernatants were boiled in Laemmli (BioRad) for 5 min. Pellets were boiled for 15 min followed by sonication in order to fully disperse aggregates for SDS-PAGE. Equal volumes of supernatant and pellet fractions were run on 4–12% Bolt Bis-Tris Plus gels (ThermoFisher), transferred to nitrocellulose membrane using an iBlot2 dry blotting system (ThermoFisher). Protein loading was analyzed by BLOT-Faststain (G-biosciences, St. Louis, MO), according to the manufacterers’ instructions. For immunodetection, membranes were blocked with 5% non-fat milk in TBST and probed by sequential incubation with the primary antibodies as detailed in the table below. Detection was by HRP-conjugated secondary antibodies/chemiluminescence using an ImageQuant LAS 4000 system (GE, Chicago, IL). To permit sequential probing of membranes without stripping, signals were quenched by incubation with prewarmed 30% H<sub>2</sub>0<sub>2</sub> for 20 min (<xref ref-type="bibr" rid="bib71">Sennepin et al., 2009</xref>). Band intensities were measured by ImageQuant software. For pellet vs. supernatant fractions, all were expressed as percent untreated control. For blots in <xref ref-type="fig" rid="fig1">Figure 1E</xref>, samples were run on 4–20% SDS PAGE minigels (ThermoFisher) and blotted to PVDF membranes (Immun-Blot PVDF, Bio-Rad) using the Bio-Rad TransBlot Turbo apparatus, and probed as above. The chemiluminescence signal was captured with a Bio-Rad ChemiDoc XRS+ digital imaging system.</p></sec><sec id="s4-16"><title>Statistical analysis</title><p>Data analysis, graphing, and statistical analyses were carried out using Prism v6-v8 (Graphpad), according to methods detailed under each experimental approach above and in the figure legends.</p></sec></sec></body><back><ack id="ack"><title>Acknowledgements</title><p>We thank all members of the Rothstein lab for helpful discussion. Lin Xue and Svetlana Vidensky provided expert technical assistance. Robert Cole and Tatiana Boronina in the Johns Hopkins Proteomics Core assisted with proteomics analysis and interpretation. We gratefully acknowledge M Rexach, M Dasso, E Onischenko and K Weis for providing expression plasmids.</p></ack><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Methodology, Validation, Formal analysis, Investigation, Data curation, Writing-original draft preparation, Writing-review &amp; editing, Visualization, Funding acquisition</p></fn><fn fn-type="con" id="con2"><p>Investigation, Formal analysis, Validation, Writing-review &amp; editing</p></fn><fn fn-type="con" id="con3"><p>Investigation, Formal analysis, Writing-review &amp; editing</p></fn><fn fn-type="con" id="con4"><p>Conceptualization, Methodology, Validation, Formal analysis, Investigation, Resources, Data curation, Writing-review &amp; editing, Visualization, Supervision</p></fn><fn fn-type="con" id="con5"><p>Conceptualization, Writing-review &amp; editing, Supervision, Project administration, Funding acquisition</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: All animal studies were approved by the Johns Hopkins University Animal Care and Use Committee (protocol MO17M75), and carried out in strict accordance with the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health.</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="transrepform"><label>Transparent reporting form</label><media mime-subtype="pdf" mimetype="application" xlink:href="elife-51685-transrepform-v1.pdf"/></supplementary-material></sec><sec id="s7" sec-type="data-availability"><title>Data availability</title><p>The mass spectrometry data have been uploaded to the ProteomeXchange Consortium (<ext-link ext-link-type="uri" xlink:href="http://proteomecentral.proteomexchange.org">http://proteomecentral.proteomexchange.org</ext-link>) via the PRIDE partner repository (Vizcaino et al., 2013) with the dataset identifier PXD015656 and <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.6019/PXD015656">https://doi.org/10.6019/PXD015656</ext-link>.</p><p>The following dataset was generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Hayes</collab><collab>Duan</collab><collab>Bowen</collab><collab>Kalab</collab><collab>Rothstein</collab></person-group><year iso-8601-date="2020">2020</year><data-title>C9orf72 arginine-rich dipeptide repeat proteins disrupt karyopherin-mediated nuclear import</data-title><source>ProteomeXchange Consortium</source><pub-id assigning-authority="other" pub-id-type="accession" xlink:href="https://doi.org/10.6019/PXD015656">PXD015656</pub-id></element-citation></p></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adam</surname> <given-names>SA</given-names></name><name><surname>Marr</surname> <given-names>RS</given-names></name><name><surname>Gerace</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="1990">1990</year><article-title>Nuclear protein import in permeabilized mammalian cells requires soluble cytoplasmic factors</article-title><source>The Journal of Cell Biology</source><volume>111</volume><fpage>807</fpage><lpage>816</lpage><pub-id pub-id-type="doi">10.1083/jcb.111.3.807</pub-id><pub-id pub-id-type="pmid">2391365</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ash</surname> <given-names>PE</given-names></name><name><surname>Bieniek</surname> <given-names>KF</given-names></name><name><surname>Gendron</surname> <given-names>TF</given-names></name><name><surname>Caulfield</surname> <given-names>T</given-names></name><name><surname>Lin</surname> <given-names>WL</given-names></name><name><surname>Dejesus-Hernandez</surname> <given-names>M</given-names></name><name><surname>van Blitterswijk</surname> <given-names>MM</given-names></name><name><surname>Jansen-West</surname> <given-names>K</given-names></name><name><surname>Paul</surname> <given-names>JW</given-names></name><name><surname>Rademakers</surname> <given-names>R</given-names></name><name><surname>Boylan</surname> <given-names>KB</given-names></name><name><surname>Dickson</surname> <given-names>DW</given-names></name><name><surname>Petrucelli</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Unconventional translation of C9ORF72 GGGGCC expansion generates insoluble polypeptides specific to c9FTD/ALS</article-title><source>Neuron</source><volume>77</volume><fpage>639</fpage><lpage>646</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2013.02.004</pub-id><pub-id pub-id-type="pmid">23415312</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baade</surname> <given-names>I</given-names></name><name><surname>Kehlenbach</surname> <given-names>RH</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>The cargo spectrum of nuclear transport receptors</article-title><source>Current Opinion in Cell Biology</source><volume>58</volume><fpage>1</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1016/j.ceb.2018.11.004</pub-id><pub-id pub-id-type="pmid">30530239</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Banani</surname> <given-names>SF</given-names></name><name><surname>Lee</surname> <given-names>HO</given-names></name><name><surname>Hyman</surname> <given-names>AA</given-names></name><name><surname>Rosen</surname> <given-names>MK</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Biomolecular condensates: organizers of cellular biochemistry</article-title><source>Nature Reviews Molecular Cell Biology</source><volume>18</volume><fpage>285</fpage><lpage>298</lpage><pub-id pub-id-type="doi">10.1038/nrm.2017.7</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boeynaems</surname> <given-names>S</given-names></name><name><surname>Bogaert</surname> <given-names>E</given-names></name><name><surname>Michiels</surname> <given-names>E</given-names></name><name><surname>Gijselinck</surname> <given-names>I</given-names></name><name><surname>Sieben</surname> <given-names>A</given-names></name><name><surname>Jovičić</surname> <given-names>A</given-names></name><name><surname>De Baets</surname> <given-names>G</given-names></name><name><surname>Scheveneels</surname> <given-names>W</given-names></name><name><surname>Steyaert</surname> <given-names>J</given-names></name><name><surname>Cuijt</surname> <given-names>I</given-names></name><name><surname>Verstrepen</surname> <given-names>KJ</given-names></name><name><surname>Callaerts</surname> <given-names>P</given-names></name><name><surname>Rousseau</surname> <given-names>F</given-names></name><name><surname>Schymkowitz</surname> <given-names>J</given-names></name><name><surname>Cruts</surname> <given-names>M</given-names></name><name><surname>Van Broeckhoven</surname> <given-names>C</given-names></name><name><surname>Van Damme</surname> <given-names>P</given-names></name><name><surname>Gitler</surname> <given-names>AD</given-names></name><name><surname>Robberecht</surname> <given-names>W</given-names></name><name><surname>Van Den Bosch</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title><italic>Drosophila</italic> screen connects nuclear transport genes to DPR pathology in c9ALS/FTD</article-title><source>Scientific Reports</source><volume>6</volume><elocation-id>20877</elocation-id><pub-id pub-id-type="doi">10.1038/srep20877</pub-id><pub-id pub-id-type="pmid">26869068</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boeynaems</surname> <given-names>S</given-names></name><name><surname>Bogaert</surname> <given-names>E</given-names></name><name><surname>Kovacs</surname> <given-names>D</given-names></name><name><surname>Konijnenberg</surname> <given-names>A</given-names></name><name><surname>Timmerman</surname> <given-names>E</given-names></name><name><surname>Volkov</surname> <given-names>A</given-names></name><name><surname>Guharoy</surname> <given-names>M</given-names></name><name><surname>De Decker</surname> <given-names>M</given-names></name><name><surname>Jaspers</surname> <given-names>T</given-names></name><name><surname>Ryan</surname> <given-names>VH</given-names></name><name><surname>Janke</surname> <given-names>AM</given-names></name><name><surname>Baatsen</surname> <given-names>P</given-names></name><name><surname>Vercruysse</surname> <given-names>T</given-names></name><name><surname>Kolaitis</surname> <given-names>RM</given-names></name><name><surname>Daelemans</surname> <given-names>D</given-names></name><name><surname>Taylor</surname> <given-names>JP</given-names></name><name><surname>Kedersha</surname> <given-names>N</given-names></name><name><surname>Anderson</surname> <given-names>P</given-names></name><name><surname>Impens</surname> <given-names>F</given-names></name><name><surname>Sobott</surname> <given-names>F</given-names></name><name><surname>Schymkowitz</surname> <given-names>J</given-names></name><name><surname>Rousseau</surname> <given-names>F</given-names></name><name><surname>Fawzi</surname> <given-names>NL</given-names></name><name><surname>Robberecht</surname> <given-names>W</given-names></name><name><surname>Van Damme</surname> <given-names>P</given-names></name><name><surname>Tompa</surname> <given-names>P</given-names></name><name><surname>Van Den Bosch</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Phase separation of C9orf72 dipeptide repeats perturbs stress granule dynamics</article-title><source>Molecular Cell</source><volume>65</volume><fpage>1044</fpage><lpage>1055</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2017.02.013</pub-id><pub-id pub-id-type="pmid">28306503</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chai</surname> <given-names>N</given-names></name><name><surname>Gitler</surname> <given-names>AD</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Yeast screen for modifiers of C9orf72 poly(glycine-arginine) dipeptide repeat toxicity</article-title><source>FEMS Yeast Research</source><volume>18</volume><elocation-id>913</elocation-id><pub-id pub-id-type="doi">10.1093/femsyr/foy024</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname> <given-names>YJ</given-names></name><name><surname>Jeng</surname> <given-names>US</given-names></name><name><surname>Chiang</surname> <given-names>YL</given-names></name><name><surname>Hwang</surname> <given-names>IS</given-names></name><name><surname>Chen</surname> <given-names>YR</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The Glycine-Alanine dipeptide repeat from C9orf72 hexanucleotide expansions forms toxic amyloids possessing Cell-to-Cell transmission properties</article-title><source>Journal of Biological Chemistry</source><volume>291</volume><fpage>4903</fpage><lpage>4911</lpage><pub-id pub-id-type="doi">10.1074/jbc.M115.694273</pub-id><pub-id pub-id-type="pmid">26769963</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chi</surname> <given-names>NC</given-names></name><name><surname>Adam</surname> <given-names>EJ</given-names></name><name><surname>Adam</surname> <given-names>SA</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Different binding domains for Ran-GTP and Ran-GDP/RanBP1 on nuclear import factor p97</article-title><source>Journal of Biological Chemistry</source><volume>272</volume><fpage>6818</fpage><lpage>6822</lpage><pub-id pub-id-type="doi">10.1074/jbc.272.10.6818</pub-id><pub-id pub-id-type="pmid">9045717</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cingolani</surname> <given-names>G</given-names></name><name><surname>Petosa</surname> <given-names>C</given-names></name><name><surname>Weis</surname> <given-names>K</given-names></name><name><surname>Müller</surname> <given-names>CW</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Structure of importin-beta bound to the IBB domain of importin-alpha</article-title><source>Nature</source><volume>399</volume><fpage>221</fpage><lpage>229</lpage><pub-id pub-id-type="doi">10.1038/20367</pub-id><pub-id pub-id-type="pmid">10353244</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Colbeau</surname> <given-names>A</given-names></name><name><surname>Nachbaur</surname> <given-names>J</given-names></name><name><surname>Vignais</surname> <given-names>PM</given-names></name></person-group><year iso-8601-date="1971">1971</year><article-title>Enzymic characterization and lipid composition of rat liver subcellular membranes</article-title><source>Biochimica Et Biophysica Acta (BBA) - Biomembranes</source><volume>249</volume><fpage>462</fpage><lpage>492</lpage><pub-id pub-id-type="doi">10.1016/0005-2736(71)90123-4</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cook</surname> <given-names>C</given-names></name><name><surname>Petrucelli</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Genetic convergence brings clarity to the enigmatic red line in ALS</article-title><source>Neuron</source><volume>101</volume><fpage>1057</fpage><lpage>1069</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2019.02.032</pub-id><pub-id pub-id-type="pmid">30897357</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DeJesus-Hernandez</surname> <given-names>M</given-names></name><name><surname>Mackenzie</surname> <given-names>IR</given-names></name><name><surname>Boeve</surname> <given-names>BF</given-names></name><name><surname>Boxer</surname> <given-names>AL</given-names></name><name><surname>Baker</surname> <given-names>M</given-names></name><name><surname>Rutherford</surname> <given-names>NJ</given-names></name><name><surname>Nicholson</surname> <given-names>AM</given-names></name><name><surname>Finch</surname> <given-names>NA</given-names></name><name><surname>Flynn</surname> <given-names>H</given-names></name><name><surname>Adamson</surname> <given-names>J</given-names></name><name><surname>Kouri</surname> <given-names>N</given-names></name><name><surname>Wojtas</surname> <given-names>A</given-names></name><name><surname>Sengdy</surname> <given-names>P</given-names></name><name><surname>Hsiung</surname> <given-names>GY</given-names></name><name><surname>Karydas</surname> <given-names>A</given-names></name><name><surname>Seeley</surname> <given-names>WW</given-names></name><name><surname>Josephs</surname> <given-names>KA</given-names></name><name><surname>Coppola</surname> <given-names>G</given-names></name><name><surname>Geschwind</surname> <given-names>DH</given-names></name><name><surname>Wszolek</surname> <given-names>ZK</given-names></name><name><surname>Feldman</surname> <given-names>H</given-names></name><name><surname>Knopman</surname> <given-names>DS</given-names></name><name><surname>Petersen</surname> <given-names>RC</given-names></name><name><surname>Miller</surname> <given-names>BL</given-names></name><name><surname>Dickson</surname> <given-names>DW</given-names></name><name><surname>Boylan</surname> <given-names>KB</given-names></name><name><surname>Graff-Radford</surname> <given-names>NR</given-names></name><name><surname>Rademakers</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS</article-title><source>Neuron</source><volume>72</volume><fpage>245</fpage><lpage>256</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2011.09.011</pub-id><pub-id pub-id-type="pmid">21944778</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dols-Icardo</surname> <given-names>O</given-names></name><name><surname>García-Redondo</surname> <given-names>A</given-names></name><name><surname>Rojas-García</surname> <given-names>R</given-names></name><name><surname>Sánchez-Valle</surname> <given-names>R</given-names></name><name><surname>Noguera</surname> <given-names>A</given-names></name><name><surname>Gómez-Tortosa</surname> <given-names>E</given-names></name><name><surname>Pastor</surname> <given-names>P</given-names></name><name><surname>Hernández</surname> <given-names>I</given-names></name><name><surname>Esteban-Pérez</surname> <given-names>J</given-names></name><name><surname>Suárez-Calvet</surname> <given-names>M</given-names></name><name><surname>Antón-Aguirre</surname> <given-names>S</given-names></name><name><surname>Amer</surname> <given-names>G</given-names></name><name><surname>Ortega-Cubero</surname> <given-names>S</given-names></name><name><surname>Blesa</surname> <given-names>R</given-names></name><name><surname>Fortea</surname> <given-names>J</given-names></name><name><surname>Alcolea</surname> <given-names>D</given-names></name><name><surname>Capdevila</surname> <given-names>A</given-names></name><name><surname>Antonell</surname> <given-names>A</given-names></name><name><surname>Lladó</surname> <given-names>A</given-names></name><name><surname>Muñoz-Blanco</surname> <given-names>JL</given-names></name><name><surname>Mora</surname> <given-names>JS</given-names></name><name><surname>Galán-Dávila</surname> <given-names>L</given-names></name><name><surname>Rodríguez De Rivera</surname> <given-names>FJ</given-names></name><name><surname>Lleó</surname> <given-names>A</given-names></name><name><surname>Clarimón</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Characterization of the repeat expansion size in C9orf72 in amyotrophic lateral sclerosis and frontotemporal dementia</article-title><source>Human Molecular Genetics</source><volume>23</volume><fpage>749</fpage><lpage>754</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddt460</pub-id><pub-id pub-id-type="pmid">24057670</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eftekharzadeh</surname> <given-names>B</given-names></name><name><surname>Daigle</surname> <given-names>JG</given-names></name><name><surname>Kapinos</surname> <given-names>LE</given-names></name><name><surname>Coyne</surname> <given-names>A</given-names></name><name><surname>Schiantarelli</surname> <given-names>J</given-names></name><name><surname>Carlomagno</surname> <given-names>Y</given-names></name><name><surname>Cook</surname> <given-names>C</given-names></name><name><surname>Miller</surname> <given-names>SJ</given-names></name><name><surname>Dujardin</surname> <given-names>S</given-names></name><name><surname>Amaral</surname> <given-names>AS</given-names></name><name><surname>Grima</surname> <given-names>JC</given-names></name><name><surname>Bennett</surname> <given-names>RE</given-names></name><name><surname>Tepper</surname> <given-names>K</given-names></name><name><surname>DeTure</surname> <given-names>M</given-names></name><name><surname>Vanderburg</surname> <given-names>CR</given-names></name><name><surname>Corjuc</surname> <given-names>BT</given-names></name><name><surname>DeVos</surname> <given-names>SL</given-names></name><name><surname>Gonzalez</surname> <given-names>JA</given-names></name><name><surname>Chew</surname> <given-names>J</given-names></name><name><surname>Vidensky</surname> <given-names>S</given-names></name><name><surname>Gage</surname> <given-names>FH</given-names></name><name><surname>Mertens</surname> <given-names>J</given-names></name><name><surname>Troncoso</surname> <given-names>J</given-names></name><name><surname>Mandelkow</surname> <given-names>E</given-names></name><name><surname>Salvatella</surname> <given-names>X</given-names></name><name><surname>Lim</surname> <given-names>RYH</given-names></name><name><surname>Petrucelli</surname> <given-names>L</given-names></name><name><surname>Wegmann</surname> <given-names>S</given-names></name><name><surname>Rothstein</surname> <given-names>JD</given-names></name><name><surname>Hyman</surname> <given-names>BT</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Tau protein disrupts nucleocytoplasmic transport in Alzheimer’s Disease</article-title><source>Neuron</source><volume>99</volume><fpage>925</fpage><lpage>940</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2018.07.039</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Freibaum</surname> <given-names>BD</given-names></name><name><surname>Lu</surname> <given-names>Y</given-names></name><name><surname>Lopez-Gonzalez</surname> <given-names>R</given-names></name><name><surname>Kim</surname> <given-names>NC</given-names></name><name><surname>Almeida</surname> <given-names>S</given-names></name><name><surname>Lee</surname> <given-names>KH</given-names></name><name><surname>Badders</surname> <given-names>N</given-names></name><name><surname>Valentine</surname> <given-names>M</given-names></name><name><surname>Miller</surname> <given-names>BL</given-names></name><name><surname>Wong</surname> <given-names>PC</given-names></name><name><surname>Petrucelli</surname> <given-names>L</given-names></name><name><surname>Kim</surname> <given-names>HJ</given-names></name><name><surname>Gao</surname> <given-names>FB</given-names></name><name><surname>Taylor</surname> <given-names>JP</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>GGGGCC repeat expansion in C9orf72 compromises nucleocytoplasmic transport</article-title><source>Nature</source><volume>525</volume><fpage>129</fpage><lpage>133</lpage><pub-id pub-id-type="doi">10.1038/nature14974</pub-id><pub-id pub-id-type="pmid">26308899</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Freibaum</surname> <given-names>BD</given-names></name><name><surname>Taylor</surname> <given-names>JP</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>The role of dipeptide repeats in C9ORF72-Related ALS-FTD</article-title><source>Frontiers in Molecular Neuroscience</source><volume>10</volume><elocation-id>35</elocation-id><pub-id pub-id-type="doi">10.3389/fnmol.2017.00035</pub-id><pub-id pub-id-type="pmid">28243191</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frey</surname> <given-names>S</given-names></name><name><surname>Rees</surname> <given-names>R</given-names></name><name><surname>Schünemann</surname> <given-names>J</given-names></name><name><surname>Ng</surname> <given-names>SC</given-names></name><name><surname>Fünfgeld</surname> <given-names>K</given-names></name><name><surname>Huyton</surname> <given-names>T</given-names></name><name><surname>Görlich</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Surface properties determining passage rates of proteins through nuclear pores</article-title><source>Cell</source><volume>174</volume><fpage>202</fpage><lpage>217</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2018.05.045</pub-id><pub-id pub-id-type="pmid">29958108</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gallivan</surname> <given-names>JP</given-names></name><name><surname>Dougherty</surname> <given-names>DA</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Cation-pi interactions in structural biology</article-title><source>PNAS</source><volume>96</volume><fpage>9459</fpage><lpage>9464</lpage><pub-id pub-id-type="doi">10.1073/pnas.96.17.9459</pub-id><pub-id pub-id-type="pmid">10449714</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gendron</surname> <given-names>TF</given-names></name><name><surname>Bieniek</surname> <given-names>KF</given-names></name><name><surname>Zhang</surname> <given-names>YJ</given-names></name><name><surname>Jansen-West</surname> <given-names>K</given-names></name><name><surname>Ash</surname> <given-names>PE</given-names></name><name><surname>Caulfield</surname> <given-names>T</given-names></name><name><surname>Daughrity</surname> <given-names>L</given-names></name><name><surname>Dunmore</surname> <given-names>JH</given-names></name><name><surname>Castanedes-Casey</surname> <given-names>M</given-names></name><name><surname>Chew</surname> <given-names>J</given-names></name><name><surname>Cosio</surname> <given-names>DM</given-names></name><name><surname>van Blitterswijk</surname> <given-names>M</given-names></name><name><surname>Lee</surname> <given-names>WC</given-names></name><name><surname>Rademakers</surname> <given-names>R</given-names></name><name><surname>Boylan</surname> <given-names>KB</given-names></name><name><surname>Dickson</surname> <given-names>DW</given-names></name><name><surname>Petrucelli</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Antisense transcripts of the expanded C9ORF72 hexanucleotide repeat form nuclear RNA foci and undergo repeat-associated non-ATG translation in c9FTD/ALS</article-title><source>Acta Neuropathologica</source><volume>126</volume><fpage>829</fpage><lpage>844</lpage><pub-id pub-id-type="doi">10.1007/s00401-013-1192-8</pub-id><pub-id pub-id-type="pmid">24129584</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gendron</surname> <given-names>TF</given-names></name><name><surname>van Blitterswijk</surname> <given-names>M</given-names></name><name><surname>Bieniek</surname> <given-names>KF</given-names></name><name><surname>Daughrity</surname> <given-names>LM</given-names></name><name><surname>Jiang</surname> <given-names>J</given-names></name><name><surname>Rush</surname> <given-names>BK</given-names></name><name><surname>Pedraza</surname> <given-names>O</given-names></name><name><surname>Lucas</surname> <given-names>JA</given-names></name><name><surname>Murray</surname> <given-names>ME</given-names></name><name><surname>Desaro</surname> <given-names>P</given-names></name><name><surname>Robertson</surname> <given-names>A</given-names></name><name><surname>Overstreet</surname> <given-names>K</given-names></name><name><surname>Thomas</surname> <given-names>CS</given-names></name><name><surname>Crook</surname> <given-names>JE</given-names></name><name><surname>Castanedes-Casey</surname> <given-names>M</given-names></name><name><surname>Rousseau</surname> <given-names>L</given-names></name><name><surname>Josephs</surname> <given-names>KA</given-names></name><name><surname>Parisi</surname> <given-names>JE</given-names></name><name><surname>Knopman</surname> <given-names>DS</given-names></name><name><surname>Petersen</surname> <given-names>RC</given-names></name><name><surname>Boeve</surname> <given-names>BF</given-names></name><name><surname>Graff-Radford</surname> <given-names>NR</given-names></name><name><surname>Rademakers</surname> <given-names>R</given-names></name><name><surname>Lagier-Tourenne</surname> <given-names>C</given-names></name><name><surname>Edbauer</surname> <given-names>D</given-names></name><name><surname>Cleveland</surname> <given-names>DW</given-names></name><name><surname>Dickson</surname> <given-names>DW</given-names></name><name><surname>Petrucelli</surname> <given-names>L</given-names></name><name><surname>Boylan</surname> <given-names>KB</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Cerebellar c9RAN proteins associate with clinical and neuropathological characteristics of C9ORF72 repeat expansion carriers</article-title><source>Acta Neuropathologica</source><volume>130</volume><fpage>559</fpage><lpage>573</lpage><pub-id pub-id-type="doi">10.1007/s00401-015-1474-4</pub-id><pub-id pub-id-type="pmid">26350237</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Görlich</surname> <given-names>D</given-names></name><name><surname>Henklein</surname> <given-names>P</given-names></name><name><surname>Laskey</surname> <given-names>RA</given-names></name><name><surname>Hartmann</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>A 41 amino acid motif in importin-alpha confers binding to importin-beta and hence transit into the nucleus</article-title><source>The EMBO Journal</source><volume>15</volume><fpage>1810</fpage><lpage>1817</lpage><pub-id pub-id-type="doi">10.1002/j.1460-2075.1996.tb00530.x</pub-id><pub-id pub-id-type="pmid">8617226</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grima</surname> <given-names>JC</given-names></name><name><surname>Daigle</surname> <given-names>JG</given-names></name><name><surname>Arbez</surname> <given-names>N</given-names></name><name><surname>Cunningham</surname> <given-names>KC</given-names></name><name><surname>Zhang</surname> <given-names>K</given-names></name><name><surname>Ochaba</surname> <given-names>J</given-names></name><name><surname>Geater</surname> <given-names>C</given-names></name><name><surname>Morozko</surname> <given-names>E</given-names></name><name><surname>Stocksdale</surname> <given-names>J</given-names></name><name><surname>Glatzer</surname> <given-names>JC</given-names></name><name><surname>Pham</surname> <given-names>JT</given-names></name><name><surname>Ahmed</surname> <given-names>I</given-names></name><name><surname>Peng</surname> <given-names>Q</given-names></name><name><surname>Wadhwa</surname> <given-names>H</given-names></name><name><surname>Pletnikova</surname> <given-names>O</given-names></name><name><surname>Troncoso</surname> <given-names>JC</given-names></name><name><surname>Duan</surname> <given-names>W</given-names></name><name><surname>Snyder</surname> <given-names>SH</given-names></name><name><surname>Ranum</surname> <given-names>LPW</given-names></name><name><surname>Thompson</surname> <given-names>LM</given-names></name><name><surname>Lloyd</surname> <given-names>TE</given-names></name><name><surname>Ross</surname> <given-names>CA</given-names></name><name><surname>Rothstein</surname> <given-names>JD</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Mutant huntingtin disrupts the nuclear pore complex</article-title><source>Neuron</source><volume>94</volume><fpage>93</fpage><lpage>107</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2017.03.023</pub-id><pub-id pub-id-type="pmid">28384479</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname> <given-names>L</given-names></name><name><surname>Kim</surname> <given-names>HJ</given-names></name><name><surname>Wang</surname> <given-names>H</given-names></name><name><surname>Monaghan</surname> <given-names>J</given-names></name><name><surname>Freyermuth</surname> <given-names>F</given-names></name><name><surname>Sung</surname> <given-names>JC</given-names></name><name><surname>O'Donovan</surname> <given-names>K</given-names></name><name><surname>Fare</surname> <given-names>CM</given-names></name><name><surname>Diaz</surname> <given-names>Z</given-names></name><name><surname>Singh</surname> <given-names>N</given-names></name><name><surname>Zhang</surname> <given-names>ZC</given-names></name><name><surname>Coughlin</surname> <given-names>M</given-names></name><name><surname>Sweeny</surname> <given-names>EA</given-names></name><name><surname>DeSantis</surname> <given-names>ME</given-names></name><name><surname>Jackrel</surname> <given-names>ME</given-names></name><name><surname>Rodell</surname> <given-names>CB</given-names></name><name><surname>Burdick</surname> <given-names>JA</given-names></name><name><surname>King</surname> <given-names>OD</given-names></name><name><surname>Gitler</surname> <given-names>AD</given-names></name><name><surname>Lagier-Tourenne</surname> <given-names>C</given-names></name><name><surname>Pandey</surname> <given-names>UB</given-names></name><name><surname>Chook</surname> <given-names>YM</given-names></name><name><surname>Taylor</surname> <given-names>JP</given-names></name><name><surname>Shorter</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Nuclear-Import receptors reverse aberrant phase transitions of RNA-Binding proteins with Prion-like domains</article-title><source>Cell</source><volume>173</volume><fpage>677</fpage><lpage>692</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2018.03.002</pub-id><pub-id pub-id-type="pmid">29677512</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gupta</surname> <given-names>R</given-names></name><name><surname>Lan</surname> <given-names>M</given-names></name><name><surname>Mojsilovic-Petrovic</surname> <given-names>J</given-names></name><name><surname>Choi</surname> <given-names>WH</given-names></name><name><surname>Safren</surname> <given-names>N</given-names></name><name><surname>Barmada</surname> <given-names>S</given-names></name><name><surname>Lee</surname> <given-names>MJ</given-names></name><name><surname>Kalb</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>The proline/Arginine dipeptide from hexanucleotide repeat expanded <italic>C9ORF72</italic> Inhibits the Proteasome</article-title><source>Eneuro</source><volume>4</volume><elocation-id>ENEURO.0249-16.2017</elocation-id><pub-id pub-id-type="doi">10.1523/ENEURO.0249-16.2017</pub-id><pub-id pub-id-type="pmid">28197542</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hofweber</surname> <given-names>M</given-names></name><name><surname>Hutten</surname> <given-names>S</given-names></name><name><surname>Bourgeois</surname> <given-names>B</given-names></name><name><surname>Spreitzer</surname> <given-names>E</given-names></name><name><surname>Niedner-Boblenz</surname> <given-names>A</given-names></name><name><surname>Schifferer</surname> <given-names>M</given-names></name><name><surname>Ruepp</surname> <given-names>MD</given-names></name><name><surname>Simons</surname> <given-names>M</given-names></name><name><surname>Niessing</surname> <given-names>D</given-names></name><name><surname>Madl</surname> <given-names>T</given-names></name><name><surname>Dormann</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Phase separation of FUS is suppressed by its nuclear import receptor and arginine methylation</article-title><source>Cell</source><volume>173</volume><fpage>706</fpage><lpage>719</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2018.03.004</pub-id><pub-id pub-id-type="pmid">29677514</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hondele</surname> <given-names>M</given-names></name><name><surname>Sachdev</surname> <given-names>R</given-names></name><name><surname>Heinrich</surname> <given-names>S</given-names></name><name><surname>Wang</surname> <given-names>J</given-names></name><name><surname>Vallotton</surname> <given-names>P</given-names></name><name><surname>Fontoura</surname> <given-names>BMA</given-names></name><name><surname>Weis</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>DEAD-box ATPases are global regulators of phase-separated organelles</article-title><source>Nature</source><volume>573</volume><fpage>144</fpage><lpage>148</lpage><pub-id pub-id-type="doi">10.1038/s41586-019-1502-y</pub-id><pub-id pub-id-type="pmid">31435012</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname> <given-names>daW</given-names></name><name><surname>Sherman</surname> <given-names>BT</given-names></name><name><surname>Lempicki</surname> <given-names>RA</given-names></name></person-group><year iso-8601-date="2009">2009a</year><article-title>Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources</article-title><source>Nature Protocols</source><volume>4</volume><fpage>44</fpage><lpage>57</lpage><pub-id pub-id-type="doi">10.1038/nprot.2008.211</pub-id><pub-id pub-id-type="pmid">19131956</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname> <given-names>daW</given-names></name><name><surname>Sherman</surname> <given-names>BT</given-names></name><name><surname>Lempicki</surname> <given-names>RA</given-names></name></person-group><year iso-8601-date="2009">2009b</year><article-title>Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists</article-title><source>Nucleic Acids Research</source><volume>37</volume><fpage>1</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1093/nar/gkn923</pub-id><pub-id pub-id-type="pmid">19033363</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hutten</surname> <given-names>S</given-names></name><name><surname>Dormann</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Nucleocytoplasmic transport defects in neurodegeneration — Cause or consequence?</article-title><source>Seminars in Cell &amp; Developmental Biology</source><volume>5</volume><elocation-id>020</elocation-id><pub-id pub-id-type="doi">10.1016/j.semcdb.2019.05.020</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jäkel</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Importin beta , transportin, RanBP5 and RanBP7 mediate nuclear import of ribosomal proteins in mammalian cells</article-title><source>The EMBO Journal</source><volume>17</volume><fpage>4491</fpage><lpage>4502</lpage><pub-id pub-id-type="doi">10.1093/emboj/17.15.4491</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jäkel</surname> <given-names>S</given-names></name><name><surname>Mingot</surname> <given-names>JM</given-names></name><name><surname>Schwarzmaier</surname> <given-names>P</given-names></name><name><surname>Hartmann</surname> <given-names>E</given-names></name><name><surname>Görlich</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Importins fulfil a dual function as nuclear import receptors and cytoplasmic chaperones for exposed basic domains</article-title><source>The EMBO Journal</source><volume>21</volume><fpage>377</fpage><lpage>386</lpage><pub-id pub-id-type="doi">10.1093/emboj/21.3.377</pub-id><pub-id pub-id-type="pmid">11823430</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jovičić</surname> <given-names>A</given-names></name><name><surname>Mertens</surname> <given-names>J</given-names></name><name><surname>Boeynaems</surname> <given-names>S</given-names></name><name><surname>Bogaert</surname> <given-names>E</given-names></name><name><surname>Chai</surname> <given-names>N</given-names></name><name><surname>Yamada</surname> <given-names>SB</given-names></name><name><surname>Paul</surname> <given-names>JW</given-names></name><name><surname>Sun</surname> <given-names>S</given-names></name><name><surname>Herdy</surname> <given-names>JR</given-names></name><name><surname>Bieri</surname> <given-names>G</given-names></name><name><surname>Kramer</surname> <given-names>NJ</given-names></name><name><surname>Gage</surname> <given-names>FH</given-names></name><name><surname>Van Den Bosch</surname> <given-names>L</given-names></name><name><surname>Robberecht</surname> <given-names>W</given-names></name><name><surname>Gitler</surname> <given-names>AD</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Modifiers of C9orf72 dipeptide repeat toxicity connect nucleocytoplasmic transport defects to FTD/ALS</article-title><source>Nature Neuroscience</source><volume>18</volume><fpage>1226</fpage><lpage>1229</lpage><pub-id pub-id-type="doi">10.1038/nn.4085</pub-id><pub-id pub-id-type="pmid">26308983</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaláb</surname> <given-names>P</given-names></name><name><surname>Pralle</surname> <given-names>A</given-names></name><name><surname>Isacoff</surname> <given-names>EY</given-names></name><name><surname>Heald</surname> <given-names>R</given-names></name><name><surname>Weis</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Analysis of a RanGTP-regulated gradient in mitotic somatic cells</article-title><source>Nature</source><volume>440</volume><fpage>697</fpage><lpage>701</lpage><pub-id pub-id-type="doi">10.1038/nature04589</pub-id><pub-id pub-id-type="pmid">16572176</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaláb</surname> <given-names>P</given-names></name><name><surname>Soderholm</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>The design of förster (fluorescence) resonance energy transfer (FRET)-based molecular sensors for ran GTPase</article-title><source>Methods</source><volume>51</volume><fpage>220</fpage><lpage>232</lpage><pub-id pub-id-type="doi">10.1016/j.ymeth.2010.01.022</pub-id><pub-id pub-id-type="pmid">20096786</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kapinos</surname> <given-names>LE</given-names></name><name><surname>Huang</surname> <given-names>B</given-names></name><name><surname>Rencurel</surname> <given-names>C</given-names></name><name><surname>Lim</surname> <given-names>RYH</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Karyopherins regulate nuclear pore complex barrier and transport function</article-title><source>The Journal of Cell Biology</source><volume>216</volume><fpage>3609</fpage><lpage>3624</lpage><pub-id pub-id-type="doi">10.1083/jcb.201702092</pub-id><pub-id pub-id-type="pmid">28864541</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khosravi</surname> <given-names>B</given-names></name><name><surname>Hartmann</surname> <given-names>H</given-names></name><name><surname>May</surname> <given-names>S</given-names></name><name><surname>Möhl</surname> <given-names>C</given-names></name><name><surname>Ederle</surname> <given-names>H</given-names></name><name><surname>Michaelsen</surname> <given-names>M</given-names></name><name><surname>Schludi</surname> <given-names>MH</given-names></name><name><surname>Dormann</surname> <given-names>D</given-names></name><name><surname>Edbauer</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Cytoplasmic poly-GA aggregates impair nuclear import of TDP-43 in <italic>C9orf72</italic> ALS/FTLD</article-title><source>Human Molecular Genetics</source><volume>26</volume><fpage>ddw432</fpage><lpage>ddw800</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddw432</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klim</surname> <given-names>JR</given-names></name><name><surname>Williams</surname> <given-names>LA</given-names></name><name><surname>Limone</surname> <given-names>F</given-names></name><name><surname>Guerra San Juan</surname> <given-names>I</given-names></name><name><surname>Davis-Dusenbery</surname> <given-names>BN</given-names></name><name><surname>Mordes</surname> <given-names>DA</given-names></name><name><surname>Burberry</surname> <given-names>A</given-names></name><name><surname>Steinbaugh</surname> <given-names>MJ</given-names></name><name><surname>Gamage</surname> <given-names>KK</given-names></name><name><surname>Kirchner</surname> <given-names>R</given-names></name><name><surname>Moccia</surname> <given-names>R</given-names></name><name><surname>Cassel</surname> <given-names>SH</given-names></name><name><surname>Chen</surname> <given-names>K</given-names></name><name><surname>Wainger</surname> <given-names>BJ</given-names></name><name><surname>Woolf</surname> <given-names>CJ</given-names></name><name><surname>Eggan</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>ALS-implicated protein TDP-43 sustains levels of STMN2, a mediator of motor neuron growth and repair</article-title><source>Nature Neuroscience</source><volume>22</volume><fpage>167</fpage><lpage>179</lpage><pub-id pub-id-type="doi">10.1038/s41593-018-0300-4</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kramer</surname> <given-names>NJ</given-names></name><name><surname>Haney</surname> <given-names>MS</given-names></name><name><surname>Morgens</surname> <given-names>DW</given-names></name><name><surname>Jovičić</surname> <given-names>A</given-names></name><name><surname>Couthouis</surname> <given-names>J</given-names></name><name><surname>Li</surname> <given-names>A</given-names></name><name><surname>Ousey</surname> <given-names>J</given-names></name><name><surname>Ma</surname> <given-names>R</given-names></name><name><surname>Bieri</surname> <given-names>G</given-names></name><name><surname>Tsui</surname> <given-names>CK</given-names></name><name><surname>Shi</surname> <given-names>Y</given-names></name><name><surname>Hertz</surname> <given-names>NT</given-names></name><name><surname>Tessier-Lavigne</surname> <given-names>M</given-names></name><name><surname>Ichida</surname> <given-names>JK</given-names></name><name><surname>Bassik</surname> <given-names>MC</given-names></name><name><surname>Gitler</surname> <given-names>AD</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>CRISPR-Cas9 screens in human cells and primary neurons identify modifiers of C9ORF72 dipeptide-repeat-protein toxicity</article-title><source>Nature Genetics</source><volume>50</volume><fpage>603</fpage><lpage>612</lpage><pub-id pub-id-type="doi">10.1038/s41588-018-0070-7</pub-id><pub-id pub-id-type="pmid">29507424</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Langdon</surname> <given-names>EM</given-names></name><name><surname>Qiu</surname> <given-names>Y</given-names></name><name><surname>Ghanbari Niaki</surname> <given-names>A</given-names></name><name><surname>McLaughlin</surname> <given-names>GA</given-names></name><name><surname>Weidmann</surname> <given-names>CA</given-names></name><name><surname>Gerbich</surname> <given-names>TM</given-names></name><name><surname>Smith</surname> <given-names>JA</given-names></name><name><surname>Crutchley</surname> <given-names>JM</given-names></name><name><surname>Termini</surname> <given-names>CM</given-names></name><name><surname>Weeks</surname> <given-names>KM</given-names></name><name><surname>Myong</surname> <given-names>S</given-names></name><name><surname>Gladfelter</surname> <given-names>AS</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>mRNA structure determines specificity of a polyQ-driven phase separation</article-title><source>Science</source><volume>360</volume><fpage>922</fpage><lpage>927</lpage><pub-id pub-id-type="doi">10.1126/science.aar7432</pub-id><pub-id pub-id-type="pmid">29650703</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname> <given-names>BJ</given-names></name><name><surname>Cansizoglu</surname> <given-names>AE</given-names></name><name><surname>Süel</surname> <given-names>KE</given-names></name><name><surname>Louis</surname> <given-names>TH</given-names></name><name><surname>Zhang</surname> <given-names>Z</given-names></name><name><surname>Chook</surname> <given-names>YM</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Rules for nuclear localization sequence recognition by karyopherin beta 2</article-title><source>Cell</source><volume>126</volume><fpage>543</fpage><lpage>558</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2006.05.049</pub-id><pub-id pub-id-type="pmid">16901787</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname> <given-names>KH</given-names></name><name><surname>Zhang</surname> <given-names>P</given-names></name><name><surname>Kim</surname> <given-names>HJ</given-names></name><name><surname>Mitrea</surname> <given-names>DM</given-names></name><name><surname>Sarkar</surname> <given-names>M</given-names></name><name><surname>Freibaum</surname> <given-names>BD</given-names></name><name><surname>Cika</surname> <given-names>J</given-names></name><name><surname>Coughlin</surname> <given-names>M</given-names></name><name><surname>Messing</surname> <given-names>J</given-names></name><name><surname>Molliex</surname> <given-names>A</given-names></name><name><surname>Maxwell</surname> <given-names>BA</given-names></name><name><surname>Kim</surname> <given-names>NC</given-names></name><name><surname>Temirov</surname> <given-names>J</given-names></name><name><surname>Moore</surname> <given-names>J</given-names></name><name><surname>Kolaitis</surname> <given-names>RM</given-names></name><name><surname>Shaw</surname> <given-names>TI</given-names></name><name><surname>Bai</surname> <given-names>B</given-names></name><name><surname>Peng</surname> <given-names>J</given-names></name><name><surname>Kriwacki</surname> <given-names>RW</given-names></name><name><surname>Taylor</surname> <given-names>JP</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>C9orf72 dipeptide repeats impair the assembly, dynamics, and function of Membrane-Less organelles</article-title><source>Cell</source><volume>167</volume><fpage>774</fpage><lpage>788</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2016.10.002</pub-id><pub-id pub-id-type="pmid">27768896</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levy</surname> <given-names>DL</given-names></name><name><surname>Heald</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Nuclear size is regulated by importin α and Ntf2 in <italic>Xenopus</italic></article-title><source>Cell</source><volume>143</volume><fpage>288</fpage><lpage>298</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2010.09.012</pub-id><pub-id pub-id-type="pmid">20946986</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname> <given-names>Y</given-names></name><name><surname>Mori</surname> <given-names>E</given-names></name><name><surname>Kato</surname> <given-names>M</given-names></name><name><surname>Xiang</surname> <given-names>S</given-names></name><name><surname>Wu</surname> <given-names>L</given-names></name><name><surname>Kwon</surname> <given-names>I</given-names></name><name><surname>McKnight</surname> <given-names>SL</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Toxic PR Poly-Dipeptides encoded by the C9orf72 repeat expansion target LC domain polymers</article-title><source>Cell</source><volume>167</volume><fpage>789</fpage><lpage>802</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2016.10.003</pub-id><pub-id pub-id-type="pmid">27768897</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ling</surname> <given-names>JP</given-names></name><name><surname>Pletnikova</surname> <given-names>O</given-names></name><name><surname>Troncoso</surname> <given-names>JC</given-names></name><name><surname>Wong</surname> <given-names>PC</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>TDP-43 repression of nonconserved cryptic exons is compromised in ALS-FTD</article-title><source>Science</source><volume>349</volume><fpage>650</fpage><lpage>655</lpage><pub-id pub-id-type="doi">10.1126/science.aab0983</pub-id><pub-id pub-id-type="pmid">26250685</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lott</surname> <given-names>K</given-names></name><name><surname>Cingolani</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>The importin β binding domain as a master regulator of nucleocytoplasmic transport</article-title><source>Biochimica Et Biophysica Acta (BBA) - Molecular Cell Research</source><volume>1813</volume><fpage>1578</fpage><lpage>1592</lpage><pub-id pub-id-type="doi">10.1016/j.bbamcr.2010.10.012</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname> <given-names>J</given-names></name><name><surname>Goryaynov</surname> <given-names>A</given-names></name><name><surname>Sarma</surname> <given-names>A</given-names></name><name><surname>Yang</surname> <given-names>W</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Self-regulated viscous channel in the nuclear pore complex</article-title><source>PNAS</source><volume>109</volume><fpage>7326</fpage><lpage>7331</lpage><pub-id pub-id-type="doi">10.1073/pnas.1201724109</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mackenzie</surname> <given-names>IR</given-names></name><name><surname>Arzberger</surname> <given-names>T</given-names></name><name><surname>Kremmer</surname> <given-names>E</given-names></name><name><surname>Troost</surname> <given-names>D</given-names></name><name><surname>Lorenzl</surname> <given-names>S</given-names></name><name><surname>Mori</surname> <given-names>K</given-names></name><name><surname>Weng</surname> <given-names>SM</given-names></name><name><surname>Haass</surname> <given-names>C</given-names></name><name><surname>Kretzschmar</surname> <given-names>HA</given-names></name><name><surname>Edbauer</surname> <given-names>D</given-names></name><name><surname>Neumann</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Dipeptide repeat protein pathology in C9ORF72 mutation cases: clinico-pathological correlations</article-title><source>Acta Neuropathologica</source><volume>126</volume><fpage>859</fpage><lpage>879</lpage><pub-id pub-id-type="doi">10.1007/s00401-013-1181-y</pub-id><pub-id pub-id-type="pmid">24096617</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mackenzie</surname> <given-names>IR</given-names></name><name><surname>Frick</surname> <given-names>P</given-names></name><name><surname>Neumann</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>The neuropathology associated with repeat expansions in the C9ORF72 gene</article-title><source>Acta Neuropathologica</source><volume>127</volume><fpage>347</fpage><lpage>357</lpage><pub-id pub-id-type="doi">10.1007/s00401-013-1232-4</pub-id><pub-id pub-id-type="pmid">24356984</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maharana</surname> <given-names>S</given-names></name><name><surname>Wang</surname> <given-names>J</given-names></name><name><surname>Papadopoulos</surname> <given-names>DK</given-names></name><name><surname>Richter</surname> <given-names>D</given-names></name><name><surname>Pozniakovsky</surname> <given-names>A</given-names></name><name><surname>Poser</surname> <given-names>I</given-names></name><name><surname>Bickle</surname> <given-names>M</given-names></name><name><surname>Rizk</surname> <given-names>S</given-names></name><name><surname>Guillén-Boixet</surname> <given-names>J</given-names></name><name><surname>Franzmann</surname> <given-names>TM</given-names></name><name><surname>Jahnel</surname> <given-names>M</given-names></name><name><surname>Marrone</surname> <given-names>L</given-names></name><name><surname>Chang</surname> <given-names>YT</given-names></name><name><surname>Sterneckert</surname> <given-names>J</given-names></name><name><surname>Tomancak</surname> <given-names>P</given-names></name><name><surname>Hyman</surname> <given-names>AA</given-names></name><name><surname>Alberti</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>RNA buffers the phase separation behavior of prion-like RNA binding proteins</article-title><source>Science</source><volume>360</volume><fpage>918</fpage><lpage>921</lpage><pub-id pub-id-type="doi">10.1126/science.aar7366</pub-id><pub-id pub-id-type="pmid">29650702</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Majounie</surname> <given-names>E</given-names></name><name><surname>Renton</surname> <given-names>AE</given-names></name><name><surname>Mok</surname> <given-names>K</given-names></name><name><surname>Dopper</surname> <given-names>EG</given-names></name><name><surname>Waite</surname> <given-names>A</given-names></name><name><surname>Rollinson</surname> <given-names>S</given-names></name><name><surname>Chiò</surname> <given-names>A</given-names></name><name><surname>Restagno</surname> <given-names>G</given-names></name><name><surname>Nicolaou</surname> <given-names>N</given-names></name><name><surname>Simon-Sanchez</surname> <given-names>J</given-names></name><name><surname>van Swieten</surname> <given-names>JC</given-names></name><name><surname>Abramzon</surname> <given-names>Y</given-names></name><name><surname>Johnson</surname> <given-names>JO</given-names></name><name><surname>Sendtner</surname> <given-names>M</given-names></name><name><surname>Pamphlett</surname> <given-names>R</given-names></name><name><surname>Orrell</surname> <given-names>RW</given-names></name><name><surname>Mead</surname> <given-names>S</given-names></name><name><surname>Sidle</surname> <given-names>KC</given-names></name><name><surname>Houlden</surname> <given-names>H</given-names></name><name><surname>Rohrer</surname> <given-names>JD</given-names></name><name><surname>Morrison</surname> <given-names>KE</given-names></name><name><surname>Pall</surname> <given-names>H</given-names></name><name><surname>Talbot</surname> <given-names>K</given-names></name><name><surname>Ansorge</surname> <given-names>O</given-names></name><name><surname>Hernandez</surname> <given-names>DG</given-names></name><name><surname>Arepalli</surname> <given-names>S</given-names></name><name><surname>Sabatelli</surname> <given-names>M</given-names></name><name><surname>Mora</surname> <given-names>G</given-names></name><name><surname>Corbo</surname> <given-names>M</given-names></name><name><surname>Giannini</surname> <given-names>F</given-names></name><name><surname>Calvo</surname> <given-names>A</given-names></name><name><surname>Englund</surname> <given-names>E</given-names></name><name><surname>Borghero</surname> <given-names>G</given-names></name><name><surname>Floris</surname> <given-names>GL</given-names></name><name><surname>Remes</surname> <given-names>AM</given-names></name><name><surname>Laaksovirta</surname> <given-names>H</given-names></name><name><surname>McCluskey</surname> <given-names>L</given-names></name><name><surname>Trojanowski</surname> <given-names>JQ</given-names></name><name><surname>Van Deerlin</surname> <given-names>VM</given-names></name><name><surname>Schellenberg</surname> <given-names>GD</given-names></name><name><surname>Nalls</surname> <given-names>MA</given-names></name><name><surname>Drory</surname> <given-names>VE</given-names></name><name><surname>Lu</surname> <given-names>CS</given-names></name><name><surname>Yeh</surname> <given-names>TH</given-names></name><name><surname>Ishiura</surname> <given-names>H</given-names></name><name><surname>Takahashi</surname> <given-names>Y</given-names></name><name><surname>Tsuji</surname> <given-names>S</given-names></name><name><surname>Le Ber</surname> <given-names>I</given-names></name><name><surname>Brice</surname> <given-names>A</given-names></name><name><surname>Drepper</surname> <given-names>C</given-names></name><name><surname>Williams</surname> <given-names>N</given-names></name><name><surname>Kirby</surname> <given-names>J</given-names></name><name><surname>Shaw</surname> <given-names>P</given-names></name><name><surname>Hardy</surname> <given-names>J</given-names></name><name><surname>Tienari</surname> <given-names>PJ</given-names></name><name><surname>Heutink</surname> <given-names>P</given-names></name><name><surname>Morris</surname> <given-names>HR</given-names></name><name><surname>Pickering-Brown</surname> <given-names>S</given-names></name><name><surname>Traynor</surname> <given-names>BJ</given-names></name><collab>Chromosome 9-ALS/FTD Consortium</collab><collab>French research network on FTLD/FTLD/ALS</collab><collab>ITALSGEN Consortium</collab></person-group><year iso-8601-date="2012">2012</year><article-title>Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study</article-title><source>The Lancet Neurology</source><volume>11</volume><fpage>323</fpage><lpage>330</lpage><pub-id pub-id-type="doi">10.1016/S1474-4422(12)70043-1</pub-id><pub-id pub-id-type="pmid">22406228</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mann</surname> <given-names>JR</given-names></name><name><surname>Gleixner</surname> <given-names>AM</given-names></name><name><surname>Mauna</surname> <given-names>JC</given-names></name><name><surname>Gomes</surname> <given-names>E</given-names></name><name><surname>DeChellis-Marks</surname> <given-names>MR</given-names></name><name><surname>Needham</surname> <given-names>PG</given-names></name><name><surname>Copley</surname> <given-names>KE</given-names></name><name><surname>Hurtle</surname> <given-names>B</given-names></name><name><surname>Portz</surname> <given-names>B</given-names></name><name><surname>Pyles</surname> <given-names>NJ</given-names></name><name><surname>Guo</surname> <given-names>L</given-names></name><name><surname>Calder</surname> <given-names>CB</given-names></name><name><surname>Wills</surname> <given-names>ZP</given-names></name><name><surname>Pandey</surname> <given-names>UB</given-names></name><name><surname>Kofler</surname> <given-names>JK</given-names></name><name><surname>Brodsky</surname> <given-names>JL</given-names></name><name><surname>Thathiah</surname> <given-names>A</given-names></name><name><surname>Shorter</surname> <given-names>J</given-names></name><name><surname>Donnelly</surname> <given-names>CJ</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>RNA binding antagonizes neurotoxic phase transitions of TDP-43</article-title><source>Neuron</source><volume>102</volume><fpage>321</fpage><lpage>338</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2019.01.048</pub-id><pub-id pub-id-type="pmid">30826182</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>May</surname> <given-names>S</given-names></name><name><surname>Hornburg</surname> <given-names>D</given-names></name><name><surname>Schludi</surname> <given-names>MH</given-names></name><name><surname>Arzberger</surname> <given-names>T</given-names></name><name><surname>Rentzsch</surname> <given-names>K</given-names></name><name><surname>Schwenk</surname> <given-names>BM</given-names></name><name><surname>Grässer</surname> <given-names>FA</given-names></name><name><surname>Mori</surname> <given-names>K</given-names></name><name><surname>Kremmer</surname> <given-names>E</given-names></name><name><surname>Banzhaf-Strathmann</surname> <given-names>J</given-names></name><name><surname>Mann</surname> <given-names>M</given-names></name><name><surname>Meissner</surname> <given-names>F</given-names></name><name><surname>Edbauer</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>C9orf72 FTLD/ALS-associated Gly-Ala dipeptide repeat proteins cause neuronal toxicity and Unc119 sequestration</article-title><source>Acta Neuropathologica</source><volume>128</volume><fpage>485</fpage><lpage>503</lpage><pub-id pub-id-type="doi">10.1007/s00401-014-1329-4</pub-id><pub-id pub-id-type="pmid">25120191</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Melamed</surname> <given-names>Z</given-names></name><name><surname>López-Erauskin</surname> <given-names>J</given-names></name><name><surname>Baughn</surname> <given-names>MW</given-names></name><name><surname>Zhang</surname> <given-names>O</given-names></name><name><surname>Drenner</surname> <given-names>K</given-names></name><name><surname>Sun</surname> <given-names>Y</given-names></name><name><surname>Freyermuth</surname> <given-names>F</given-names></name><name><surname>McMahon</surname> <given-names>MA</given-names></name><name><surname>Beccari</surname> <given-names>MS</given-names></name><name><surname>Artates</surname> <given-names>JW</given-names></name><name><surname>Ohkubo</surname> <given-names>T</given-names></name><name><surname>Rodriguez</surname> <given-names>M</given-names></name><name><surname>Lin</surname> <given-names>N</given-names></name><name><surname>Wu</surname> <given-names>D</given-names></name><name><surname>Bennett</surname> <given-names>CF</given-names></name><name><surname>Rigo</surname> <given-names>F</given-names></name><name><surname>Da Cruz</surname> <given-names>S</given-names></name><name><surname>Ravits</surname> <given-names>J</given-names></name><name><surname>Lagier-Tourenne</surname> <given-names>C</given-names></name><name><surname>Cleveland</surname> <given-names>DW</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration</article-title><source>Nature Neuroscience</source><volume>22</volume><fpage>180</fpage><lpage>190</lpage><pub-id pub-id-type="doi">10.1038/s41593-018-0293-z</pub-id><pub-id pub-id-type="pmid">30643298</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mohr</surname> <given-names>D</given-names></name><name><surname>Frey</surname> <given-names>S</given-names></name><name><surname>Fischer</surname> <given-names>T</given-names></name><name><surname>Güttler</surname> <given-names>T</given-names></name><name><surname>Görlich</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Characterisation of the passive permeability barrier of nuclear pore complexes</article-title><source>The EMBO Journal</source><volume>28</volume><fpage>2541</fpage><lpage>2553</lpage><pub-id pub-id-type="doi">10.1038/emboj.2009.200</pub-id><pub-id pub-id-type="pmid">19680228</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nachury</surname> <given-names>MV</given-names></name><name><surname>Weis</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>The direction of transport through the nuclear pore can be inverted</article-title><source>PNAS</source><volume>96</volume><fpage>9622</fpage><lpage>9627</lpage><pub-id pub-id-type="doi">10.1073/pnas.96.17.9622</pub-id><pub-id pub-id-type="pmid">10449743</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nesvizhskii</surname> <given-names>AI</given-names></name><name><surname>Keller</surname> <given-names>A</given-names></name><name><surname>Kolker</surname> <given-names>E</given-names></name><name><surname>Aebersold</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>A statistical model for identifying proteins by tandem mass spectrometry</article-title><source>Analytical Chemistry</source><volume>75</volume><fpage>4646</fpage><lpage>4658</lpage><pub-id pub-id-type="doi">10.1021/ac0341261</pub-id><pub-id pub-id-type="pmid">14632076</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neumann</surname> <given-names>M</given-names></name><name><surname>Sampathu</surname> <given-names>DM</given-names></name><name><surname>Kwong</surname> <given-names>LK</given-names></name><name><surname>Truax</surname> <given-names>AC</given-names></name><name><surname>Micsenyi</surname> <given-names>MC</given-names></name><name><surname>Chou</surname> <given-names>TT</given-names></name><name><surname>Bruce</surname> <given-names>J</given-names></name><name><surname>Schuck</surname> <given-names>T</given-names></name><name><surname>Grossman</surname> <given-names>M</given-names></name><name><surname>Clark</surname> <given-names>CM</given-names></name><name><surname>McCluskey</surname> <given-names>LF</given-names></name><name><surname>Miller</surname> <given-names>BL</given-names></name><name><surname>Masliah</surname> <given-names>E</given-names></name><name><surname>Mackenzie</surname> <given-names>IR</given-names></name><name><surname>Feldman</surname> <given-names>H</given-names></name><name><surname>Feiden</surname> <given-names>W</given-names></name><name><surname>Kretzschmar</surname> <given-names>HA</given-names></name><name><surname>Trojanowski</surname> <given-names>JQ</given-names></name><name><surname>Lee</surname> <given-names>VM</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis</article-title><source>Science</source><volume>314</volume><fpage>130</fpage><lpage>133</lpage><pub-id pub-id-type="doi">10.1126/science.1134108</pub-id><pub-id pub-id-type="pmid">17023659</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nguyen</surname> <given-names>AW</given-names></name><name><surname>Daugherty</surname> <given-names>PS</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Evolutionary optimization of fluorescent proteins for intracellular FRET</article-title><source>Nature Biotechnology</source><volume>23</volume><fpage>355</fpage><lpage>360</lpage><pub-id pub-id-type="doi">10.1038/nbt1066</pub-id><pub-id pub-id-type="pmid">15696158</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nordin</surname> <given-names>A</given-names></name><name><surname>Akimoto</surname> <given-names>C</given-names></name><name><surname>Wuolikainen</surname> <given-names>A</given-names></name><name><surname>Alstermark</surname> <given-names>H</given-names></name><name><surname>Jonsson</surname> <given-names>P</given-names></name><name><surname>Birve</surname> <given-names>A</given-names></name><name><surname>Marklund</surname> <given-names>SL</given-names></name><name><surname>Graffmo</surname> <given-names>KS</given-names></name><name><surname>Forsberg</surname> <given-names>K</given-names></name><name><surname>Brännström</surname> <given-names>T</given-names></name><name><surname>Andersen</surname> <given-names>PM</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Extensive size variability of the GGGGCC expansion in C9orf72 in both neuronal and non-neuronal tissues in 18 patients with ALS or FTD</article-title><source>Human Molecular Genetics</source><volume>24</volume><fpage>3133</fpage><lpage>3142</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddv064</pub-id><pub-id pub-id-type="pmid">25712133</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oka</surname> <given-names>M</given-names></name><name><surname>Yoneda</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Importin α: functions as a nuclear transport factor and beyond</article-title><source>Proceedings of the Japan Academy, Series B</source><volume>94</volume><fpage>259</fpage><lpage>274</lpage><pub-id pub-id-type="doi">10.2183/pjab.94.018</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Onischenko</surname> <given-names>E</given-names></name><name><surname>Tang</surname> <given-names>JH</given-names></name><name><surname>Andersen</surname> <given-names>KR</given-names></name><name><surname>Knockenhauer</surname> <given-names>KE</given-names></name><name><surname>Vallotton</surname> <given-names>P</given-names></name><name><surname>Derrer</surname> <given-names>CP</given-names></name><name><surname>Kralt</surname> <given-names>A</given-names></name><name><surname>Mugler</surname> <given-names>CF</given-names></name><name><surname>Chan</surname> <given-names>LY</given-names></name><name><surname>Schwartz</surname> <given-names>TU</given-names></name><name><surname>Weis</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Natively unfolded FG repeats stabilize the structure of the nuclear pore complex</article-title><source>Cell</source><volume>171</volume><fpage>904</fpage><lpage>917</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2017.09.033</pub-id><pub-id pub-id-type="pmid">29033133</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patel</surname> <given-names>SS</given-names></name><name><surname>Belmont</surname> <given-names>BJ</given-names></name><name><surname>Sante</surname> <given-names>JM</given-names></name><name><surname>Rexach</surname> <given-names>MF</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Natively unfolded nucleoporins gate protein diffusion across the nuclear pore complex</article-title><source>Cell</source><volume>129</volume><fpage>83</fpage><lpage>96</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2007.01.044</pub-id><pub-id pub-id-type="pmid">17418788</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patel</surname> <given-names>SS</given-names></name><name><surname>Rexach</surname> <given-names>MF</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Discovering novel interactions at the nuclear pore complex using bead halo: a rapid method for detecting molecular interactions of high and low affinity at equilibrium</article-title><source>Molecular &amp; Cellular Proteomics : MCP</source><volume>7</volume><fpage>121</fpage><lpage>131</lpage><pub-id pub-id-type="doi">10.1074/mcp.M700407-MCP200</pub-id><pub-id pub-id-type="pmid">17897934</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qamar</surname> <given-names>S</given-names></name><name><surname>Wang</surname> <given-names>G</given-names></name><name><surname>Randle</surname> <given-names>SJ</given-names></name><name><surname>Ruggeri</surname> <given-names>FS</given-names></name><name><surname>Varela</surname> <given-names>JA</given-names></name><name><surname>Lin</surname> <given-names>JQ</given-names></name><name><surname>Phillips</surname> <given-names>EC</given-names></name><name><surname>Miyashita</surname> <given-names>A</given-names></name><name><surname>Williams</surname> <given-names>D</given-names></name><name><surname>Ströhl</surname> <given-names>F</given-names></name><name><surname>Meadows</surname> <given-names>W</given-names></name><name><surname>Ferry</surname> <given-names>R</given-names></name><name><surname>Dardov</surname> <given-names>VJ</given-names></name><name><surname>Tartaglia</surname> <given-names>GG</given-names></name><name><surname>Farrer</surname> <given-names>LA</given-names></name><name><surname>Kaminski Schierle</surname> <given-names>GS</given-names></name><name><surname>Kaminski</surname> <given-names>CF</given-names></name><name><surname>Holt</surname> <given-names>CE</given-names></name><name><surname>Fraser</surname> <given-names>PE</given-names></name><name><surname>Schmitt-Ulms</surname> <given-names>G</given-names></name><name><surname>Klenerman</surname> <given-names>D</given-names></name><name><surname>Knowles</surname> <given-names>T</given-names></name><name><surname>Vendruscolo</surname> <given-names>M</given-names></name><name><surname>St George-Hyslop</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>FUS phase separation is modulated by a molecular chaperone and methylation of arginine Cation-π interactions</article-title><source>Cell</source><volume>173</volume><fpage>720</fpage><lpage>734</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2018.03.056</pub-id><pub-id pub-id-type="pmid">29677515</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reichelt</surname> <given-names>R</given-names></name><name><surname>Holzenburg</surname> <given-names>A</given-names></name><name><surname>Buhle</surname> <given-names>EL</given-names></name><name><surname>Jarnik</surname> <given-names>M</given-names></name><name><surname>Engel</surname> <given-names>A</given-names></name><name><surname>Aebi</surname> <given-names>U</given-names></name></person-group><year iso-8601-date="1990">1990</year><article-title>Correlation between structure and mass distribution of the nuclear pore complex and of distinct pore complex components</article-title><source>The Journal of Cell Biology</source><volume>110</volume><fpage>883</fpage><lpage>894</lpage><pub-id pub-id-type="doi">10.1083/jcb.110.4.883</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Renton</surname> <given-names>AE</given-names></name><name><surname>Majounie</surname> <given-names>E</given-names></name><name><surname>Waite</surname> <given-names>A</given-names></name><name><surname>Simón-Sánchez</surname> <given-names>J</given-names></name><name><surname>Rollinson</surname> <given-names>S</given-names></name><name><surname>Gibbs</surname> <given-names>JR</given-names></name><name><surname>Schymick</surname> <given-names>JC</given-names></name><name><surname>Laaksovirta</surname> <given-names>H</given-names></name><name><surname>van Swieten</surname> <given-names>JC</given-names></name><name><surname>Myllykangas</surname> <given-names>L</given-names></name><name><surname>Kalimo</surname> <given-names>H</given-names></name><name><surname>Paetau</surname> <given-names>A</given-names></name><name><surname>Abramzon</surname> <given-names>Y</given-names></name><name><surname>Remes</surname> <given-names>AM</given-names></name><name><surname>Kaganovich</surname> <given-names>A</given-names></name><name><surname>Scholz</surname> <given-names>SW</given-names></name><name><surname>Duckworth</surname> <given-names>J</given-names></name><name><surname>Ding</surname> <given-names>J</given-names></name><name><surname>Harmer</surname> <given-names>DW</given-names></name><name><surname>Hernandez</surname> <given-names>DG</given-names></name><name><surname>Johnson</surname> <given-names>JO</given-names></name><name><surname>Mok</surname> <given-names>K</given-names></name><name><surname>Ryten</surname> <given-names>M</given-names></name><name><surname>Trabzuni</surname> <given-names>D</given-names></name><name><surname>Guerreiro</surname> <given-names>RJ</given-names></name><name><surname>Orrell</surname> <given-names>RW</given-names></name><name><surname>Neal</surname> <given-names>J</given-names></name><name><surname>Murray</surname> <given-names>A</given-names></name><name><surname>Pearson</surname> <given-names>J</given-names></name><name><surname>Jansen</surname> <given-names>IE</given-names></name><name><surname>Sondervan</surname> <given-names>D</given-names></name><name><surname>Seelaar</surname> <given-names>H</given-names></name><name><surname>Blake</surname> <given-names>D</given-names></name><name><surname>Young</surname> <given-names>K</given-names></name><name><surname>Halliwell</surname> <given-names>N</given-names></name><name><surname>Callister</surname> <given-names>JB</given-names></name><name><surname>Toulson</surname> <given-names>G</given-names></name><name><surname>Richardson</surname> <given-names>A</given-names></name><name><surname>Gerhard</surname> <given-names>A</given-names></name><name><surname>Snowden</surname> <given-names>J</given-names></name><name><surname>Mann</surname> <given-names>D</given-names></name><name><surname>Neary</surname> <given-names>D</given-names></name><name><surname>Nalls</surname> <given-names>MA</given-names></name><name><surname>Peuralinna</surname> <given-names>T</given-names></name><name><surname>Jansson</surname> <given-names>L</given-names></name><name><surname>Isoviita</surname> <given-names>VM</given-names></name><name><surname>Kaivorinne</surname> <given-names>AL</given-names></name><name><surname>Hölttä-Vuori</surname> <given-names>M</given-names></name><name><surname>Ikonen</surname> <given-names>E</given-names></name><name><surname>Sulkava</surname> <given-names>R</given-names></name><name><surname>Benatar</surname> <given-names>M</given-names></name><name><surname>Wuu</surname> <given-names>J</given-names></name><name><surname>Chiò</surname> <given-names>A</given-names></name><name><surname>Restagno</surname> <given-names>G</given-names></name><name><surname>Borghero</surname> <given-names>G</given-names></name><name><surname>Sabatelli</surname> <given-names>M</given-names></name><name><surname>Heckerman</surname> <given-names>D</given-names></name><name><surname>Rogaeva</surname> <given-names>E</given-names></name><name><surname>Zinman</surname> <given-names>L</given-names></name><name><surname>Rothstein</surname> <given-names>JD</given-names></name><name><surname>Sendtner</surname> <given-names>M</given-names></name><name><surname>Drepper</surname> <given-names>C</given-names></name><name><surname>Eichler</surname> <given-names>EE</given-names></name><name><surname>Alkan</surname> <given-names>C</given-names></name><name><surname>Abdullaev</surname> <given-names>Z</given-names></name><name><surname>Pack</surname> <given-names>SD</given-names></name><name><surname>Dutra</surname> <given-names>A</given-names></name><name><surname>Pak</surname> <given-names>E</given-names></name><name><surname>Hardy</surname> <given-names>J</given-names></name><name><surname>Singleton</surname> <given-names>A</given-names></name><name><surname>Williams</surname> <given-names>NM</given-names></name><name><surname>Heutink</surname> <given-names>P</given-names></name><name><surname>Pickering-Brown</surname> <given-names>S</given-names></name><name><surname>Morris</surname> <given-names>HR</given-names></name><name><surname>Tienari</surname> <given-names>PJ</given-names></name><name><surname>Traynor</surname> <given-names>BJ</given-names></name><collab>ITALSGEN Consortium</collab></person-group><year iso-8601-date="2011">2011</year><article-title>A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD</article-title><source>Neuron</source><volume>72</volume><fpage>257</fpage><lpage>268</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2011.09.010</pub-id><pub-id pub-id-type="pmid">21944779</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ribbeck</surname> <given-names>K</given-names></name><name><surname>Görlich</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>The permeability barrier of nuclear pore complexes appears to operate via hydrophobic exclusion</article-title><source>The EMBO Journal</source><volume>21</volume><fpage>2664</fpage><lpage>2671</lpage><pub-id pub-id-type="doi">10.1093/emboj/21.11.2664</pub-id><pub-id pub-id-type="pmid">12032079</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rondón</surname> <given-names>AG</given-names></name><name><surname>Jimeno</surname> <given-names>S</given-names></name><name><surname>Aguilera</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>The interface between transcription and mRNP export: from THO to THSC/TREX-2</article-title><source>Biochimica Et Biophysica Acta (BBA) - Gene Regulatory Mechanisms</source><volume>1799</volume><fpage>533</fpage><lpage>538</lpage><pub-id pub-id-type="doi">10.1016/j.bbagrm.2010.06.002</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmidt</surname> <given-names>HB</given-names></name><name><surname>Görlich</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Transport selectivity of nuclear pores, phase separation, and membraneless organelles</article-title><source>Trends in Biochemical Sciences</source><volume>41</volume><fpage>46</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.1016/j.tibs.2015.11.001</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sennepin</surname> <given-names>AD</given-names></name><name><surname>Charpentier</surname> <given-names>S</given-names></name><name><surname>Normand</surname> <given-names>T</given-names></name><name><surname>Sarré</surname> <given-names>C</given-names></name><name><surname>Legrand</surname> <given-names>A</given-names></name><name><surname>Mollet</surname> <given-names>LM</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Multiple reprobing of western blots after inactivation of peroxidase activity by its substrate, hydrogen peroxide</article-title><source>Analytical Biochemistry</source><volume>393</volume><fpage>129</fpage><lpage>131</lpage><pub-id pub-id-type="doi">10.1016/j.ab.2009.06.004</pub-id><pub-id pub-id-type="pmid">19523435</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname> <given-names>KY</given-names></name><name><surname>Mori</surname> <given-names>E</given-names></name><name><surname>Nizami</surname> <given-names>ZF</given-names></name><name><surname>Lin</surname> <given-names>Y</given-names></name><name><surname>Kato</surname> <given-names>M</given-names></name><name><surname>Xiang</surname> <given-names>S</given-names></name><name><surname>Wu</surname> <given-names>LC</given-names></name><name><surname>Ding</surname> <given-names>M</given-names></name><name><surname>Yu</surname> <given-names>Y</given-names></name><name><surname>Gall</surname> <given-names>JG</given-names></name><name><surname>McKnight</surname> <given-names>SL</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Toxic PR<sub>n</sub> poly-dipeptides encoded by the <italic>C9orf72</italic> repeat expansio<sub>n</sub> block nuclear import and export</article-title><source>PNAS</source><volume>114</volume><fpage>E1111</fpage><lpage>E1117</lpage><pub-id pub-id-type="doi">10.1073/pnas.1620293114</pub-id><pub-id pub-id-type="pmid">28069952</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Siomi</surname> <given-names>H</given-names></name><name><surname>Dreyfuss</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>A nuclear localization domain in the hnRNP A1 protein</article-title><source>The Journal of Cell Biology</source><volume>129</volume><fpage>551</fpage><lpage>560</lpage><pub-id pub-id-type="doi">10.1083/jcb.129.3.551</pub-id><pub-id pub-id-type="pmid">7730395</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soderholm</surname> <given-names>JF</given-names></name><name><surname>Bird</surname> <given-names>SL</given-names></name><name><surname>Kalab</surname> <given-names>P</given-names></name><name><surname>Sampathkumar</surname> <given-names>Y</given-names></name><name><surname>Hasegawa</surname> <given-names>K</given-names></name><name><surname>Uehara-Bingen</surname> <given-names>M</given-names></name><name><surname>Weis</surname> <given-names>K</given-names></name><name><surname>Heald</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Importazole, a small molecule inhibitor of the transport receptor importin-β</article-title><source>ACS Chemical Biology</source><volume>6</volume><fpage>700</fpage><lpage>708</lpage><pub-id pub-id-type="doi">10.1021/cb2000296</pub-id><pub-id pub-id-type="pmid">21469738</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soniat</surname> <given-names>M</given-names></name><name><surname>Chook</surname> <given-names>YM</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Nuclear localization signals for four distinct karyopherin-β nuclear import systems</article-title><source>Biochemical Journal</source><volume>468</volume><fpage>353</fpage><lpage>362</lpage><pub-id pub-id-type="doi">10.1042/BJ20150368</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taylor</surname> <given-names>T</given-names></name><name><surname>Denson</surname> <given-names>JP</given-names></name><name><surname>Esposito</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Optimizing expression and solubility of proteins in <italic>E. coli</italic> using modified media and induction parameters</article-title><source>Methods in Molecular Biology</source><volume>1586</volume><fpage>65</fpage><lpage>82</lpage><pub-id pub-id-type="doi">10.1007/978-1-4939-6887-9_5</pub-id><pub-id pub-id-type="pmid">28470599</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Timney</surname> <given-names>BL</given-names></name><name><surname>Raveh</surname> <given-names>B</given-names></name><name><surname>Mironska</surname> <given-names>R</given-names></name><name><surname>Trivedi</surname> <given-names>JM</given-names></name><name><surname>Kim</surname> <given-names>SJ</given-names></name><name><surname>Russel</surname> <given-names>D</given-names></name><name><surname>Wente</surname> <given-names>SR</given-names></name><name><surname>Sali</surname> <given-names>A</given-names></name><name><surname>Rout</surname> <given-names>MP</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Simple rules for passive diffusion through the nuclear pore complex</article-title><source>The Journal of Cell Biology</source><volume>215</volume><fpage>57</fpage><lpage>76</lpage><pub-id pub-id-type="doi">10.1083/jcb.201601004</pub-id><pub-id pub-id-type="pmid">27697925</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Blitterswijk</surname> <given-names>M</given-names></name><name><surname>Baker</surname> <given-names>MC</given-names></name><name><surname>DeJesus-Hernandez</surname> <given-names>M</given-names></name><name><surname>Ghidoni</surname> <given-names>R</given-names></name><name><surname>Benussi</surname> <given-names>L</given-names></name><name><surname>Finger</surname> <given-names>E</given-names></name><name><surname>Hsiung</surname> <given-names>GY</given-names></name><name><surname>Kelley</surname> <given-names>BJ</given-names></name><name><surname>Murray</surname> <given-names>ME</given-names></name><name><surname>Rutherford</surname> <given-names>NJ</given-names></name><name><surname>Brown</surname> <given-names>PE</given-names></name><name><surname>Ravenscroft</surname> <given-names>T</given-names></name><name><surname>Mullen</surname> <given-names>B</given-names></name><name><surname>Ash</surname> <given-names>PE</given-names></name><name><surname>Bieniek</surname> <given-names>KF</given-names></name><name><surname>Hatanpaa</surname> <given-names>KJ</given-names></name><name><surname>Karydas</surname> <given-names>A</given-names></name><name><surname>Wood</surname> <given-names>EM</given-names></name><name><surname>Coppola</surname> <given-names>G</given-names></name><name><surname>Bigio</surname> <given-names>EH</given-names></name><name><surname>Lippa</surname> <given-names>C</given-names></name><name><surname>Strong</surname> <given-names>MJ</given-names></name><name><surname>Beach</surname> <given-names>TG</given-names></name><name><surname>Knopman</surname> <given-names>DS</given-names></name><name><surname>Huey</surname> <given-names>ED</given-names></name><name><surname>Mesulam</surname> <given-names>M</given-names></name><name><surname>Bird</surname> <given-names>T</given-names></name><name><surname>White</surname> <given-names>CL</given-names></name><name><surname>Kertesz</surname> <given-names>A</given-names></name><name><surname>Geschwind</surname> <given-names>DH</given-names></name><name><surname>Van Deerlin</surname> <given-names>VM</given-names></name><name><surname>Petersen</surname> <given-names>RC</given-names></name><name><surname>Binetti</surname> <given-names>G</given-names></name><name><surname>Miller</surname> <given-names>BL</given-names></name><name><surname>Petrucelli</surname> <given-names>L</given-names></name><name><surname>Wszolek</surname> <given-names>ZK</given-names></name><name><surname>Boylan</surname> <given-names>KB</given-names></name><name><surname>Graff-Radford</surname> <given-names>NR</given-names></name><name><surname>Mackenzie</surname> <given-names>IR</given-names></name><name><surname>Boeve</surname> <given-names>BF</given-names></name><name><surname>Dickson</surname> <given-names>DW</given-names></name><name><surname>Rademakers</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>C9ORF72 repeat expansions in cases with previously identified pathogenic mutations</article-title><source>Neurology</source><volume>81</volume><fpage>1332</fpage><lpage>1341</lpage><pub-id pub-id-type="doi">10.1212/WNL.0b013e3182a8250c</pub-id><pub-id pub-id-type="pmid">24027057</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vanneste</surname> <given-names>J</given-names></name><name><surname>Vercruysse</surname> <given-names>T</given-names></name><name><surname>Boeynaems</surname> <given-names>S</given-names></name><name><surname>Sicart</surname> <given-names>A</given-names></name><name><surname>Van Damme</surname> <given-names>P</given-names></name><name><surname>Daelemans</surname> <given-names>D</given-names></name><name><surname>Van Den Bosch</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>C9orf72-generated poly-GR and poly-PR do not directly interfere with nucleocytoplasmic transport</article-title><source>Scientific Reports</source><volume>9</volume><elocation-id>15728</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-019-52035-6</pub-id><pub-id pub-id-type="pmid">31673013</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vizcaíno</surname> <given-names>JA</given-names></name><name><surname>Côté</surname> <given-names>RG</given-names></name><name><surname>Csordas</surname> <given-names>A</given-names></name><name><surname>Dianes</surname> <given-names>JA</given-names></name><name><surname>Fabregat</surname> <given-names>A</given-names></name><name><surname>Foster</surname> <given-names>JM</given-names></name><name><surname>Griss</surname> <given-names>J</given-names></name><name><surname>Alpi</surname> <given-names>E</given-names></name><name><surname>Birim</surname> <given-names>M</given-names></name><name><surname>Contell</surname> <given-names>J</given-names></name><name><surname>O'Kelly</surname> <given-names>G</given-names></name><name><surname>Schoenegger</surname> <given-names>A</given-names></name><name><surname>Ovelleiro</surname> <given-names>D</given-names></name><name><surname>Pérez-Riverol</surname> <given-names>Y</given-names></name><name><surname>Reisinger</surname> <given-names>F</given-names></name><name><surname>Ríos</surname> <given-names>D</given-names></name><name><surname>Wang</surname> <given-names>R</given-names></name><name><surname>Hermjakob</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>The PRoteomics IDEntifications (PRIDE) database and associated tools: status in 2013</article-title><source>Nucleic Acids Research</source><volume>41</volume><fpage>D1063</fpage><lpage>D1069</lpage><pub-id pub-id-type="doi">10.1093/nar/gks1262</pub-id><pub-id pub-id-type="pmid">23203882</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weis</surname> <given-names>K</given-names></name><name><surname>Ryder</surname> <given-names>U</given-names></name><name><surname>Lamond</surname> <given-names>AI</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>The conserved amino-terminal domain of hSRP1 alpha is essential for nuclear protein import</article-title><source>The EMBO Journal</source><volume>15</volume><fpage>1818</fpage><lpage>1825</lpage><pub-id pub-id-type="doi">10.1002/j.1460-2075.1996.tb00531.x</pub-id><pub-id pub-id-type="pmid">8617227</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wen</surname> <given-names>X</given-names></name><name><surname>Tan</surname> <given-names>W</given-names></name><name><surname>Westergard</surname> <given-names>T</given-names></name><name><surname>Krishnamurthy</surname> <given-names>K</given-names></name><name><surname>Markandaiah</surname> <given-names>SS</given-names></name><name><surname>Shi</surname> <given-names>Y</given-names></name><name><surname>Lin</surname> <given-names>S</given-names></name><name><surname>Shneider</surname> <given-names>NA</given-names></name><name><surname>Monaghan</surname> <given-names>J</given-names></name><name><surname>Pandey</surname> <given-names>UB</given-names></name><name><surname>Pasinelli</surname> <given-names>P</given-names></name><name><surname>Ichida</surname> <given-names>JK</given-names></name><name><surname>Trotti</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Antisense Proline-Arginine RAN dipeptides linked to C9ORF72-ALS/FTD form toxic nuclear aggregates that initiate in Vitro and In Vivo Neuronal Death</article-title><source>Neuron</source><volume>84</volume><fpage>1213</fpage><lpage>1225</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2014.12.010</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Woerner</surname> <given-names>AC</given-names></name><name><surname>Frottin</surname> <given-names>F</given-names></name><name><surname>Hornburg</surname> <given-names>D</given-names></name><name><surname>Feng</surname> <given-names>LR</given-names></name><name><surname>Meissner</surname> <given-names>F</given-names></name><name><surname>Patra</surname> <given-names>M</given-names></name><name><surname>Tatzelt</surname> <given-names>J</given-names></name><name><surname>Mann</surname> <given-names>M</given-names></name><name><surname>Winklhofer</surname> <given-names>KF</given-names></name><name><surname>Hartl</surname> <given-names>FU</given-names></name><name><surname>Hipp</surname> <given-names>MS</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Cytoplasmic protein aggregates interfere with nucleocytoplasmic transport of protein and RNA</article-title><source>Science</source><volume>351</volume><fpage>173</fpage><lpage>176</lpage><pub-id pub-id-type="doi">10.1126/science.aad2033</pub-id><pub-id pub-id-type="pmid">26634439</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname> <given-names>D</given-names></name><name><surname>Farmer</surname> <given-names>A</given-names></name><name><surname>Collett</surname> <given-names>G</given-names></name><name><surname>Grishin</surname> <given-names>NV</given-names></name><name><surname>Chook</surname> <given-names>YM</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Sequence and structural analyses of nuclear export signals in the NESdb database</article-title><source>Molecular Biology of the Cell</source><volume>23</volume><fpage>3677</fpage><lpage>3693</lpage><pub-id pub-id-type="doi">10.1091/mbc.e12-01-0046</pub-id><pub-id pub-id-type="pmid">22833565</pub-id></element-citation></ref><ref id="bib85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yachdav</surname> <given-names>G</given-names></name><name><surname>Kloppmann</surname> <given-names>E</given-names></name><name><surname>Kajan</surname> <given-names>L</given-names></name><name><surname>Hecht</surname> <given-names>M</given-names></name><name><surname>Goldberg</surname> <given-names>T</given-names></name><name><surname>Hamp</surname> <given-names>T</given-names></name><name><surname>Hönigschmid</surname> <given-names>P</given-names></name><name><surname>Schafferhans</surname> <given-names>A</given-names></name><name><surname>Roos</surname> <given-names>M</given-names></name><name><surname>Bernhofer</surname> <given-names>M</given-names></name><name><surname>Richter</surname> <given-names>L</given-names></name><name><surname>Ashkenazy</surname> <given-names>H</given-names></name><name><surname>Punta</surname> <given-names>M</given-names></name><name><surname>Schlessinger</surname> <given-names>A</given-names></name><name><surname>Bromberg</surname> <given-names>Y</given-names></name><name><surname>Schneider</surname> <given-names>R</given-names></name><name><surname>Vriend</surname> <given-names>G</given-names></name><name><surname>Sander</surname> <given-names>C</given-names></name><name><surname>Ben-Tal</surname> <given-names>N</given-names></name><name><surname>Rost</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>PredictProtein--an open resource for online prediction of protein structural and functional features</article-title><source>Nucleic Acids Research</source><volume>42</volume><fpage>W337</fpage><lpage>W343</lpage><pub-id pub-id-type="doi">10.1093/nar/gku366</pub-id><pub-id pub-id-type="pmid">24799431</pub-id></element-citation></ref><ref id="bib86"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamada</surname> <given-names>J</given-names></name><name><surname>Phillips</surname> <given-names>JL</given-names></name><name><surname>Patel</surname> <given-names>S</given-names></name><name><surname>Goldfien</surname> <given-names>G</given-names></name><name><surname>Calestagne-Morelli</surname> <given-names>A</given-names></name><name><surname>Huang</surname> <given-names>H</given-names></name><name><surname>Reza</surname> <given-names>R</given-names></name><name><surname>Acheson</surname> <given-names>J</given-names></name><name><surname>Krishnan</surname> <given-names>VV</given-names></name><name><surname>Newsam</surname> <given-names>S</given-names></name><name><surname>Gopinathan</surname> <given-names>A</given-names></name><name><surname>Lau</surname> <given-names>EY</given-names></name><name><surname>Colvin</surname> <given-names>ME</given-names></name><name><surname>Uversky</surname> <given-names>VN</given-names></name><name><surname>Rexach</surname> <given-names>MF</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>A bimodal distribution of two distinct categories of intrinsically disordered structures with separate functions in FG nucleoporins</article-title><source>Molecular &amp; Cellular Proteomics</source><volume>9</volume><fpage>2205</fpage><lpage>2224</lpage><pub-id pub-id-type="doi">10.1074/mcp.M000035-MCP201</pub-id></element-citation></ref><ref id="bib87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yin</surname> <given-names>S</given-names></name><name><surname>Lopez-Gonzalez</surname> <given-names>R</given-names></name><name><surname>Kunz</surname> <given-names>RC</given-names></name><name><surname>Gangopadhyay</surname> <given-names>J</given-names></name><name><surname>Borufka</surname> <given-names>C</given-names></name><name><surname>Gygi</surname> <given-names>SP</given-names></name><name><surname>Gao</surname> <given-names>FB</given-names></name><name><surname>Reed</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Evidence that C9ORF72 dipeptide repeat proteins associate with U2 snRNP to cause Mis-splicing in ALS/FTD patients</article-title><source>Cell Reports</source><volume>19</volume><fpage>2244</fpage><lpage>2256</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2017.05.056</pub-id><pub-id pub-id-type="pmid">28614712</pub-id></element-citation></ref><ref id="bib88"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoshizawa</surname> <given-names>T</given-names></name><name><surname>Ali</surname> <given-names>R</given-names></name><name><surname>Jiou</surname> <given-names>J</given-names></name><name><surname>Fung</surname> <given-names>HYJ</given-names></name><name><surname>Burke</surname> <given-names>KA</given-names></name><name><surname>Kim</surname> <given-names>SJ</given-names></name><name><surname>Lin</surname> <given-names>Y</given-names></name><name><surname>Peeples</surname> <given-names>WB</given-names></name><name><surname>Saltzberg</surname> <given-names>D</given-names></name><name><surname>Soniat</surname> <given-names>M</given-names></name><name><surname>Baumhardt</surname> <given-names>JM</given-names></name><name><surname>Oldenbourg</surname> <given-names>R</given-names></name><name><surname>Sali</surname> <given-names>A</given-names></name><name><surname>Fawzi</surname> <given-names>NL</given-names></name><name><surname>Rosen</surname> <given-names>MK</given-names></name><name><surname>Chook</surname> <given-names>YM</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Nuclear import receptor inhibits phase separation of FUS through binding to multiple sites</article-title><source>Cell</source><volume>173</volume><fpage>693</fpage><lpage>705</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2018.03.003</pub-id><pub-id pub-id-type="pmid">29677513</pub-id></element-citation></ref><ref id="bib89"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>K</given-names></name><name><surname>Donnelly</surname> <given-names>CJ</given-names></name><name><surname>Haeusler</surname> <given-names>AR</given-names></name><name><surname>Grima</surname> <given-names>JC</given-names></name><name><surname>Machamer</surname> <given-names>JB</given-names></name><name><surname>Steinwald</surname> <given-names>P</given-names></name><name><surname>Daley</surname> <given-names>EL</given-names></name><name><surname>Miller</surname> <given-names>SJ</given-names></name><name><surname>Cunningham</surname> <given-names>KM</given-names></name><name><surname>Vidensky</surname> <given-names>S</given-names></name><name><surname>Gupta</surname> <given-names>S</given-names></name><name><surname>Thomas</surname> <given-names>MA</given-names></name><name><surname>Hong</surname> <given-names>I</given-names></name><name><surname>Chiu</surname> <given-names>SL</given-names></name><name><surname>Huganir</surname> <given-names>RL</given-names></name><name><surname>Ostrow</surname> <given-names>LW</given-names></name><name><surname>Matunis</surname> <given-names>MJ</given-names></name><name><surname>Wang</surname> <given-names>J</given-names></name><name><surname>Sattler</surname> <given-names>R</given-names></name><name><surname>Lloyd</surname> <given-names>TE</given-names></name><name><surname>Rothstein</surname> <given-names>JD</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>The C9orf72 repeat expansion disrupts nucleocytoplasmic transport</article-title><source>Nature</source><volume>525</volume><fpage>56</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.1038/nature14973</pub-id><pub-id pub-id-type="pmid">26308891</pub-id></element-citation></ref><ref id="bib90"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>YJ</given-names></name><name><surname>Gendron</surname> <given-names>TF</given-names></name><name><surname>Grima</surname> <given-names>JC</given-names></name><name><surname>Sasaguri</surname> <given-names>H</given-names></name><name><surname>Jansen-West</surname> <given-names>K</given-names></name><name><surname>Xu</surname> <given-names>YF</given-names></name><name><surname>Katzman</surname> <given-names>RB</given-names></name><name><surname>Gass</surname> <given-names>J</given-names></name><name><surname>Murray</surname> <given-names>ME</given-names></name><name><surname>Shinohara</surname> <given-names>M</given-names></name><name><surname>Lin</surname> <given-names>WL</given-names></name><name><surname>Garrett</surname> <given-names>A</given-names></name><name><surname>Stankowski</surname> <given-names>JN</given-names></name><name><surname>Daughrity</surname> <given-names>L</given-names></name><name><surname>Tong</surname> <given-names>J</given-names></name><name><surname>Perkerson</surname> <given-names>EA</given-names></name><name><surname>Yue</surname> <given-names>M</given-names></name><name><surname>Chew</surname> <given-names>J</given-names></name><name><surname>Castanedes-Casey</surname> <given-names>M</given-names></name><name><surname>Kurti</surname> <given-names>A</given-names></name><name><surname>Wang</surname> <given-names>ZS</given-names></name><name><surname>Liesinger</surname> <given-names>AM</given-names></name><name><surname>Baker</surname> <given-names>JD</given-names></name><name><surname>Jiang</surname> <given-names>J</given-names></name><name><surname>Lagier-Tourenne</surname> <given-names>C</given-names></name><name><surname>Edbauer</surname> <given-names>D</given-names></name><name><surname>Cleveland</surname> <given-names>DW</given-names></name><name><surname>Rademakers</surname> <given-names>R</given-names></name><name><surname>Boylan</surname> <given-names>KB</given-names></name><name><surname>Bu</surname> <given-names>G</given-names></name><name><surname>Link</surname> <given-names>CD</given-names></name><name><surname>Dickey</surname> <given-names>CA</given-names></name><name><surname>Rothstein</surname> <given-names>JD</given-names></name><name><surname>Dickson</surname> <given-names>DW</given-names></name><name><surname>Fryer</surname> <given-names>JD</given-names></name><name><surname>Petrucelli</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>C9ORF72 poly(GA) aggregates sequester and impair HR23 and nucleocytoplasmic transport proteins</article-title><source>Nature Neuroscience</source><volume>19</volume><fpage>668</fpage><lpage>677</lpage><pub-id pub-id-type="doi">10.1038/nn.4272</pub-id><pub-id pub-id-type="pmid">26998601</pub-id></element-citation></ref><ref id="bib91"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>YJ</given-names></name><name><surname>Gendron</surname> <given-names>TF</given-names></name><name><surname>Ebbert</surname> <given-names>MTW</given-names></name><name><surname>O'Raw</surname> <given-names>AD</given-names></name><name><surname>Yue</surname> <given-names>M</given-names></name><name><surname>Jansen-West</surname> <given-names>K</given-names></name><name><surname>Zhang</surname> <given-names>X</given-names></name><name><surname>Prudencio</surname> <given-names>M</given-names></name><name><surname>Chew</surname> <given-names>J</given-names></name><name><surname>Cook</surname> <given-names>CN</given-names></name><name><surname>Daughrity</surname> <given-names>LM</given-names></name><name><surname>Tong</surname> <given-names>J</given-names></name><name><surname>Song</surname> <given-names>Y</given-names></name><name><surname>Pickles</surname> <given-names>SR</given-names></name><name><surname>Castanedes-Casey</surname> <given-names>M</given-names></name><name><surname>Kurti</surname> <given-names>A</given-names></name><name><surname>Rademakers</surname> <given-names>R</given-names></name><name><surname>Oskarsson</surname> <given-names>B</given-names></name><name><surname>Dickson</surname> <given-names>DW</given-names></name><name><surname>Hu</surname> <given-names>W</given-names></name><name><surname>Gitler</surname> <given-names>AD</given-names></name><name><surname>Fryer</surname> <given-names>JD</given-names></name><name><surname>Petrucelli</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Poly(GR) impairs protein translation and stress granule dynamics in C9orf72-associated frontotemporal dementia and amyotrophic lateral sclerosis</article-title><source>Nature Medicine</source><volume>24</volume><fpage>1136</fpage><lpage>1142</lpage><pub-id pub-id-type="doi">10.1038/s41591-018-0071-1</pub-id><pub-id pub-id-type="pmid">29942091</pub-id></element-citation></ref><ref id="bib92"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>YJ</given-names></name><name><surname>Guo</surname> <given-names>L</given-names></name><name><surname>Gonzales</surname> <given-names>PK</given-names></name><name><surname>Gendron</surname> <given-names>TF</given-names></name><name><surname>Wu</surname> <given-names>Y</given-names></name><name><surname>Jansen-West</surname> <given-names>K</given-names></name><name><surname>O'Raw</surname> <given-names>AD</given-names></name><name><surname>Pickles</surname> <given-names>SR</given-names></name><name><surname>Prudencio</surname> <given-names>M</given-names></name><name><surname>Carlomagno</surname> <given-names>Y</given-names></name><name><surname>Gachechiladze</surname> <given-names>MA</given-names></name><name><surname>Ludwig</surname> <given-names>C</given-names></name><name><surname>Tian</surname> <given-names>R</given-names></name><name><surname>Chew</surname> <given-names>J</given-names></name><name><surname>DeTure</surname> <given-names>M</given-names></name><name><surname>Lin</surname> <given-names>WL</given-names></name><name><surname>Tong</surname> <given-names>J</given-names></name><name><surname>Daughrity</surname> <given-names>LM</given-names></name><name><surname>Yue</surname> <given-names>M</given-names></name><name><surname>Song</surname> <given-names>Y</given-names></name><name><surname>Andersen</surname> <given-names>JW</given-names></name><name><surname>Castanedes-Casey</surname> <given-names>M</given-names></name><name><surname>Kurti</surname> <given-names>A</given-names></name><name><surname>Datta</surname> <given-names>A</given-names></name><name><surname>Antognetti</surname> <given-names>G</given-names></name><name><surname>McCampbell</surname> <given-names>A</given-names></name><name><surname>Rademakers</surname> <given-names>R</given-names></name><name><surname>Oskarsson</surname> <given-names>B</given-names></name><name><surname>Dickson</surname> <given-names>DW</given-names></name><name><surname>Kampmann</surname> <given-names>M</given-names></name><name><surname>Ward</surname> <given-names>ME</given-names></name><name><surname>Fryer</surname> <given-names>JD</given-names></name><name><surname>Link</surname> <given-names>CD</given-names></name><name><surname>Shorter</surname> <given-names>J</given-names></name><name><surname>Petrucelli</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Heterochromatin anomalies and double-stranded RNA accumulation underlie <italic>C9orf72</italic> poly(PR) toxicity</article-title><source>Science</source><volume>363</volume><elocation-id>eaav2606</elocation-id><pub-id pub-id-type="doi">10.1126/science.aav2606</pub-id><pub-id pub-id-type="pmid">30765536</pub-id></element-citation></ref><ref id="bib93"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname> <given-names>Y</given-names></name><name><surname>Liu</surname> <given-names>TW</given-names></name><name><surname>Madden</surname> <given-names>Z</given-names></name><name><surname>Yuzwa</surname> <given-names>SA</given-names></name><name><surname>Murray</surname> <given-names>K</given-names></name><name><surname>Cecioni</surname> <given-names>S</given-names></name><name><surname>Zachara</surname> <given-names>N</given-names></name><name><surname>Vocadlo</surname> <given-names>DJ</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Post-translational O-GlcNAcylation is essential for nuclear pore integrity and maintenance of the pore selectivity filter</article-title><source>Journal of Molecular Cell Biology</source><volume>8</volume><fpage>2</fpage><lpage>16</lpage><pub-id pub-id-type="doi">10.1093/jmcb/mjv033</pub-id><pub-id pub-id-type="pmid">26031751</pub-id></element-citation></ref><ref id="bib94"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zu</surname> <given-names>T</given-names></name><name><surname>Liu</surname> <given-names>Y</given-names></name><name><surname>Bañez-Coronel</surname> <given-names>M</given-names></name><name><surname>Reid</surname> <given-names>T</given-names></name><name><surname>Pletnikova</surname> <given-names>O</given-names></name><name><surname>Lewis</surname> <given-names>J</given-names></name><name><surname>Miller</surname> <given-names>TM</given-names></name><name><surname>Harms</surname> <given-names>MB</given-names></name><name><surname>Falchook</surname> <given-names>AE</given-names></name><name><surname>Subramony</surname> <given-names>SH</given-names></name><name><surname>Ostrow</surname> <given-names>LW</given-names></name><name><surname>Rothstein</surname> <given-names>JD</given-names></name><name><surname>Troncoso</surname> <given-names>JC</given-names></name><name><surname>Ranum</surname> <given-names>LP</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>RAN proteins and RNA foci from antisense transcripts in C9ORF72 ALS and frontotemporal dementia</article-title><source>PNAS</source><volume>110</volume><fpage>E4968</fpage><lpage>E4977</lpage><pub-id pub-id-type="doi">10.1073/pnas.1315438110</pub-id><pub-id pub-id-type="pmid">24248382</pub-id></element-citation></ref></ref-list></back><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.51685.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group><contrib contrib-type="editor"><name><surname>Cleveland</surname><given-names>Don W</given-names></name><role>Reviewing Editor</role><aff><institution>University of California, San Diego</institution><country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text><p>In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.</p></boxed-text><p><bold>Acceptance summary:</bold></p><p>We recognize that you and your colleagues have taken the earlier advice from our reviewers seriously. We believe that the revised manuscript represents a sophisticated set of approaches to identify how the two arginine containing polydipetide repeat proteins encoded by the ALS-causing repeat expansion in <italic>C9orf72</italic> affect nuclear import and will be of interest to a broad audience.</p><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;<italic>C9orf72</italic> arginine-rich dipeptide repeat proteins disrupt importin β-mediated nuclear import&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by three peer reviewers, one of whom is a member of our Board of Reviewing Editors, and the evaluation has been overseen Huda Zoghbi as the Senior Editor. The reviewers have opted to remain anonymous.</p><p>The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.</p><p>Summary:</p><p>The reviewers agree that your work represents a comprehensive, sophisticated, well-designed set of experimental efforts that test how the arginine containing polydipeptide repeat (R-DPRs) proteins produced in an inherited form of ALS affect nucleocytoplasmic transport. All reviewers agreed that the FRET and biochemical assays, including in situ permeabilized cell reconstitutions, do establish a direct interaction with importin β which disrupts its cargo loading, and correspondingly, inhibiting nuclear import in a manner that can be diminished by increasing RNA concentration (with the RNA presumably competing with importin β for R-DPR binding). Additionally, your efforts support that transport inhibition is not through sequestration of nuclear import components or blockage of the nuclear pore complex. One reviewer reported that the text and figures have been beautifully prepared, producing a compelling manuscript that was a pleasure to read.</p><p>That said, there are areas where we would like further clarification.</p><p>Essential revisions:</p><p>1) Your effort begins by probing a link between R-DPRs and importin β, and the first few figures appear to confirm this link as being important for interruption of NCT in <italic>C9ALS</italic>. However, subsequent experiments argue against this mechanism, and indicate that the action of GR differs from that of PR. By the end, we felt as if the original hypothesis had been disproved to some degree, but an alternative hypothesis had not been presented or adequately explored. The result was some confusion over what, precisely, R-DPRs are doing and how their actions result in NCT impairment.</p><p>2) The experiments raise several questions that are not addressed in the text or in subsequent investigations. These include:</p><p>a) The modest effect of PA and GA upon NCT (Figure 1K);</p><p>b) The inhibition of Trp1-mediated NCT (Figure 1L) which argues against importin β as a mechanism of action; the inconsistent effects of R-DPR length, particularly with regards to the Rango reporter (Figure 1—figure supplement 2B, C);</p><p>c) The troublesome nonspecific binding of GR/PR in Figures 2 and 3;</p><p>d) The increase in PR binding with addition of lysate (Figure 2);</p><p>e) The apparent increase in passive NCT flux with PR/GR (Figure 3); and</p><p>f) The isolation of more proteins by GR than by PR (Figure 4B) despite the more pronounced effect of PR in most assays.</p><p>3) The DPRs used in this study are considerably shorter than those observed in patients. Indeed, the purified DPRs used in this study are 10-mers and 20-mers, well within the normal range for non-ALS individuals, and used at μM amounts. Even though there is evidence of toxicity with these repeat sizes in various cellular systems, exploration of key aspects of this mechanism in the context of repeat sizes more reflective of those observed in patients should be considered.</p><p>4) The majority of assays are executed in HeLa cells. Given data that there may be important differences in NCT in different cell types, the main claims should be explored in neurons; if not at least discussed.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.51685.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>1) Your effort begins by probing a link between R-DPRs and importin β, and the first few figures appear to confirm this link as being important for interruption of NCT in C9ALS. However, subsequent experiments argue against this mechanism, and indicate that the action of GR differs from that of PR. By the end, we felt as if the original hypothesis had been disproved to some degree, but an alternative hypothesis had not been presented or adequately explored. The result was some confusion over what, precisely, R-DPRs are doing and how their actions result in NCT impairment.</p></disp-quote><p>Thank you for this feedback. It seems that in trying to be very clear about the model, we oversimplified things, both in terms of the expected differences between GR and PR and the narrow focus on importin β. Indeed, the action of GR clearly differs from PR, throughout our current study and in other recent publications. Moreover, while we focused on the possibility that importin β could be targeted by R-DPRs that mimic its cargoes, we assume that in parallel, R-DPRs could disrupt other nuclear transport receptors (karyopherins), as supported by our transportin (M9) data. All of this would be predicted based on the divergent molecular properties of GR and PR and the role of basic residues in nuclear import complex formation. We have therefore changed the title from “importin β” to “karyopherin” and made major edits throughout the manuscript reflecting both of the above topics.</p><p>Based on their structure and published studies, the differing behavior of GR and PR is not surprising. On one hand, both are positively charged (theoretical π = 12.95 for PR10 and GR10), with a predicted disordered state and polynucleotide-binding activity (https://predictprotein.org/; Yachdav et al., 2014). However, because glycine is conformationally flexible and its side chain is comprised of a single hydrogen, while the integrated proline cyclic side-chain induces a rigid bend in the peptide backbone, poly-GR is predicted to accommodate many different macromolecular ligands, while poly-PR may be more selective. As recently reviewed by Freibaum and Taylor, 2017, GR and PR have differing half-lives, differing intracellular localization, and differing properties with regard to stress granule dynamics and mitochondrial function. Moreover, in yeast the modifiers of GR and PR toxicity showed little overlap (Chai and Gitler, 2018).</p><p>Accordingly, although both GR and PR showed low nanomolar displacement of importin β from the Rango (IBB) FRET sensor (Figure 1D-FRET), in the presence of cell lysate, PR had greater potency for inhibiting importin- and transportin-mediated nuclear import (Figure 1-permeabilized cell assays), higher relative selectivity for importin β (Figure 2C-D-bead halo assays), and differing behavior with respect to the soluble phase of nuclear import (Figure 5C-permeabilized cell assays). Although not quantitative in this regard, our mass spectrometry results showed 21% of hits uniquely bound GR10, and 11% PR10. This was even higher at 35% (GR50) and 25% (PR50) unique hits in the data set from Lee and colleagues (2016). We have edited the manuscript to discuss the differences between GR and PR in our assays and how that relates to the conclusions. Namely, that although in a purified system both of the R-DPRs show a similar propensity to bind importin β (unlike GP, GA, and PA), in the more complex environment of the cell, our findings predict PR to be the more potent disruptor.</p><p>In summary, our results do support our initial hypothesis <italic>vis-à-vis</italic> importin β, although we find that PR acts as a more selective inhibitor relative to GR, and there are broader implications of our findings for other karyopherins.</p><disp-quote content-type="editor-comment"><p>2) The experiments raise several questions that are not addressed in the text or in subsequent investigations. These include:</p><p>a) The modest effect of PA and GA upon NCT (Figure 1K);</p></disp-quote><p>In permeabilized primary neurons exposed to 100 µM GA10 and PA10, we saw a mild but statistically significant decrease in nuclear enrichment of the Rango import cargo at steady state (2 hours, Figure 1K). This was a late effect (&gt;30 min), as we did not see any separation from controls within the first 30 minutes of nuclear import (data added to Figure 1—figure supplement 1). The potential mechanism and physiologic relevance are not clear, given the high concentrations used and the lack of a similar effect in HeLa cells (Figure 1—figure supplement 2). In both cases the reaction mixture (cell lysate, cargo, and energy) is equivalent, therefore it is possible that high concentrations of GA and PA may somehow react differently with either the neuronal nuclear pore complexes or nuclear contents required for the transport reaction. In more complex in vitroand in vivomodel systems, GA has been proposed to sequester nuclear transport components (Khosravi et al., 2016; Zhang et al., 2016), although we did not observe that in the sedimentation assay when compared to R-DPRs at equivalent concentrations (Figure 4C). We have added additional comments to the Discussion.</p><disp-quote content-type="editor-comment"><p>b) The inhibition of Trp1-mediated NCT (Figure 1L) which argues against importin-ß as a mechanism of action; the inconsistent effects of R-DPR length, particularly with regards to the Rango reporter (Figure 1—figure supplement 2B, C);</p></disp-quote><p>The nuclear import and export pathways, including those that are mediated by transportin and importin β, do not operate in series, but rather simultaneously in parallel, and for a wide repertoire of distinct cargoes. In the revised manuscript, we describe how the known features of importin β/α and transportin NLSs, and the properties of R-DPRs, predict that R-DPRs could employ distinct mechanisms to disrupt cargo loading on both transportin and importin β, in parallel.</p><p>In case of transportin cargos, the positive charge of arginines in R-DPRs could promote their electrostatic interactions with the aromatic ring of the side chain of tyrosine (cation-pi interactions) which is the essential part of the PY-NLS of transportin. Since the PY-NLS also contains an N-terminal basic and R-containing region, R-DPRs could at the same bind transportin via cargo mimicry. Both mechanisms may be contributing. Although we focused on mechanistic implications for importin β, we did not want to overlook what we anticipated would be parallel biology affecting the transportin pathway. We have elaborated further on this issue, and have substituted “karyopherin” for “importin β” in the title, to reflect the importance of this observation.</p><disp-quote content-type="editor-comment"><p>c) The troublesome nonspecific binding of GR/PR in Figures 2 and 3;</p></disp-quote><p>The GR and PR peptides indeed showed a high propensity for nonspecific binding, as would be expected for these highly-charged peptides. To mitigate this, the bead halo assays were done at neutral pH with EDTA (to reduce cation-mediated interactions), NaCl (to disrupt weak ionic interactions), and Tween (to disrupt weak hydrophobic interactions). 10 mg/ml (150 µM) BSA was also included as an additional blocking agent. Nevertheless, such measures did not eliminate the nonspecific binding, either in this paradigm or in our attempts to optimize conventional immunoprecipitation assays with these peptides (not shown).</p><p>Within the techniques available to us, we found the bead halo assay to be the most reproducible and quantitative approach to account for this nonspecific binding. We have included well-defined positive and negative controls for expected specific binding, and bare beads as well as sham-coated beads (biotinylated BSA in Figure 2, and F→A mutant Nup116 in Figure 3), to quantify the level of nonspecific binding for valid comparison. Based on minor comment 13, we also added Figure 2—figure supplement 2, confirming the ability of free importin β to compete for R-DPR binding in a dose-dependent manner. This further supports the specificity of the binding.</p><p>Moreover, the effect of adding cell lysate in Figure 2 (marked by dotted lines in 2A, and graphed in 2C-D), precisely predicts the results of Figure 5 in the permeabilized cell assay. That is, in the context of cell lysate, PR retains its specific binding for importin β, whereas GR is consumed by binding to other targets (even the nonspecific binding goes away).</p><p>Additional comments about this have been added to the description of the bead halo results.</p><disp-quote content-type="editor-comment"><p>d) The increase in PR binding with addition of lysate (Figure 2);</p></disp-quote><p>This may be due to recruitment of additional importin β- and PR-binding partners from the cell lysate onto the beads, providing additional sites for AF488-PR to bind. We added this comment to the Results section describing these data.</p><disp-quote content-type="editor-comment"><p>e) The apparent increase in passive NCT flux with PR/GR (Figure 3); and</p></disp-quote><p>The acceleration of passive transport that we observed for PR and GR (but not for GP, GA, or PA, as has been added to Figure 3—figure supplement 1), was indeed surprising. There are several possible scenarios to explain this, outlined below and discussed in the revised manuscript. Please see also further comments under minor comment #14.</p><p>Studies in yeast suggest that to pass through the NPC, cargos must overcome collisions with highly mobile, disordered FG domains, particularly the Nup98 homologues Nup100 and Nup116 (Timney et al., 2016). If R-DPRs target these FG domains, as indicated by the findings of Shi and colleagues (2017) and by our bead halo studies (Figure 3—figure supplement 2), this could drastically increase their positive charge or reduce their mobility, thus reducing their gate-keeping function. The passive cargo exclusion properties of the NPC have also been shown to depend on importin β. By superresolution microscopy, Ma and colleagues (2012) showed that when extra importin β accumulates within the NPCs, concentrating inside the peripherally-localized active transport zone, the central passive transport channel widens, thus allowing faster passive cargo flux. Alternatively, when Kapinos et al., 2017, monitored the passive cargo influx rate in permeabilized cells, they showed that when importin•cargo complexes were depleted from the NPC, the pore became functionally leaky. Although our permeabilized cell experiments indicated the R-DPR-induced accumulation of AF647-labeled importin β at the nuclear rim (Figure 5D), concomitant with the transport blockade, these assays did not apply sufficient resolution to conclude if importin β was accumulated in or depleted from NPC channels. Superresolution microscopy studies would be needed to show the precise site of importin β accumulation (cytoplasmic face or within the peripheral or central channel), to test which of the above effects may be contributing. Single molecule tracking of passive transport through NPCs would also aid in definitively establishing the precise effect of R-DPRs on putative opening of the NPC permeability barrier.</p><p>Nevertheless, our passive transport data (Figure 3) do not support the notion that R-DPRs induce block to nuclear transport by occluding the NPC transport channels. Such a conclusion is also strongly supported by the results of the “nuclei preincubation” experiment (Figure 5E-F), where the NPCs were exposed to high R-DPR concentration for 1h before the start of the nuclear import assay, and no deceleration of nuclear import was observed.</p><disp-quote content-type="editor-comment"><p>f) The isolation of more proteins by GR than by PR (Figure 4B) despite the more pronounced effect of PR in most assays.</p></disp-quote><p>This is explained by the structural differences in these two R-DPRs as discussed above in #1. Poly-GR is predicted to accommodate many different macromolecular ligands, while poly-PR is expected to be more selective, due to the marked difference in the flexibility of the peptide backbone. Our assays consistently demonstrate that PR has a higher selectivity for importin β in conditions mimicking the complex cellular milieu, consistent with the more pronounced inhibition of nuclear import.</p><disp-quote content-type="editor-comment"><p>3) The DPRs used in this study are considerably shorter than those observed in patients. Indeed, the purified DPRs used in this study are 10-mers and 20-mers, well within the normal range for non-ALS individuals, and used at μM amounts. Even though there is evidence of toxicity with these repeat sizes in various cellular systems, exploration of key aspects of this mechanism in the context of repeat sizes more reflective of those observed in patients should be considered.</p></disp-quote><p>The length of GR and PR in affected individuals remains unknown due to technical challenges in determining protein size. This issue aside, there is no evidence, to our knowledge, that RAN translation of &lt;30 <italic>C9orf72</italic> repeat sequences occurs in neurologically healthy individuals, nor has deposition of GR and PR been reported in individuals with normal <italic>C9orf72</italic> repeat length. Although all individuals possess short C9 RNA repeats, there are no data at this time to support the idea that non-ALS individuals express short DPRs.</p><p>The reviewers’ suggestion to try longer repeats is nevertheless very reasonable, and was why we compared 10mers to 20mers in the transport assays in Figure 1. The marked increase in transport inhibition that we observed for 20mers compared to 10mers does suggest that we would see even more potent effects at longer repeat lengths. However for both of the commercial entities we contracted with to make the peptides for this study, even producing 20mers by solid phase synthesis was technically challenging. Our own attempts at purifying recombinant DPRs in <italic>E. coli</italic> was met with significant difficulty. These remain very technically difficult experiments to do, due to the nature of these proteins.</p><disp-quote content-type="editor-comment"><p>4) The majority of assays are executed in HeLa cells. Given data that there may be important differences in NCT in different cell types, the main claims should be explored in neurons; if not at least discussed.</p></disp-quote><p>Certainly, we agree with the critical need to verify the major claims of this paper in neurons. That was the basis for our extensive efforts (shown in Figure 1 and the supplement) to optimize a method for selective permeabilization of neuronal nuclei. When we first encountered difficulty with the fragility of neurons compared to HeLa, we searched the literature and found no convincing reports of this assay in neurons. We then devised a novel method that allowed us to selectively permeabilize neurons without also rupturing the nuclear membrane. To our knowledge, this is the first convincing and reproducible use of the nuclear transport assay in permeabilized neurons.</p><p>Upon doing so, we observed that the effects of GR and PR on Rango nuclear import (the direct importin β cargo) were very reminiscent of that seen in HeLa. Having verified this, we did not see a scientific rationale for continuing to duplicate all assays in neurons, which is significantly more time- and resource-intensive.</p></body></sub-article></article>